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Abstract: The difluoromethylene (CF2) group has a strong tendency 
to adopt corner over edge locations in aliphatic macrocycles. In this 
study, the CF2 group has been introduced into musk relevant 
macrocyclic ketones. Nine civetone and five muscone analogues 
have been prepared by synthesis for structural and odour 
comparison. X-Ray studies indeed show that the CF2 groups 
influence ring structure and they give some insight into the preferred 
ring conformations, triggering a musk odour as determined in a 
professional perfumery environment. The historical conformational 
model of Bersuker et al. for musk fragrance generally holds, and 
structures that become distorted from this consensus, by the 
particular placement of the CF2 groups, lose their musk fragrance 
and become less pleasant.  
Introduction 
There has been a long interest in the molecular basis of 
perfumes and fragrances, and particularly, the relationship 
between molecular shape and the olfactory response.[1] Some of 
the most iconic fragrances are the musk odorants, a large family 
of natural and synthetic aliphatic macrocycles that have been 
widely used for their olfactory and fixative properties.[2] For 
instance, macrocyclic ketones (1 and 2) and lactones (3), 
aromatic nitro derivatives (4) or fused bi- and poly(hetero)cyclic 
compounds (5) all produce a well-defined musk odour, despite 
their structural diversity (Figure 1). This has complicated a 
rational understanding of structure-odour relationships.[3] In 
addition, it has been proposed that more than one musk 
receptor is involved in the recognition of these molecules.[4] 
Natural macrocyclic musk odorants, such as 1-3, are medium 
sized ring lactones and ketones, which are highly aliphatic and 
display significant conformational freedom. Attempts to constrain 
such compounds have resulted in limited success in deducing 
the optimal conformation for maximum odour effect. For 
example, bridging bonds have been introduced to achieve more 
rigid structures,[5] but this approach to constrain conformational 
freedom has resulted in weaker fragrances and has failed to 
identify clear musk-related conformations. 
 
Figure 1. Structures of diverse musk odorants. Macrocycles 1-3 are natural 
products whereas 4 and 5 are synthetic. 
The replacement of hydrogen for fluorine is a strategy used for 
altering the properties of organic compounds, which has been 
widely practiced in pharmaceuticals research.[6] We have been 
exploring the role of the CF2 group[7] in influencing aliphatic 
macrocyclic ring conformations.[8] For example, X-ray crystal 
structure analyses of cyclododecanes 6-8, which each contain 
two CF2 groups at different locations around the 12-membered 
ring, have shown that the CF2 groups only occupy corner 
positions of these rings in the solid state (Figure 2). For 
cyclododecanes 6 and 7, the CF2 groups stabilise a [3333][9] 
square conformation, as the fluorines are located at either 
adjacent or opposite corners of the square. However, in the case 
of cyclododecane 8, where the CF2 groups are positioned 1,6 to 
each other, this results in considerable distortion of the ring. A 
square structure for 8 would force one of the CF2 groups to an 
edge position, however, this is avoided and the ring distorts to 
create a new corner and a distorted rectangular conformation.  
This behaviour can be explained by two factors; the fluorines 
avoid edge locations because they are slightly larger than 
hydrogen and there is a steric cost to be paid in projecting a 
fluorine into the ring, as the fluorine will sterically impact in 
transannular interactions with internal methylene hydrogens. 
Also, the C−CF2−C angle (~118o) is significantly wider than the 
C−CH2−C angle (~112o). This angle widening is a general 
phenomenon which can be rationalised both by Bent’s rule[10] 
and valence shell electron pair repulsions (VSEPR) theory.[11] 
The angle widening relaxes 1,4-H-H intra-annular interactions 
across the corner sites. These two factors mutually reinforce a 
preference for the fluorines to adopt corner locations. These 
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observations have extended to the larger C14 and C16 rings, 
where various placements of CF2 groups dictate the preferred 
ring conformation as determined by X-ray structure analyses.[12] 
 
   
6 7 8 
Figure 2. X-ray crystal structures of 1,1,4,4-(6), 1,1,7,7-(7) and 1,1,6,6-(8) 
tetrafluorocyclododecanes. 
There are very few reports on the outcome of replacing 
hydrogen for fluorine in flavour and fragrance compounds. 
Schlosser and Michel reported that the smell (and taste) of the 
raspberry ketone 9a was not significantly affected by the 
presence of a fluorine at specific locations (9b-e), but that the 
smell was profoundly altered by methyl groups incorporated at 
the same positions (Figure 3).[13] Also, Schlosser and Michel 
reported that the musk odour of exaltone 10a was significantly 
changed in compound 10b when an α-hydrogen of the 
macrocyclic ketone was replaced by a fluorine (Figure 3).[14] The 
authors suggested that the fluorine may induce a deleterious 
change in ring conformation, although being adjacent to the 
ketone it may also have altered the electronic properties of the 
carbonyl group and its interactions with a receptor. 
 
Figure 3. Structures of mono-fluorinated odorants. 
These observations have led us to explore the impact of the 
incorporation of CF2 groups into natural musk macrocycles, with 
the substituent remote from the carbonyl. We have recently 
reported such analogues of the 14-membered musk lactone 3[15] 
and in that study, a preference for the CF2 groups to dictate 
corner positions was obvious in the preferred ring conformations. 
In order to extend the scope of this study we now describe the 
synthesis and structure of a range of CF2 containing analogues 
of the natural musk ketones, civetone 1 and (R)-muscone 2. 
These macrocyclic ketones are among the most widely 
recognised natural fragrances. 
Results and Discussion 
1. Civetone 
Civetone 1 (Figure 1) is a natural pheromone, which was first 
isolated from the African civet over a hundred years ago by 
Sack.[16] Civetone 1 has a musk scent and this pleasant olfactory 
property has made the natural product desirable. However, 
ethical and conservation concerns have led to protection of the 
African civet and as a consequence, the macrocycle has 
received significant synthesis attention.[17] Regarding structure 
and conformation, cis-civetone 1 is a solid at room temperature 
(m.p. 32 °C),[16] but the conformationally labile nature of the 
molecule has precluded successful X-ray crystallography. Odd-
membered rings are more difficult to crystallise than their even-
membered homologues. For civetone 1, a 2,4-dinitrophenyl 
hydrazone (DNP) derivative was required to successfully 
crystallise the macrocycle, and this resolved as two conformers 
1a and 1b (Figure 4).[18] In each case, the macrocycle adopts a 
pseudo-rectangular conformation with the hydrazone located at 
the head of the longer axis (Figure 4). A “straight” alignment of 
six methylenes defined by a corner at C7 is notable in each 
polymorph. 
  
   
cis-1a cis-1b trans-1 
                        
                11a                       11b 
Figure 4. Solid state (X ray) conformers of DNP-hydrazone derivatives of cis- 
and trans-civetone 1, and dihydrocivetone 11. 
The corresponding DNP-hydrazone derivative of the non-natural 
trans-1 isomer shows a less ordered overall conformation 
(Figure 4). The linear arrangement of the six methylenes 
observed in conformers 1a and 1b is distorted and the “straight” 
edge is now composed of seven methylene groups (Figure 4).[19] 
On the other hand, the natural product dihydrocivetone 11, with 
the double bond saturated (Scheme 1), is also a solid compound 
(m.p. 63 °C),[20] but there is no crystallographic information 
available. In this project, we prepared a synthetic sample of 
dihydrocivetone 11 by a ring closing metathesis (RCM)-
hydrogenation sequence (Scheme 1), and a suitable crystal of 
the dihydrocivetone DNP-hydrazone derivative was subjected to 
X-ray crystallographic analysis. The resultant structure also had 
two different conformers within the same unit cell, suggesting 






that they are close in energy (Figure 4). The first, 11a, has a 
similar conformation to the corresponding unsaturated 
counterparts, 1a and 1b, with an edge of six methylenes and 
corner locations at C7 and C10. The second, 11b, shows a 
wider pentagonal shape, with C1 located in a longer edge and 
with corners at C8 and C11 (Figure 4). 
 
Scheme 1. Synthesis of civetone 1 and dihydrocivetone 11. Reagents and 
conditions: (a) Grubbs' 1st generation catalyst (5 mol%), DCM, reflux, 2 h, 
33%; (b) H2, Pd(C) (10 mol%), EtOH, rt, overnight, 60%. 
With these structural insights in place, we then addressed CF2-
containing analogues. The fluorinated targets 13-21 emerged as 
candidate compounds for synthesis (Figure 5). They were 
designed on the assumption that the CF2 groups would prefer 
corner locations and that the preferred conformation in the 
crystalline state will be a low energy conformer. Furthermore, 
our working hypothesis assumes that the low energy conformers 
will be relevant in contributing to odour.[21] Some of the 
analogues 13-19 were designed to reinforce the consensus 
structures that emerged from the crystallography (Figure 4), 
whereas 20 and 21 were designed to be distorted relative to the 
consensus structures. It was envisaged that the selective 
replacement of the CH2 groups next to the cis-double bond of 
the civetone, by two CF2 groups could reinforce or mimic the ring 
constraint induced by the olefin moiety in compounds 13-16. The 
influence of the carbonyl group location on conformation might 
also be addressed by the preparation of the regioisomer pairs 
13/15 and 14/16. Compounds 17-19 should reinforce some of 
the crystallographic conformations by inducing corners in the 
macrocycle at C7 and C9. Conversely, fluorine substitution of 
compounds 20 and 21 should lead to distorted conformations by 
the creation of corners at positions not observed in the 
structures in Figure 4. 
 
Synthesis. The introduction of the 1,4-di-CF2 groups during the 
preparation of 13-16 was carried out by difluorination of 
propargylic ketones[22] and then RCM as the key synthesis steps 
(Scheme 2). The route started with a 2-iodoxybenzoic acid (IBX) 
oxidation of commercially-available alcohols 22 and 23 to afford 
aldehydes 24 and 25, respectively. Addition of 
ethynylmagnesium bromide to 24, followed by oxidation of the 
intermediate alcohol 26, gave propargylic ketone 27. The first 
gem-difluoromethylene group was introduced in a reaction with 
diethylaminosulfur trifluoride (DAST)[23] at 50 °C. The coupling of 
volatile alkyne 28 with previously prepared aldehyde 25, and 
subsequent oxidation of the intermediate alcohol, gave the 
second propargylic ketone 30, which was fluorinated under the 
same DAST conditions to give tetrafluoro-hydrocarbon 31.
Macrocyclisation was carried out by a RCM reaction with the 
Grubbs' 1st generation catalyst. The resultant 17-membered 
macrocycle 32 was obtained in good yield as a mixture of 
diastereoisomers (E/Z 2:1). A hydroboration-oxidation sequence 
afforded a 1:1 inseparable mixture of regioisomeric alcohols. 
Fortunately, direct oxidation of this mixture generated ketones 
33 and 34, which were readily separated by column 
chromatography. Interestingly, hydroboration occurred 
exclusively to the double bond, presumably because the four 
fluorine atoms deactivated the triple bond to borane attack. 
Acetylenic ketones 33 and 34 might be considered to be 
civetone analogues, however, they had no detectable odour. 
Finally, fluorinated targets 13 and 15 were prepared by partial 
hydrogenation of 33 and 34 under Lindlar conditions. The 
saturated dihydrocivetones 14 and 16 were obtained by 
complete catalytic hydrogenation of 33 and 34, respectively. 
Compounds 13-16 posessed a faint musk odour relative to our 
synthetic reference samples of civetone 1 and dihydrocivetone 
11. 
Mono-CF2 civetone analogue 17 was readily synthesised from 
nonadeca-1,18-dien-10-one 12[24] in four steps (Scheme 3). The 
open chain hydrocarbon 35 was obtained in modest yield, by 
treatment of 12 with DAST. Diene 35 was then subject to an 
RCM reaction to afford macrocycle 36 as a 1:8 mixture of 
cis/trans isomers. Finally, a hydroboration-oxidation/oxidation 
sequence of cyclic olefin 36 gave the desired macrocyclic 
ketone 17. Symmetry dictates that a single isomer was 
generated. A pleasant musk odour was observed for 
dihydrocivetone analogue 17. 
 
Figure 5. Target civetone analogue structures containing CF2 groups. 







Scheme 2. Synthesis of fluorinated civetone analogues containing the 1,4-di-
CF2 motif. Reagents and conditions: (a) IBX, DMSO, rt, overnight, 97% (n=5), 
87% (n=6); (b) Ethynylmagnesium bromide, THF, 0 °C → rt, 3 h, 66%; (c) IBX, 
DMSO, rt, overnight, 85%; (d) DAST, 50 °C, overnight, 63%; (e) 1) n-BuLi, 
THF, −78 °C → 0 °C, 1 h; 2) 25, 0 °C → rt, 1 h, 71%; (f) IBX, DMSO, rt, 
overnight, 82%; (g) DAST, 50 °C, overnight, 69%. (h) Grubbs' 1st generation 
catalyst (5 mol%), DCM, reflux, 24 h, 83%; (i) 1) BH3•SMe2, THF, 0 °C → rt, 
overnight; 2) EtOH, NaOH, H2O2, rt, 4 h; 3) IBX, DMSO, rt, overnight, 36%; (j) 
H2, Pd/BaSO4 (10 mol%), quinoline, Py, rt, overnight, 96%; (k) H2, Pd/BaSO4 
(10 mol%), quinoline, Py, rt, overnight, 81%; (l) H2, Pd(C) (10 mol%), EtOH, rt, 
overnight, 86%; (m) H2, Pd(C) (10 mol%), EtOH, rt, overnight, 79%. 
 
Scheme 3. Synthesis of the fluorinated civetone analogue containing a CF2 
group in C9. Reagents and conditions: (a) DAST, 50 °C, 3 days, 27%; (b) 
Grubbs' 1st generation catalyst (10 mol%), DCM, reflux, 3 h, 38%; (c) 1) BH3•
SMe2, THF, 0 °C → rt, overnight; 2) EtOH, NaOH, H2O2, rt, 4 h; 85%; (d) IBX, 
DMSO, rt, overnight, 61%. 
The syntheses of the mono-CF2 targets 18 and 19 were 
achieved following a similar strategy to that of 13-16 described 
above (Scheme 4). Initially, mono-protection of heptane-1,7-diol 
38 with the p-methoxybenzyl (PMB) group was carried out to 
generate alcohol 39, which was then oxidised to aldehyde 40. 
Treatment of 40 with allylmagnesium bromide, followed by 
oxidation of alcohol 41 with IBX afforded homoallylic ketone 42. 
This ketone was then treated with DAST to give the difluoro-
olefin 43. Deprotection, followed by oxidation of the released 
alcohol 44 gave aldehyde 45. The open chain ketone 47 was 
then prepared by addition of an in situ generated Grignard 
reagent, followed by oxidation of the resultant alcohol 46. RCM 
of 47 afforded the desired difluorinated civetone 18 as an 
inseparable mixture of diastereoisomers (E/Z, 3:1). Finally, 
catalytic hydrogenation of the double bond generated mono-CF2 
macrocyclic ketone 19. Both fluorinated compounds 18 and 19 
were musk odorants, showing a comparable odour intensity to 
reference compounds 1 and 11, respectively. 
Analogue 20 was prepared as illustrated in Scheme 4, following 
the same strategy employed for 19. Compound 20 displayed a 
distinct floral odour, but without the characteristic musk notes of 
1 and 11. 
 
Scheme 4. Synthesis of fluorinated civetone analogues containing a CF2 
group in C7 and C5. Reagents and conditions: (a) NaH, PMBCl, TBAI, THF, 
0 °C → 60 °C, overnight, 41% (n=5), 45% (n=3); (b) (COCl)2, DMSO, Et3N, 
DCM, −78 °C → 0 °C, 1 h, 98% (n=5,3); (c) Allylmagnesium bromide, THF, 
0 °C → rt, overnight, 58% (n=5), 46% (n=3); (d) IBX, DMSO, rt, overnight, 85% 
(n=5), 79% (n=3); (e) DAST, 50 °C, overnight, 43% (n=5), 34% (n=3); (f) DDQ, 
DCM/H2O, rt, overnight, 74% (n=5), 78% (n=3); (g) IBX, DMSO, rt, overnight, 
98% (n=5), 72% (n=3); (h) 1) 9-Bromonon-1-ene (for n=5) or 11-bromoundec-
1-ene (for n=3), Mg (turnings), I2 (trace), THF, reflux, 6 h; 2) 45 (n=5) or 55 
(n=3), rt, overnight, 62% (n=5), 49% (n=3); (i) IBX, DMSO, rt, overnight, 93% 
(n=5), 81% (n=3); (j) Grubbs' 1st generation catalyst (5 mol%), DCM, reflux, 3 
h, 46% (n=5), 64% (n=3); (k) H2, Pd(C) (10 mol%), EtOH, rt, overnight, 91% 
(n=5), 87% (n=3). 
The final dihydrocivetone target 21 was addressed, using 
dithiane chemistry by the route shown in Scheme 5. Bis-dithiane 
60 was prepared using two equivalents of lithiated 1,3-dithiane 
59 and 1,3-dibromopropane. This was followed by a double 
alkylation using n-butyllithium and then two equivalents of 7-
bromoheptene, to generate diene 61. Macrocyclisation of 61 by 
RCM gave the cyclic bis-dithiane 62 (E/Z 2:1) in a relatively 
good yield for such a reaction, perhaps promoted by a Thorpe-
Ingold type effect associated with the dithiane motifs.[7c] A 
hydroboration-oxidation sequence was successfully achieved to 
obtain the non-symmetrical alcohol 63. Direct difluorination[25] of 
63 with N-iodosuccinimide (NIS) and hydrogen fluoride in 
pyridine (HF·Py), was rather inefficient (14% yield), but afforded 
the tetrafluorinated alcohol 64. In an attempt to improve this 






fluorination step, a number of protection strategies for the 
alcohol were explored, but this was unproductive, giving only 
very complex reaction mixtures. Finally, oxidation of 64 with IBX 
gave the desired tetrafluorinated civetone 21. In contrast to the 
parent civetone 1 and dihydrocivetone 11, musk notes were not 
recognised at all for 19. The odour was significantly modified, 
having a non-pleasant solvent character (see ESI).[26] The 
distinctly different olfactory outcome for 20 and 21, relative to 
civetone 1, is consistent with the general hypothesis that these 
compounds were designed to adopt a distorted macrocyclic ring 
structure. 
 
Scheme 5. Synthesis of the fluorinated civetone analogue containing the 1,5-
di-CF2 motif. Reagents and conditions: (a) 1) n-BuLi, THF, −30 °C, 2 h; 2) 1,3-
dibromopropane, −30 °C → rt,  overnight, 62%; (b) 1) n-BuLi, THF, −30 °C → 
0 °C, 2 h; 2) 7-bromohept-1-ene, −30 °C → rt,  overnight, 60%; (c) Grubbs' 1st 
generation catalyst (5 mol%), DCM, reflux, 2 h, 58%; (d) 1) BH3·SMe2, THF, 
0 °C → rt, overnight; 2) EtOH, NaOH, H2O2, rt, 4 h, 97%;  (e) NIS, HF·Py, 
DCM, −78 °C → rt, overnight, 14%; (f) IBX, DMSO, rt, overnight, 59%. 
Structure-odour relationships. The X-ray structures of all of 
the synthesis targets were acquired, where possible, either as 
ketones or as their DNP derivatives. Macrocycles 12-17, and 21 
were crystalline and X-ray crystal structures were obtained 
directly for these ketones. Meanwhile, compounds 18-20 had to 
be derivatised to obtain X-ray crystal structure data. The 
structures for all of these compounds are shown in Figure 6. 
As anticipated, the CF2 groups occupy corner locations in all 
cases but one (structure DNP-20), and the group clearly 
influences the overall conformation of the macrocycles. The         
C−CF2−C angles are significantly wider (114.5°-118.9°) than 
those usually found in aliphatic chains, a feature previously 
observed.[7,8,12] Macrocyclic ketones 13 and 15 display almost 
identical ring conformations (Figure 6) and are very similar to 
that of civetone 1. The cis double bond is now located directly 
between the two corners, which are defined by the CF2 groups 
at C8 and C11, instead of lying in the arch created by C7-C11 as 
in cis-1a and cis-1b (Figure 4). The main difference between 
both regioisomers is the location of the carbonyl group in 13 
(similar to civetone 1) and for 15, displaced to the adjacent 
carbon on the top edge and pointing in the opposite direction. 
Dihydrocivetone derivatives 14 and 16 also mimic very closely 
the dihydrocivetone structure 11a (Figure 4). The presence of 
the fluorines at corners C7-C10 in regioisomer 16 reinforces the 
overall conformation observed for dihydrocivetone 11. Despite 
the very clear similarities in the conformation of these four 
analogues, relative to civetone 1 and dihydrocivetone 11, only a 
faint musk odour was observed for all of these compounds. 
Musk odours were retained but other parameters may impact on 
odour intensity, such as increasing the molecular mass and 
reducing volatility with the introduction of four fluorines.[27] 
 
   
13 (weak musk odour) 14 (weak musk odour) 15 (weak musk odour) 
  
 
16 (weak musk odour) 17 (musk odour) DNP-17 (musk odour) 
  
DNP-18 (musk odour) DNP-19 (musk odour) 
 
 
DNP-20 (no musk odour) 21 (no musk odour) 
Figure 6. Preferred solid-state conformations of fluorinated civetone 
derivatives. 
In the case of macrocycle 17 (Figure 6), the CF2 group 
reinforces a corner at C9 and has the same overall shape found 
for dihydrocivetone 11a (Figure 4). Ketone 17 retains an intense 
musk odour. Although compound 17 was a crystalline solid and 
an X-ray structure was obtained, the DNP-derivative of 17 was 
also analysed by X-ray to explore the influence of the hydrazone 






motif on ring conformation. These structures are shown in Figure 
6. Very different ring conformations are found. The CF2 groups 
occupy different corners relative to the long edge of six 
methylene groups, closer to structure 11b (Figure 4), suggesting 
that there is a relatively low energy barrier between these two 
ring arrangements, however, they retain a similar overall shape. 
Strikingly, a very regular, symmetric pentagonal conformation 
was obtained for the DNP-derivative of 20 (Figure 6). However, 
the unexpected observation in this case is that the structure 
locates the CF2 group at an edge and the carbonyl group 
(hydrazone) at a corner, a reversal of all other situations so 
far.[28] It must be assumed that conformations of 20 with the CF2 
at a corner location will impact negatively on an appropriate 
location for the carbonyl and the ring conformation rearranges 
as observed. Macrocyclic ketone 20 has no observable musk 
odour, which is again consistent with not being able to access 
ring conformations observed for 1 and 11. 
A very different and distinctive conformation in the solid state 
was found for compound 21 (Figure 6). The presence of the 1,5-
di-CF2 motif was designed to induce a C5 edge into the ring and 
this has imposed a distorted rectangular structure, quite different 
from the structures described so far. It is perhaps not surprising 
that ketone 21 is absent of a detectable musk note. 
Some general conclusions on the civetone ring structure, 
relative to odour can be made. Excluding compounds 20 and 21, 
the fluorinated analogues fit with the olfactophore model for 
musk activity described by Bersuker and co-workers.[29] This 
model proposed that a musk note requires a pseudo-rectangular 
structure with a slightly shorter horizontal axis (5-6 Å), a slightly 
longer vertical axis (6.2-7.2 Å) and the carbonyl (C=O) centered 
on a horizontal edge (Figure 7). Whilst the conformation of 
analogues 13-19 fits this model well, the distorted conformations 
of macrocycles 20 and 21 do not. 
 
Figure 7. Proposed structural features for macrocyclic musk odorants and 
ellipsoid-like shape of fluorinated targets 19 and 21 (DNP fragment was 
omitted to simplify the Figure). 
The more intense odour found in the mono-CF2 derivatives 17-
19 versus the weak musk character observed for the 1,4-di-CF2 
compounds 13-16 could reasonably be due to volatility. A 
comparative GC experiment was carried out (See ESI) in order 
to establish the relative volatility of the civetone macrocycles, 
and there was a tendency towards longer retention times for the 
tetrafluoroanalogues, particularly the olefins, although the 




(R)-Muscone 2 (Figure 1) was first discovered in 1906, isolated 
from the male musk deer, Moschus moschiferus.[30] The (S) 
enantiomer is described as having a poorer musk odour.[31] As a 
key perfumery component, (R)-2 has been the target of a 
number of total syntheses;[32] however, little work has been 
carried out on assessing muscone ring conformation and odour. 
(R)-Muscone 2 is a liquid at room temperature, and no X-ray 
crystallography of the parent macrocycle has been recorded. In 
1982, Bernardinelli and Gerdil prepared the DNP-derivative of 
muscone 2.[33] X-Ray crystal analysis revealed significant 
disorder, not unexpected for a 15-membered ring. Deconvolution 
of the diffraction data led to the conclusion that up to eight 
closely related, but different ring conformations were adopted by 
the (R)-muscone macrocycle in the solid state (Figure 8), 
indicative of a very flexible ring system. 
 
    
2a 2b 2c 2d 
    
2e 2f 2g 2h 
Figure 8. Proposed ring conformations 2a-2h of (R)-muscone from 
Bernardinelli and Gerdil’s X-ray study of the (R)-muscone-DNP derivative. 
As a start point to this study, a sample of (R)-muscone 2 was 
prepared by the route illustrated in Scheme 6, to reinvestigate 
the X-ray crystal structure analysis. This involved RCM of 65 
and then hydrogenation of the resultant olefin 66, following a 
previously described protocol.[34] Crystallography of the DNP 
derivative of (R)-2 gave a well resolved structure, as illustrated 




Scheme 6. Synthesis of (R)-muscone 2 and crystal structure of its DNP-
hydrazone derivative. Reagents and conditions: (a) Grubbs' 2nd generation 
catalyst (8 mol%), DCM, reflux, overnight, 30%; (b) H2, Pd(C) (10 mol%), 
MeOH, rt, overnight, 95%. 






In this structure the macrocycle has a regular pentagonal 
conformation with corners at the carbonyl group, the stereogenic 
centre and carbons C6, C9 and C13. Interestingly, none of the 
predicted structures of Bernardinelli and Gerdil[34] maps onto this 
structure, although all have a corner located at C-9 and 
conformers 2b, 2e, 2g and 2h (Figure 8) locate the methyl group 
of the stereogenic centre at corner locations. The earlier 
predictions had corner locations at C7/C12 rather than C6/C13 
as is observed in the new crystallographic data. In overview, it 
may be that all of these structures are close in energy and 
different crystallographic studies will find various conformations. 
It was attractive to explore the incorporation of CF2 groups into 
(R)-muscone 2 at different locations, but particularly covering C6 
to C10, as a strategy to influence and limit the conformational 
flexibility of the ring. To this end, the difluorinated muscone 
derivatives 67-71 were chosen as synthetic targets (Figure 9). 
The early X-ray data[33] indicated a corner at C9, thus 68 was 
selected as a target to stabilise this feature. Structures 67 and 
69 were selected to move this corner by one methylene group in 
each direction, to assess disruption of this feature. Many of the 
predicted conformations in Figure 8 have one edge which 
adopts a linear chain of five methylene groups from C-3 (the 
stereogenic centre) to C-7. For this reason, a CF2 group was 
engineered into the design of 70 at C7 to try to stabilise this 
aspect. In a similar manner, by placing the CF2 group at the C-6 
position in 71, it should be possible to mimic the conformation of 
the X-ray structure of the DNP derivative of (R)-2 shown in 
Scheme 6, where only four carbon atoms form the “side” of the 
structure from C-3 to C-6. 
 
Figure 9. Structures of synthetic (R)-muscone targets containing CF2 groups. 
Synthesis. In order to prepare the targets, a ring closing 
metathesis approach was again adopted, a strategy that has 
previously been employed for the synthesis of (R)-muscone 
2.[33a-f] The stereogenic centre can usefully be contributed from 
commercially-available (+)-citronellal 72. 
The synthesis of analogue 67 containing a CF2 group at C10 
was carried out as illustrated in Scheme 7. A key early reaction 
involved the conversion of alcohol 79 to bromide 80 by an Appel 
reaction.[27] Bromide 80 was then converted into the 
corresponding Grignard reagent for condensation with aldehyde 
81, itself derived from (+)-citronellal 72 as previously 
described.[33b] Alcohol 82 was generated as a 1:1 mixture of 
diastereoisomers, and then oxidation gave ketone 83. This 
ketone was subject to a RCM reaction to afford 84 as a 
separable E/Z mixture (1:1). To conclude this synthesis, 
macrocycles (E)-84 and (Z)-84 were independently 
hydrogenated to generate difluoro-muscone derivative 67. 
Ketone 67 exhibited a weak musk odour but, perhaps 
surprisingly, the trans-olefin precursor, (E)-84 displayed stronger 
musky notes. It was interesting to note a total absence of a 
musk odour when the cis-isomer (Z)-84 was assessed, 
indicating that the configuration of the double bond has a 
significant influence on the olfactory properties. 
 
Scheme 7. Synthesis of fluorinated muscone analogue containing a CF2 
group in C10. Reagents and conditions: (a) NaH, PMBCl, TBAI, THF, 0 °C → 
60 °C, overnight, 55%; (b) DMP, DCM, rt, overnight; (c) 1) 4-Bromo-1-butene, 
Mg (turnings), I2 (trace), Et2O, reflux, 2 h; 2) 74, 0 °C → rt, overnight, 52% 
(three steps); (d) DMP, DCM, rt, 2 h; (e) DAST, 50 °C, overnight, 67% (two 
steps); (f) DDQ, DCM/H2O, rt, 1 h, 81%; (g) CBr4, PPh3, DCM, 0 °C → rt, 
overnight, 75%; (h) 1) 80, Mg (turnings), I2 (trace), Et2O, reflux, 2 h; 2) 81, 0 °C 
→ rt, overnight, 43%; (i) DMP, DCM, rt, 1 h; (j) Grubbs' 1st generation catalyst 
(6 mol%), DCM, reflux, overnight, 52% (two steps); (k) H2, Pd(C) (10 mol%), 
MeOH, rt, overnight,  59% from (Z)-84; 79% from (E)-84. 
The synthesis of muscone 68 was addressed as illustrated in 
Scheme 8. The previously synthesised alcohol 44 (Scheme 4) 
was converted to bromide 85 by an Appel reaction, and was 
then used to prepare the corresponding Grignard reagent for 
condensation with aldehyde 81. This coupling gave alcohol 86 
as a 1:1 mixture of diastereoisomers. Oxidation to ketone 87 and 
then an RCM reaction gave macrocyclic ketone 88 as an E/Z 
mixture (2:1). Finally, catalytic hydrogenation of 88 afforded 
muscone 68. This compound had a weak musk note relative to 
our synthetic sample of muscone 2. 
 







Scheme 8. Synthesis of fluorinated muscone analogue containing a CF2 
group in C9. Reagents and conditions:  (a) CBr4, PPh3, DCM, 0 °C → rt, 
overnight, 67%. (b) 1) 85, Mg (turnings), I2 (trace), THF, reflux, 6 h; 2) 81, rt, 
overnight, 40%; (c) DMP, DCM, rt, 1 h; (d) Grubbs' 1st generation catalyst (6 
mol%), DCM, r.t., reflux, overnight, 94% (two steps); (e) H2, Pd(C) (10 mol%), 
MeOH, rt, overnight, 41%. 
8,8-Difluoromuscone 69 was prepared by coupling fluorinated 
aldehyde 96 with the enantiopure alkyl bromide 97,[35] as 
illustrated in Scheme 9. Aldehyde 96 was obtained in a similar 
manner to 45 (Scheme 4), but starting from the nonadiol 89. A 
Grignard reaction between these entities generated 98, which 
was then oxidised to ketone 99. RCM of 99 with the Hoveyda-
Grubbs' 2nd generation catalyst generated macrocycle 100 as 
an E/Z mixture (9:1). Finally, hydrogenation of the olefin gave 
muscone 69, which had a good musk profile. The unsaturated 
precursor 100 (E/Z, 9:1) had a nice musky odour too and the 
perfumers also detected an exaltone aspect with compound 69. 
The synthesis of difluoro muscone derivatives 70 and 71 
required modification of the chiral fragment. The preparation of 
70 from (R)-citronellal 72 is shown in Scheme 10. (R)-Citronellol 
101[30b] was PMB protected to give 102, then ozonolysis followed 
by a Wittig reaction gave terminal alkene 103. A hydroboration-
oxidation sequence afforded primary alcohol 104, which was 
sequentially oxidised and treated with a Grignard reagent 
derived from 4-bromo-1-butene to give alcohol 106. This alcohol 
was oxidised and fluorinated using DAST to generate 108. 
Ketone 112 was prepared after PMB deprotection followed by 
the sequence of reactions used to convert 104 to 107. Finally, 
macrocyclisation of 112 by RCM afforded a separable mixture of 
E/Z isomers (5:2) 113 that were hydrogenated to generate the 
target muscone 70. This ketone had only a very faint musk 
odour. 
The last compound prepared in this series was muscone 71 as 
illustrated in Scheme 11. Alkene 102 was subjected to 
ozonolysis, and the resultant aldehyde was treated with a 
Grignard reagent derived from 4-bromo-1-butene, to generate 
alcohol 114. This alcohol was oxidised to ketone 115 and was 
then fluorinated with DAST.  Deprotection gave alcohol 117, 
which was progressed by an oxidation, Grignard reaction, 
oxidation sequence to give ketone 119. An RCM reaction 
generated macrocycle 120 (E/Z 3:2) and then hydrogenation 
gave the target muscone 71. This molecule had a pleasant 
musky odour, very similar to synthetic (R)-muscone 2. 
 
Scheme 9. Synthesis of fluorinated muscone analogue containing a CF2 
group in C8. Reagents and conditions: (a) NaH, PMBCl, TBAI, THF, 0 °C → 
60 °C, overnight, 46%; (b) IBX, DMSO, rt, overnight,  80%; (c) Allylmagnesium 
bromide, THF, 0 °C → rt, overnight, 44%; (d) IBX, DMSO, rt, overnight, 83%.; 
(e) DAST, 50 °C, overnight, 63%; (f) DDQ, DCM/H2O, rt, 1 h, 69%; (g) IBX, 
DMSO, rt, overnight, 80%.; (h) 1) 97, Mg (turnings), I2 (trace), THF, reflux, 4 h; 
2) 96, rt, overnight, 60%; (i) IBX, DMSO, rt, overnight, 95%.; (j) Hoveyda-
Grubbs' 2nd generation catalyst (6 mol%), toluene, reflux, overnight, 56%; (k) 
H2, Pd(C) (10 mol%), MeOH, rt, overnight, 93%. 
Scheme 10. Synthesis of fluorinated muscone analogue containing a CF2 
group in C7. Reagents and conditions:  (a) NaH, PMBCl, TBAI, THF, 0 °C → 
60 °C, overnight, 82%; (b) 1) O3, DCM, -78 ºC, 30 min.; 2) PPh3, -78 ºC → rt, 
overnight; 3) n-BuLi, PMe(Ph)3Br, THF, -78 ºC → rt, overnight, 36%; (c) 1) 9-
BBN dimer, THF, rt, overnight; 2) EtOH, NaOH, H2O2, 0 ºC, 4 h, 99%; (d) DMP, 
DCM, rt, 2 h; (e) 4-Bromo-1-butene, Mg (turnings), I2 (trace), THF, reflux, 6 h; 
2) 105, rt, 16 h, 65% (two steps); (f) DMP, DCM, rt, 2 h; (g) DAST, 50 °C, 
overnight, 70% (two steps); (h) DDQ, DCM/H2O, rt, 1 h, 74%; (i) DMP, DCM, rt, 
1 h, 97%; (j) 1) 6-Bromo-1-hexene, Mg (turnings), I2 (trace), THF, reflux, 30 
min; 2) 110, 0 °C → rt, overnight, 72%; (k) DMP, DCM, rt, 1 h, 99%; (l) 
Grubbs' 1st generation catalyst (6 mol%), DCM, reflux, 46 h, 58%; (m) H2, 
Pd(C) (10 mol%), MeOH, rt, overnight, 72%. 







Scheme 11. Synthesis of fluorinated muscone analogue containing a CF2 
group in C6. Reagents and conditions:  (a) 1) O3, DCM, −78 ºC, 15 min.; 2) 
PPh3, −78 ºC → rt, overnight; 3) 4-Bromo-1-butene, Mg (turnings), I2 (traces), 
Et2O, reflux, 2 h; 4) Aldehyde, 0 °C → rt, overnight, 58%; (b) DMP, DCM, rt, 2 
h, 96%; (c) DAST, 50 °C, overnight, 64%; (d) DDQ, DCM/H2O, rt, 1 h, 88%; (e) 
1) DMP, DCM, rt, 1 h; 2) 7-Bromo-1-heptene, Mg (turnings), I2 (trace), Et2O, 
reflux, 2 h; 3) Aldehyde, 0 °C → rt, 4 h, 60%; (f) DMP, DCM, rt, 1 h; (g) 
Grubbs' 1st generation catalyst (6 mol%), DCM, reflux, overnight, 50% (two 
steps); (h) H2, Pd(C) (10 mol%), MeOH, rt, overnight,  65%. 
Structure-odour relationships. With muscones 67-71 in hand, 
it was of interest to obtain X-ray structural data where possible. 
Suitable crystals of ketones 67 and 70 were forthcoming, and 
DNP derivatives of ketones 68 and 69 were successfully 
prepared.  Some of the unsaturated RCM products, such as (Z)-
84, (E)-100 and (Z)-113 also proved amenable to crystallisation. 
The resultant solid state structures are shown in Figure 10.  
It is again clear that the CF2 groups adopt corner locations and 
induce some predictable order into the structures. Regarding 
muscone 67, a pseudo-rectangular conformation is apparent 
with corners at C10 (CF2) and C7 and the methyl group-
stereogenic centre is at a corner (Figure 10) similar to the 
conformers described by Bernardinelli and Gerdil (Figure 8).[34] 
This feature is also found in the DNP structure of synthetic 
muscone 2 (Scheme 7). These compounds all have weak musk 
odours. The RCM product cis-olefin 84 is interesting in that it 
has a regular rectangular structure; however, the carbonyl is 
unusually pointing into the ring suggesting some significance 
with respect to its lack of odour. On the other hand, the trans 
olefin (E)-84 has a good musk profile and presumably does not 
have this endo preference for the carbonyl. 
Ketone 70 has a similar conformation to that of 67, with a 
corner defined at C7. The carbonyl locates in the middle of an 
edge. Two conformers 70a and 70b were observed in the crystal 
structure, which differ only around the C10-C11 corner. 
Conformer 70b is very similar to that of the unsaturated 
macrocycle (Z)-113. The common features between saturated 
and unsaturated muscones fluorinated at C10 or C7, and the 
absence of a defined musky character in these derivatives, 
suggest this squareoid shape is less relevant than that of the 
more rectangular conformation for olfactory stimulation.  
On the other hand, the structure of DNP-68 showed the 
corresponding CF2-corner at C9. This conformation is virtually 
identical to 2d proposed by Bernardineli,[34] with the methyl group 
at an edge. A hint of musk was recognised with ketone 68.   
 
   
67 (weak musk odour) (Z)-84 (no musk odour) DNP-68 (weak musk odour) 
   
DNP-69 (musk odour) (E)-100a (musk odour) (E)-100b (musk odour) 
   
70a (very weak musk odour) 70b (very weak musk odour) (Z)-113 
Figure 10. X-Ray structures of fluorinated muscone derivatives. 
The structure of the DNP-derivative 69, has a distorted 
rectangular conformation as shown in Figure 10, with well 
defined corners at C11 and C8, and a corner formed at C3 by 
the stereogenic centre. The overall structure is strikingly similar 
to the rectangular civetone structures 13-19 in Figure 6, 
although the six methylenes forming the long edge in those 
compounds is shortened to five in this structure. Ketone 69 
exhibits a very good musk profile. The trans isomer (E)-100 was 
also analysed by X-ray and two different conformers (E)-100a 
and (E)-100b are observed in the unit cell, with a CF2 corner at 
C8 as shown in Figure 10. The overall rectangular shape is 
conserved in (E)-100a, and in (E)-100b the corner has moved 
from C11 to C12, defining a longer five carbon edge. Curiously, 
both structures have the stereogenic centre at an edge rather 
than a corner possibly dictated by the trans double bond.  
It was interesting to find ‘exaltone’ notes described by the 
perfumers for compound 69. Exaltone 10a 
(cyclopentanodecanone) is a natural 15-membered ketone 
structurally related to muscone 2, but without the stereogenic 
methyl group at C3 (Figure 11). The X-ray structure of the DNP 
derivative of 10a was solved by Fronczek and co-workers in 
2008 and is shown in Figure 11.[36] There is clearly a high level of 
homology between this conformation of exaltone 10a and the 
DNP derivative of 69 consistent with their odour relationship. 
These structures relate to the civetones 13-19 in Figure 6 too, 
with a five, rather than six, carbon long edge, due to the smaller 
ring size. Presumably, this overall shape could be close to a 
relevant bioactive conformation for 15-membered musk ketones. 








10a, Exaltone DNP-10a 
Figure 11. X-ray crystal structure of exaltone DNP-derivative. 
Conclusions 
In summary, a set of fluorinated civetone and muscone 
analogues with one or more CF2 groups placed at strategic 
positions of the ring have been prepared by synthesis. The 
conformation of all these molecules can be significantly 
influenced by the location of CF2 groups. Our study 
demonstrates that this motif has a clear preference for 
occupying corner locations across a wider range of more 
complex and functionalised macrocycles. The majority of the 
civetone and muscone analogues, and some of the olefin 
precursors which result from RCM reactions, retain a muskoid 
scent, as the structures reinforce the conformation of the natural 
ketones and fit the generalized Bersuker model. However, some 
structures emerged that do not retain a musk scent, such as 20 
and 21 of the civetone class. These compounds clearly have a 
distorted conformation relative to the parent compounds. 
Compound (Z)-84 of the muscone class, was also devoid of any 
distinctive scent, but conspicuously it has a carbonyl group 
pointing into the ring, the only such example in all of the X-ray 
structures. Also, there is a tendency for weaker muscone notes 
as the ring structures deviate from rectangular to square 
conformations comparing, for example, muscones 69 with 70. 
These observations offer structural information which contributes 
to our understanding of musk odorants. It follows that the utility 
of this conformational tool could be extended to other 
macrocycles in order to influence properties in other arenas. 
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All reactions were conducted under an atmosphere of argon using standard vacuum line techniques. All 
glassware was flamedried and allowed to cool under high vacuum. Reactions with fluorinating reagents 
(DAST or HF·Py) were carried out in a PTFE flask wich was oven dried and allowed to cool under high 
vacuum.  
 
All commercially availble reagents were purchased from Acros, Alfa Aesar, Fisher Scientific, 
Fluorochem or Sigma-Aldrich and used without further purification unless otherwise stated. Dry 
solvents were obtained from the MBraun SPS-800 Solvent Purification System, by passing the solvent 
through two drying columns under an argon atmosphere.   
 
Thin layer chromatography (TLC) was performed using Merck TLC silica gel 60 F254 aluminium-
backed plates. Compounds were visualised by either UV light (254 nm) or by the use of potassium 
permanganate stain or molybdenum-based stain. Column chromatography was performed using Merck 
silica gel 60 (40-63 µm).  
 
NMR spectra were acquired on a Bruker Avance III 500 spectrometer (1H at 500 MHz, 13C at 125 MHz, 
19F at 470.6 MHz). Chemical shifts (δ) are reported in parts per million (ppm) and are quoted relative to 
the residual peak of CDCl3. Coupling constants (J) are given in Hertz (Hz). Signal splitting patterns are 
described as: s, singlet; d, doublet; dd, doublet of doublets; ddd, doublet of doublets of doublets; t, 
triplet; tt, triplet of triplets; ddt, doublet of doublets of triplets; tdt, triplet of doublets of triplets; q, 
quartet; quint, quintet; m, multiplet; b, broad; AB, AB system; AA'XX', AA'XX' system. 
 
High and low resolution mass spectra were recorded at the EPSRC National Mass Spectrometry 
Service, Swansea or at the University of St Andrews by Caroline Horsburgh on a Waters Micromass 
LCT time of flight mass spectrometer coupled to a Waters 2975 HPLC system. Values are reported as a 
ratio of mass to charge (m/z). 
 
Infrared spectra were recorded on a Perkin Elmer Spectrum GX FT-IR system. 
 
Single crystal X-ray Diffraction analysis was carried out by Prof Alexandra M. Z. Slawin and Dr David 
Cordes at University of St Andrews. 
  
Melting points were determined in Pyrex capillaries using a Gallenkamp Griffin Melting Point 
Apparatus 350 and were uncorrected. 
  






Synthesis and Characterisation 
 
The following compounds were prepared according to previously described procedures: 12,1 22-31,2 39-
30,3 49-50,4 60,5 65,6 74-75,7 81,6 90-91,8 979 and 101.6 
 
Civetone (1). Grubbs’ 1st generation catalyst (20 mg, 0.02 mmol, 0.05 equiv.) was added to a stirred 
solution (protected from sunlight) of nonadeca-1,18-dien-10-one 12 (134 mg, 0.48 mmol, 1.0 equiv.) in 
dry DCM (25 mL) under argon atmosphere at room temperature. The mixture was heated at reflux 
temperature for 2 h. Then, the mixture was allowed to warm to room temperature and the solvent was 
removed under reduced pressure. Purification by column chromatography using silica gel (pentane/Et2O 
50:1) gave compound 1 (E/Z 3:1 inseparable mixture of diastereoisomers, 40 mg, 33%) as a colourless 
oil. (E)-1. 1H NMR (500 MHz, CDCl3) δ = 1.20-1.36 (16H, m, 8 x CH2), 1.58-1.66 (4H, m, 2 x CH2), 
2.01-2.02 (4H, m, 2 x CH2), 2.38 (4H, t, J(H,H)= 7.1 Hz, 2 x CH2), 5.28-5.32 (2H, m, 2 x =CH); 13C 
NMR (125 MHz, CDCl3) δ = 24.0 (2 x CH2), 27.4 (2 x CH2), 28.3 (2 x CH2), 28.76 (2 x CH2), 28.80 (2 
x CH2), 31.9 (2 x CH2), 42.5 (2 x CH2), 131.0 (2 x =CH), 213.3 (C=O); IR (thin film) ν (cm-1) = 1703 
(C=O); HRMS (CI+) m/z calcd for C17H32F2ON [M+NH4]+: 304.2446, found: 304.2449; (Z)-1. 1H NMR 
(500 MHz, CDCl3) δ = 1.20-1.36 (16H, m, 8 x CH2), 1.58-1.66 (4H, m, 2 x CH2), 2.01-2.02 (4H, m, 2 x 
CH2), 2.40 (4H, t, J(H,H)= 6.7 Hz, 2 x CH2), 5.33-5.38 (2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) 
δ = 23.8 (2 x CH2), 26.7 (2 x CH2), 28.1 (2 x CH2), 28.2 (2 x CH2), 28.6 (2 x CH2), 29.0 (2 x CH2), 42.4 
(2 x CH2), 130.1 (2 x =CH), 212.6 (C=O). These data are in good agreement with the literature values.10 
 
Dihydrocivetone (11). A mixture of 5% Pd/C (17 mg, 0.008 mmol, 0.1 equiv.) in 0.5 mL of absolute 
EtOH was stirred for a few minutes under a small positive pressure of H2. A solution of civetone 1 (20 
mg, 0.08 mmol, 1.0 equiv.) in 1.0 mL of absolute EtOH was added to the above mixture and the 
reaction was stirred overnight under H2 atmosphere at room temperature. Then, the catalyst was 
removed by filtration through a short pad of celite and washed with Et2O (56 mL). The solvent was 
removed under reduced pressure. Purification by column chromatography using silica gel 
(hexanes/EtOAc 15:1) gave compound 11 (12 mg, 60%) as a white solid; m.p. 61-63 ºC (lit.11 63-64 
ºC); 1H NMR (500 MHz, CDCl3) δ = 1.25-1.32 (24H, m, 12 x CH2), 1.60-1.64 (4H, m, 2 x CH2), 2.41 
(4H, t, J(H,H)= 6.8 Hz, 2 x CH2); 13C NMR (125 MHz, CDCl3) δ = 23.7 (2 x CH2), 26.8 (2 x CH2), 27.1 
(2 x CH2), 27.2 (2 x CH2), 27.5 (2 x CH2), 27.8 (2 x CH2), 28.2 (2 x CH2), 42.4 (2 x CH2), 212.6 (C=O); 
IR (thin film) ν (cm-1) = 1706 (C=O); HRMS (CI+) m/z calcd for C17H34F2ON [M+NH4]+: 306.2603, 
found: 306.2606. 
 
8,8,11,11-tetrafluorocycloheptadec-1-en-9-yne (32). Grubbs’ 1st generation catalyst (9 mg, 0.01 mmol, 
                                                
1 Marx, V. M.; Herbert, M. B.; Keitz, B. K.; Grubbs, R. H. J. Am. Chem. Soc. 2013, 135, 94. 
2 Wang, Y.; Callejo, R.; Slawin, A. M. Z.; O’Hagan, D. Belstein J. Org. Chem. 2014, 10, 18. 
3 Sui, B.; Yeh, E. A.-H.; Curran, D. P. J. Org. Chem. 2010, 75, 2942. 
4 Egger, J.; Fischer, S.; Bretscher, P.; Freigang, S.; Kopf, M.; Carreira, E. M. Org. Lett. 2015, 17, 4340. 
5 Skibiński, M.; Urbina-Blanco, C. A.; Slawin, A. M. Z.; Nolan, S. P.; O'Hagan, D. Org. Biomol. Chem., 2013, 
11, 8209. 
6 Kamat, V. P.; Hagiwara, H.; Katsumi, T.; Hoshi, T.; Suzuki, T.; Ando, M. Tetrahedron 2000, 56, 4397. 
7 Trost, B. M.; Grese, T. A.; Chan, D. M. T. J. Am. Chem. Soc. 1991, 113, 7350. 
8 Jaschinski, T.; Hiersemann, M. Org. Lett. 2012, 14, 4114. 
9 (a) Meiries, S.; Bartoli, A.; Decostanzi, M.; Parrain, J.-L.; Commeiras, L. Org. Biomol. Chem. 2013, 11, 4882. 
(b) Fürstner, A.; Leitner, A. Angew. Chem. Int. Ed. 2003, 42, 308. 
10 Rosebrugh, L. E.; Herbert, M. B.; Marx, V. M.; Keitz, B. K.; Grubbs, R. H. J. Am. Chem. Soc. 2013, 135, 
1276. 
11 Ruzicka, L. Helv. Chim. Acta 1926, 9, 230. 
 






0.05 equiv.) was added to a stirred solution (protected from sunlight) of 8,8,11,11-tetrafluorononadeca-
1,18-dien-9-yne 31 (72 mg, 0.21 mmol, 1.0 equiv.) in dry DCM (10.7 mL) under argon atmosphere at 
room temperature. The mixture was heated at reflux temperature for 24 h. Then, the mixture was 
allowed to warm to room temperature and the solvent was removed under reduced pressure. Purification 
by column chromatography using silica gel (hexanes) gave compound 32 (E/Z 2:1 inseparable mixture 
of diastereoisomers, 54 mg, 83%) as a colourless oil. (E)-32. 1H NMR (500 MHz, CDCl3) δ = 1.25-1.49 
(12H, m, 6 x CH2), 1.51-1.61 (2H, m, CH2), 2.01-2.18 (8H, m, 4 x CH2), 5.31-5.43 (2H, m, 2 x =CH); 
13C NMR (125 MHz, CDCl3) δ = 23.3 (t, J(C,F)= 3.7 Hz, CH2), 23.4 (t, J(C,F)= 3.4 Hz, CH2), 27.0 
(CH2), 27.1 (CH2), 27.39 (CH2), 27.41 (CH2), 29.5 (CH2), 31.1 (CH2), 31.6 (CH2), 38.5 (t, J(C,F)= 24.8 
Hz, CH2), 39.0 (t, J(C,F)= 25.8 Hz, CH2), 79.0 (tt, J(C,F)= 42.0, 6.4 Hz, ≡C), 79.5 (tt, J(C,F)= 42.0, 6.5 
Hz, ≡C), 114.5 (t, J(C,F)= 237 Hz, CF2), 114.7 (t, J(C,F)= 235 Hz, CF2), 130.7 (=CH), 131.2 (=CH); 
19F{1H} NMR (470 MHz, CDCl3) δ = -84.9 (2F, m, CF2), -85.4 (2F, m, CF2); (Z)-32. 1H NMR (500 
MHz, CDCl3) δ = 1.27-1.47 (12H, m, 6 x CH2), 1.51-1.60 (2H, m, CH2), 2.00-2.13 (8H, m, 4 x CH2), 
5.41-5.44 (2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 22.8 (t, J(C,F)= 3.7 Hz, CH2), 22.5 (t, 
J(C,F)= 3.8 Hz, CH2), 26.4 (CH2), 27.3 (CH2), 27.4 (CH2), 27.5 (CH2), 27.8 (CH2), 28.0 (CH2), 29.0 
(CH2), 38.5 (t, J(C,F)= 25.0 Hz, CH2), 38.9 (t, J(C,F)= 24.9 Hz, CH2), 78.9 (tt, J(C,F)= 41.7, 6.5 Hz, 
≡C), 79.2 (tt, J(C,F)= 41.8, 6.7 Hz, ≡C), 114.5 (t, J(C,F)= 235 Hz, CF2), 114.6 (t, J(C,F)= 235 Hz, CF2), 
130.0 (=CH), 130.1 (=CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -83.5 (2F, m, CF2), -83.9 (2F, m, 
CF2); HRMS (CI+) m/z calcd for C17H25F4 [M+H]+: 305.1887, found: 305.1889. 
  
8,8,11,11-tetrafluorocycloheptadec-9-yn-1-one (33) and 7,7,10,10-tetrafluorocycloheptadec-8-yn-1-
one (34). Borane dimethyl sulfide complex (0.1 mL, 2M solution in THF, 0.19 mmol, 1.25 equiv.) was 
added to a stirred solution of 8,8,11,11-tetrafluorocycloheptadec-1-en-9-yne 32 (47 mg, 0.15 mmol, 1.0 
equiv.) in dry THF (1.6 mL) under argon atmosphere at 0 ºC. The solution was warmed to room 
temperature and stirred overnight. Then, EtOH (0.1 mL), aq. NaOH (2 M, 0.1 mL) and aq. H2O2 (30% 
w/w, 0.1 mL) were sequentially added and the reaction mixture was stirred for 4 h. After evaporation of 
the volatiles, H2O (0.5 mL) was added and the solution was extracted with EtOAc (3 x 3.0 mL). The 
combined organic layers were washed with brine (3.0 mL), dried over MgSO4 and the solvent was 
removed under reduced pressure. The intermediate 1:1 mixture of alcohols was dissolved in DMSO (1.5 
mL) and IBX (86 mg, 0.31 mmol, 2.0 equiv.) was added at room temperature. The resulting mixture 
was stirred overnight. Then, H2O (3.5 mL) and EtOAc (3.5 mL) were sequentially added and the 
precipitated white solid was filtered and the filtrate collected. The organic layer was separated and 
washed with H2O (2 x 3.5 mL) and brine (3.5 mL), dried over anhydrous MgSO4 and the solvent was 
removed under reduced pressure. Separation by column chromatography using silica gel 
(hexanes/EtOAc 10:1) gave compound 33 (9.0 mg, 18%) as a colourless oil and compound 34 (9.0 mg, 
18%) as a colourless oil. 33. 1H NMR (500 MHz, CDCl3) δ = 1.26-1.37 (4H, m, 2 x CH2), 1.39-1.44 
(4H, m, 2 x CH2), 1.51-1.57 (4H, m, 2 x CH2), 1.65 (4H, quint, J(H,H)= 7.1 Hz, 2 x CH2), 2.01-2.11 
(4H, m, 2 x CH2), 2.42 (4H, t, J(H,H)= 6.8 Hz, 2 x CH2); 13C NMR (125 MHz, CDCl3) δ = 23.1 (2 x 
CH2), 27.8 (2 x CH2), 23.7 (2 x CH2), 28.5 (2 x CH2), 38.6 (t, J(C,F)= 25.5 Hz, 2 x CH2), 42.2 (2 x 
CH2), 79.1 (t, J(C,F)= 43.4 Hz, 2 x ≡C), 114.4 (t, J(C,F)= 235 Hz, 2 x CF2), 212.3 (C=O); 19F{1H} 
NMR (470 MHz, CDCl3) δ = -84.4 (4F, s, 2 x CF2); IR (thin film) ν (cm-1) = 1707 (C=O); HRMS (CI+) 
m/z calcd for C17H25F4O [M+H]+: 321.1836, found: 321.1835; 34. 1H NMR (500 MHz, CDCl3) δ = 
1.24-1.31 (2H, m, CH2), 1.34-1.39 (2H, m, CH2), 1.40-1.47 (4H, m, 2 x CH2), 1.48-1.54 (4H, m, 2 x 
CH2), 1.64-1.70 (4H, m, 2 x CH2), 2.01-2.12 (4H, m, 2 x CH2), 2.43 (2H, t, J(H,H)= 6.3 Hz, CH2), 2.45 
(2H, t, J(H,H)= 6.8 Hz, CH2); 13C NMR (125 MHz, CDCl3) δ = 22.5 (t, J(C,F)= 3.8 Hz, CH2), 22.6 (t, 
J(C,F)= 3.9 Hz, CH2), 23.0 (CH2), 24.1 (CH2), 27.5 (CH2), 27.6 (CH2), 28.0 (CH2), 28.1 (CH2), 38.62 
(t, J(C,F)= 24.9 Hz, CH2), 38.65 (t, J(C,F)= 25.2 Hz, CH2), 41.7 (CH2), 42.1 (CH2), 79.1 (2 x ≡C), 
114.2 (t, J(C,F)= 236 Hz, CF2), 114.5 (t, J(C,F)= 235 Hz, CF2), 211.8 (C=O); 19F{1H} NMR (470 MHz, 






CDCl3) δ = -83.7 (2F, t, J(F,F)= 3.6 Hz, CF2), -83.9 (2F, t, J(F,F)= 3.5 Hz, CF2); IR (thin film) ν (cm-1) 
= 1707 (C=O); HRMS (CI+) m/z calcd for C17H25F4O [M+H]+: 321.1836, found: 321.1837.  
 
(Z)-8,8,11,11-tetrafluorocycloheptadec-9-en-1-one (13). A mixture of 5% Pd/BaSO4 (6.3 mg) and 
quinoline (2.1 mg) in 0.9 mL of pyridine was stirred for a few minutes under a small positive pressure 
of H2. A solution of 8,8,11,11-tetrafluorocycloheptadec-9-yn-1-one 33 (16 mg, 0.05 mmol, 1 equiv.) in 
0.7 mL of pyridine was added to the above mixture after the catalyst turned black. The resulting mixture 
was stirred overnight under H2 atmosphere at room temperature. Then, the catalyst was removed by 
filtration through a short pad of celite and washed with Et2O (35 mL). The filtrate was washed with sat. 
aq. CuSO4·5H2O solution (8.5 mL), dried over MgSO4 and the solvent was removed under reduced 
pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 7:1) gave compound 
13 (15 mg, 96%) as a white solid; m.p. 64-66 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.23-1.29 (4H, m, 2 
x CH2), 1.33-1.40 (4H, m, 2 x CH2), 1.44-1.50 (4H, m, 2 x CH2), 1.62-1.67 (4H, m, 2 x CH2), 1.92-2.04 
(4H, m, 2 x CH2), 2.43 (4H, t, J(H,H)= 6.5 Hz, 2 x CH2), 5.69-5.83 (2H, m, 2 x =CH); 13C NMR (125 
MHz, CDCl3) δ = 21.9 (2 x CH2), 23.7 (2 x CH2), 27.9 (2 x CH2), 28.2 (2 x CH2), 36.5-37.0 (m, 2 x 
CH2), 42.0 (2 x CH2), 120.9 (t, J(C,F)= 242 Hz, 2 x CF2), 130.8-131.5 (m, 2 x =CH), 212.2 (C=O); 
19F{1H} NMR (470 MHz, CDCl3) δ = -90.8 (4F, s, 2 x CF2); IR (thin film) ν (cm-1) = 1709 (C=O); 
HRMS (CI+) m/z calcd for C17H30F4ON [M+NH4]+: 340.2258, found: 340.2256. 
  
8,8,11,11-tetrafluorocycloheptadecan-1-one (14). A mixture of 5% Pd/C (14 mg, 0.007 mmol, 0.1 
equiv.) in 0.7 mL of absolute EtOH was stirred for a few minutes under a small positive pressure of H2. 
A solution of 8,8,11,11-tetrafluorocycloheptadec-9-yn-1-one 33 (21 mg, 0.06 mmol, 1 equiv.) in 0.7 mL 
of absolute EtOH was added to the above mixture and the reaction was stirred overnight under H2 
atmosphere at room temperature. Then, the catalyst was removed by filtration through a short pad of 
celite and washed with Et2O (46 mL). The solvent was removed under reduced pressure. Purification by 
column chromatography using silica gel (hexanes/EtOAc 10:1) gave compound 14 (18 mg, 86%) as a 
white solid; m.p. 49-51 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.26-1.47 (12H, m, 6 x CH2), 1.62 (4H, 
quint, J(H,H)= 7.0 Hz, 2 x CH2), 1.82-1.92 (4H, m, 2 x CH2), 1.97-2.03 (4H, m, 2 x CH2), 2.41 (4H, t, 
J(H,H)= 6.8 Hz, 2 x CH2); 13C NMR (125 MHz, CDCl3) δ = 22.3 (t, J(C,F)= 5.1 Hz, 2 x CH2), 23.3 (2 x 
CH2), 27.7 (2 x CH2), 28.0 (2 x CH2), 28.8 (tt, J(C,F)= 27.4, 5.0 Hz, 2 x CH2), 34.8 (t, J(C,F)= 25.4 Hz, 
2 x CH2), 42.2 (2 x CH2), 125.0 (t, J(C,F)= 241 Hz, 2 x CF2), 212.0 (C=O); 19F{1H} NMR (470 MHz, 
CDCl3) δ = -94.1 (4F, s, 2 x CF2); IR (thin film) ν (cm-1) = 1708 (C=O); HRMS (CI+) m/z calcd for 
C17H32F4ON [M+NH4]+: 342.2415, found: 342.2415. 
(Z)-7,7,10,10-tetrafluorocycloheptadec-8-en-1-one (15). A mixture of 5% Pd/BaSO4 (6.5 mg) and 
quinoline (2.2 mg) in 0.9 mL of pyridine was stirred for a few minutes under a small positive pressure 
of H2. A solution of 7,7,10,10-tetrafluorocycloheptadec-8-yn-1-one 34 (17 mg, 0.05 mmol, 1 equiv.) in 
0.8 mL of pyridine was added to the above mixture after the catalyst turned black. The resulting mixture 
was stirred overnight under H2 atmosphere at room temperature. Then, the catalyst was removed by 
filtration through a short pad of celite and washed with Et2O (35 mL). The filtrate was washed with aq. 
sat. CuSO4·5H2O (8.6 mL), dried over MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography using silica gel (hexanes/EtOAc 7:1) gave compound 15 (14 
mg, 81%) as a white solid; m.p. 61-62 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.23-1.29 (4H, m, 2 x CH2), 
1.32-1.50 (8H, m, 4 x CH2), 1.62-1.68 (4H, m, 2 x CH2), 1.93-2.07 (4H, m, 2 x CH2), 2.41 (2H, t, 
J(H,H)= 6.7 Hz, CH2), 2.42 (2H, t, J(H,H)= 6.5 Hz, CH2), 5.74 (1H, q, J = 13.9 Hz, =CH), 5.83 (1H, q, 
J(H,H)= 13.7 Hz, =CH); 13C NMR (125 MHz, CDCl3) δ = 21.3 (t, J(C,F)= 3.4 Hz, CH2), 21.8 (t, 
J(C,F)= 3.5 Hz, CH2), 23.5 (CH2), 27.4 (CH2), 27.5 (CH2), 27.9 (CH2), 28.2 (CH2), 36.8 (t, J(C,F)= 
26.4 Hz, CH2), 37.0 (t, J(C,F)= 26.0 Hz, CH2), 41.4 (CH2), 42.1 (CH2), 121.0 (t, J(C,F)= 240 Hz, CF2), 
121.1 (t, J(C,F)= 240 Hz, CF2), 131.1 (tt, J(C,F)= 31.3, 7.2 Hz, =CH), 131.4 (tt, J(C,F)= 32.1, 6.3 Hz, 
=CH), 212.0 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -89.6-89.7 (2F, m, CF2), -92.0-92.1 (2F, m, 






CF2); IR (thin film) ν (cm-1) = 1707 (C=O); HRMS (CI+) m/z calcd for C17H30F4ON [M+NH4]+: 
340.2258, found: 340.2256. 
7,7,10,10-tetrafluorocycloheptadecan-1-one (16). A mixture of 5% Pd/C (12 mg, 0.006 mmol, 0.1 
equiv.) in 0.5 mL of absolute EtOH was stirred for a few minutes under a small positive pressure of H2. 
A solution of 7,7,10,10-tetrafluorocycloheptadec-8-yn-1-one 34 (18 mg, 0.05 mmol, 1 equiv.) in 0.5 mL 
of absolute EtOH was added to the above mixture and the reaction was stirred overnight under H2 
atmosphere at room temperature. Then, the catalyst was removed by filtration through a short pad of 
celite and washed with Et2O (39 mL). The solvent was removed under reduced pressure. Purification by 
column chromatography using silica gel (hexanes/EtOAc 10:1) gave compound 16 (14 mg, 79%) as a 
white solid; m.p. 69-70 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.20-1.40 (12H, m, 6 x CH2), 1.59-1.68 
(4H, m, 2 x CH2), 1.80-2.05 (8H, m, 4 x CH2), 2.41-2.45 (4H, m, 2 x CH2); 13C NMR (125 MHz, 
CDCl3) δ = 21.7 (t, J(C,F)= 5.2 Hz, CH2), 22.4 (t, J(C,F)= 5.4 Hz, CH2), 22.5 (CH2), 23.5 (CH2), 27.4 
(CH2), 27.6 (2 x CH2), 28.2 (CH2), 28.5 (tt, J(C,F)= 27.8, 5.4 Hz, CH2), 28.9 (tt, J(C,F)= 27.2, 5.4 Hz, 
CH2), 34.8 (t, J(C,F)= 25.1 Hz, CH2), 35.4 (t, J(C,F)= 25.3 Hz, CH2), 41.9 (CH2), 42.1 (CH2), 124.8 (t, 
J(C,F)= 241 Hz, CF2), 125.2 (t, J(C,F)= 240 Hz, CF2), 211.4 (C=O); 19F{1H} NMR (470 MHz, CDCl3) 
δ = -93.2 (2F, s, CF2), -94.5 (2F, s, CF2); IR (thin film) ν (cm-1) = 1701 (C=O); HRMS (CI+) m/z calcd 
for C17H32F4ON [M+NH4]+: 342.2415, found: 342.2413. 
10,10-difluorononadeca-1,18-diene (35). Neat DAST (7.3 mL, 55.7 mmol, 12 equiv.) was added to 
nonadeca-1,18-dien-10-one 12 (1.29 g, 4.64 mmol) under argon atmosphere. The mixture was heated at 
50 °C and stirred for 3 days. Crude reaction was added portionwise to a biphasic mixture of sat. aq.  
NaHCO3 solution (150 mL) and DCM (100 mL) at 0 °C. The aqueous layer was separated and extracted 
with DCM (3 x 50 mL). The combined organic extracts were dried over anhydrous MgSO4 and the 
solvent was removed under reduced pressure. Purification by column chromatography using silica gel 
(hexanes) gave compound 35 (379 mg, 27%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.30-
1.48 (20H, m, 10 x CH2), 1.75-1.84 (4H, m, 2 x CH2), 2.05 (4H, q, J(H,H)= 7.1 Hz, 2 x CH2), 4.93-5.02 
(4H, m, 2 x =CH2), 5.82 (2H, ddt, J(H,H)= 17.1, 10.2, 6.7 Hz, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ 
= 22.3 (t, J(C,F)= 4.4 Hz, 2 x CH2), 28.8 (2 x CH2), 28.9 (2 x CH2), 29.2 (2 x CH2), 29.3 (2 x CH2), 33.7 
(2 x CH2), 36.3 (t, J(C,F)= 25.1 Hz, 2 x CH2), 125.4 (t, J(C,F)= 240 Hz, CF2), 139.1 (2 x =CH); 
19F{1H} NMR (470 MHz, CDCl3) δ = -97.6 (2F, s, CF2); HRMS (EI+) m/z calcd for C19H34F2 [M]+: 
300.2628, found: 300.2623. 
 
10,10-difluorocycloheptadec-1-ene (36). Grubbs’ 1st generation catalyst (28.3 mg, 0.03 mmol, 0.1 
equiv.) was added to a stirred solution (protected from sunlight) of 10,10-difluorononadeca-1,18-diene 
35 (103 mg, 0.34 mmol, 1.0 equiv.) in dry DCM (69 mL) under argon atmosphere at room temperature. 
The mixture was heated at reflux temperature for 3 h. Then, the mixture was allowed to warm to room 
temperature and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes) gave compound 36 (E/Z 8:1 inseparable mixture of 
diastereoisomers, 35 mg, 38%) as a colourless oil. (E)-36. 1H NMR (400 MHz, CDCl3) δ = 1.32-1.41 
(20H, m, 10 x CH2), 1.75-1.84 (4H, m, 2 x CH2), 1.86-2.07 (4H, m, 2 x CH2), 5.33-5.36 (2H, m, 2 x 
=CH); 13C NMR (100 MHz, CDCl3) δ = 21.3 (t, J(C,F)= 5.5 Hz, 2 x CH2), 27.0 (2 x CH2), 27.6 (2 x 
CH2), 28.3 (2 x CH2), 28.9 (2 x CH2), 32.4 (2 x CH2), 34.9 (t, J(C,F)= 25.5 Hz, 2 x CH2), 126.5 (t, 
J(C,F)= 239 Hz, CF2), 130.8 (2 x =CH); 19F{1H} NMR (376 MHz, CDCl3) δ = -90.9 (2F, s, CF2); (Z)-
36. 1H NMR (400 MHz, CDCl3) δ = 1.32-1.41 (20H, m, 10 x CH2), 1.75-1.84 (4H, m, 2 x CH2), 1.86-
2.07 (4H, m, 2 x CH2), 5.33-5.36 (2H, m, 2 x =CH); 
 13C NMR (100 MHz, CDCl3) δ = 21.6 (t, J(C,F)= 5.2 Hz, 2 x CH2), 27.0 (2 x CH2), 27.6 (2 x CH2), 
28.3 (2 x CH2), 29.1 (2 x CH2), 32.4 (2 x CH2), 34.9 (t, J(C,F)= 25.5 Hz, 2 x CH2), 126.5 (t, J(C,F)= 
239 Hz, CF2), 130.1 (2 x =CH); 19F{1H} NMR (376 MHz, CDCl3) δ = -91.2 (2F, s, CF2); HRMS (CI+) 
m/z calcd for C17H25F4 [M+H]+: 305.1887, found: 305.1889. 







9,9-difluorocycloheptadecan-1-ol (37). Borane dimethyl sulfide complex (0.13 mL, 2M solution in 
THF, 0.25 mmol, 1.5 equiv.) was added to a stirred solution of 10,10-difluorocycloheptadec-1-ene 36 
(46 mg, 0.17 mmol, 1.0 equiv.) in dry THF (1.7 mL) under argon atmosphere at 0 ºC. The solution was 
warmed to room temperature and stirred overnight. Then, EtOH (0.13 mL), aq. NaOH (2 M, 0.13 mL) 
and aq. H2O2 (30% w/w, 0.13 mL) were sequentially added and the reaction mixture was stirred for 4 h. 
After evaporation of the volatiles, H2O (0.6 mL) was added and the solution was extracted with EtOAc 
(3 x 4.0 mL). The combined organic layers were washed with brine (4.0 mL), dried over MgSO4 and the 
solvent was removed under reduced pressure to gave compound 37 (42 mg, 85%) as a white solid, 
which was used without further purification; m.p. 64-65 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.41-1.59 
(26H, m, 13 x CH2), 1.79-1.87 (4H, m, 2 x CH2), 3.71 (1H, quint, J(H,H)= 5.8 Hz, OCH); 13C NMR 
(125 MHz, CDCl3) δ = 21.7 (t, J(C,F)= 5.2 Hz, CH2), 21.9 (t, J(C,F)= 5.3 Hz, CH2), 23.8 (CH2), 23.9 
(CH2), 27.2 (CH2), 27.3 (CH2), 27.55 (CH2), 27.58 (CH2), 27.61 (2 x CH2), 27.7 (CH2), 34.7 (t, J(C,F)= 
25.7 Hz, CH2), 34.9 (t, J(C,F)= 24.9 Hz, CH2), 35.1 (CH2), 36.1 (CH2), 70.4 (OCH2), 126.2 (t, J(C,F)= 
240 Hz, CF2); 19F{1H} NMR (470 MHz, CDCl3) δ = -92.3 (2F, s, CF2); HRMS (EI+) m/z calcd for 
C17H29F [M-HF]+: 252.2253, found: 252.2252. 
 
9,9-difluorocycloheptadecanone (17). IBX (62 mg, 0.22 mmol, 2 equiv.) was added to a solution of 
9,9-difluorocycloheptadecan-1-ol 37 (32 mg, 0.11 mmol, 1.0 equiv.) in DMSO (2.0 mL) at room 
temperature. The resulting mixture was stirred overnight. Then, H2O (2.6 mL) and EtOAc (2.6 mL) 
were sequentially added and the precipitated white solid was filtered and the filtrate collected. The 
organic layer was separated and washed with H2O (2 x 2.6 mL) and brine (2.6 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 10:1) gave compound 17 (20 mg, 61%) as a white 
solid; m.p. 50-51 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.24-1.39 (18H, m, 9 x CH2), 1.60-1.66 (4H, m, 2 
x CH2), 1.76-1.86 (4H, m, 2 x CH2), 2.42 (4H, t, J(H,H)= 6.5 Hz, 2 x CH2); 13C NMR (125 MHz, 
CDCl3) δ = 21.6 (t, J(C,F)= 5.3 Hz, CH2), 21.8 (t, J(C,F)= 5.4 Hz, CH2), 23.4 (CH2), 23.8 (CH2), 27.3 
(CH2), 27.4 (CH2), 27.6 (CH2), 27.7 (CH2), 28.0 (2 x CH2), 28.1 (CH2), 34.5 (t, J(C,F)= 25.4 Hz, CH2), 
34.8 (t, J(C,F)= 25.5 Hz, CH2), 42.1 (CH2), 42.5 (CH2), 126.3 (t, J(C,F)= 240 Hz, CF2), 212 (C=O); 
19F{1H} NMR (470 MHz, CDCl3) δ = -91.7 (2F, s, CF2); IR (thin film) ν (cm-1) = 1710 (C=O); HRMS 
(CI−) m/z calcd for C17H29F [M-H]−: 287.2192, found: 287.2189. 
 
10-(4-methoxybenzyloxy)dec-1-en-4-ol (41). Allylmagnesium bromide (90.5 mL, 1M solution in Et2O, 
90.5 mmol, 1.5 equiv.) was added to a solution of 7-(4-methoxybenzyloxy)heptanal 40 (15.1 g, 60.4 
mmol, 1.0 equiv.) in dry THF (215 mL) at 0ºC. The resulting mixture was stirred overnight at room 
temperature. Then, sat. aq. NH4Cl solution (107 mL) and Et2O (54 mL) were sequentially added and the 
aqueous layer was extracted with Et2O (3 x 107 mL). The combined organic extracts were dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 4:1) gave compound 41 (10.2 g, 58%) as a colourless 
oil; 1H NMR (500 MHz, CDCl3) δ = 1.30-1.40 (6H, m, 3 x CH2), 1.44-1.48 (2H, m, CH2), 1.56-1.64 
(4H, m, 2 x CH2), 3.44 (2H, t, J(H,H)= 6.7 Hz, CH2O), 3.64 (1H, bs, OCH), 3.81 (3H, s, MeO), 4.44 
(2H, s, CH2O), 5.13-5.16 (2H, m, =CH2), 5.79-5.87 (1H, m, =CH), 6.88 (2H, AA'XX', 2 x CHAr), 7.27 
(2H, AA'XX', 2 x CHAr); 13C NMR (125 MHz, CDCl3) δ = 25.6 (CH2), 26.2 (CH2), 29.4 (CH2), 29.7 
(CH2), 36.7 (CH2), 41.9 (CH2), 55.3 (MeO), 70.1 (CH2O), 70.6 (OCH), 72.5 (CH2O), 113.7 (2 x CHAr), 
118.1 (=CH2), 129.2 (2 x CHAr), 130.7 (CAr), 134.9 (=CH), 159.1 (CAr). HRMS (ESI+) m/z calcd for 
C18H28NaO3 [M+Na]+: 315.1931, found: 315.1922. 
 
10-(4-methoxybenzyloxy)dec-1-en-4-ona (42). IBX (10.8 g, 38.6 mmol, 1.2 equiv.) was added to a 
solution of 10-(4-methoxybenzyloxy)dec-1-en-4-ol 41 (9.40 g, 32.2 mmol, 1.0 equiv.) in DMSO (151 






mL) at room temperature. The resulting mixture was stirred overnight. Then, H2O (355 mL) and EtOAc 
(355 mL) were sequentially added and the precipitated white solid was filtered and the filtrate collected. 
The organic layer was separated and washed with H2O (2 x 355 mL) and brine (355 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure to gave compound 42 (7.93 g, 
85%) as a colourless oil, which was used without further purification; 1H NMR (500 MHz, CDCl3) δ = 
1.26-1.40 (4H, m, 2 x CH2), 1.55-1.62 (4H, m, 2 x CH2), 2.44 (2H, t, J(H,H)= 7.4 Hz, CH2), 3.17 (2H, 
dt, J(H,H)= 7.1, 1.3 Hz, CH2), 3.43 (2H, t, J(H,H)= 6.6 Hz, CH2O), 3.81 (3H, s, MeO), 4.43 (2H, s, 
CH2O), 5.12-5.20 (2H, m, =CH2), 5.92 (1H, ddt, J(H,H)= 17.1, 10.2, 7.0 Hz, =CH), 6.88 (2H, AA'XX', 
2 x CHAr), 7.26 (2H, AA'XX', 2 x CHAr); 13C NMR (125 MHz, CDCl3) δ = 23.6 (CH2), 26.0 (CH2), 29.0 
(CH2), 29.6 (CH2), 42.3 (CH2), 47.7 (CH2), 55.3 (MeO), 70.0 (CH2O), 72.5 (CH2O), 113.7 (2 x CHAr), 
118.7 (=CH2), 129.2 (2 x CHAr), 130.6 (CAr), 130.7 (=CH), 159.1 (CAr), 209.0 (C=O); HRMS (ESI+) m/z 
calcd for C18H26NaO3 [M+Na]+: 313.1774, found: 313.1767. 
 
1-((7,7-difluorodec-9-en-1-yloxy)methyl)-4-methoxybenzene (43). Neat DAST (14.4 mL, 109.4 
mmol, 4.0 equiv.) was added to 10-(4-methoxybenzyloxy)dec-1-en-4-ona 42 (7.93 g, 27.3 mmol, 1.0 
equiv.) under argon atmosphere. The mixture was heated at 50 °C and stirred overnight. Crude reaction 
was added portionwise to a biphasic mixture of sat. aq.  NaHCO3 solution (300 mL) and DCM (104 
mL) at 0 °C. The aqueous layer was separated and extracted with DCM (3 x 52 mL). The combined 
organic extracts were dried over anhydrous MgSO4 and the solvent was removed under reduced 
pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 15:1) gave 
compound 43 (3.62 g, 43%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.31-1.41 (4H, m, 2 x 
CH2), 1.44-1.51 (2H, m, CH2), 1.55-1.63 (2H, m, CH2), 1.75-1.85 (2H, m, CH2), 2.59 (2H, td, J(H,F)= 
15.9 Hz, J(H,H)= 7.1 Hz, CH2), 3.44 (2H, t, J(H,H)= 6.6 Hz, CH2O), 3.81 (3H, s, MeO), 4.44 (2H, s, 
CH2O), 5.18-5.22 (2H, m, =CH2), 5.80 (1H, ddt, J(H,H)= 16.6, 10.8, 7.1 Hz, =CH), 6.89 (2H, AA'XX', 
2 x CHAr), 7.27 (2H, AA'XX', 2 x CHAr); 13C NMR (125 MHz, CDCl3) δ = 22.0 (t, J(C,F)= 4.4 Hz, 
CH2), 26.0 (CH2), 29.1 (CH2), 29.6 (CH2), 35.8 (t, J(C,F)= 24.6 Hz, CH2), 41.1 (t, J(C,F)= 26.6 Hz, 
CH2), 55.3 (MeO), 70.0 (CH2O), 72.5 (CH2O), 113.7 (2 x CHAr), 120.0 (=CH2), 124.3 (t, J(C,F)= 241 
Hz, CF2), 129.2 (2 x CHAr), 129.8 (t, J(C,F)= 5.8 Hz, =CH), 130.7 (CAr), 159.1 (CAr); 19F{1H} NMR 
(470 MHz, CDCl3) δ = -97.2 (2F, s, CF2); HRMS (ESI+) m/z calcd for C18H26F2NaO2 [M+Na]+: 
335.1793, found: 335.1786. 
 
7,7-difluorodec-9-en-1-ol (44). DDQ (5.27 g, 23.2 mmol, 2.0 equiv.) was added to a solution of 1-
((7,7-difluorodec-9-en-1-yloxy)methyl)-4-methoxybenzene 43 (3.62 g, 11.6 mmol, 1.0 eq) in DCM (93 
mL) and water (2.3 mL) at room temperature. The resulting mixture was stirred overnight. Then, aq. sat. 
NaHCO3 solution (93 mL) was added and the aqueous layer was extracted with DCM (2 x 45 mL). The 
combined organic extracts were dried over anhydrous MgSO4 and the solvent was removed under 
reduced pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 7:1) gave 
compound 44 (1.66 g, 74%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.34-1.42 (4H, m, 2 x 
CH2), 1.46-1.52 (2H, m, CH2), 1.55-1.60 (2H, m, CH2), 1.76-1.86 (2H, m, CH2), 2.60 (2H, td, J(H,F)= 
15.9 Hz, J(H,H)= 7.1 Hz, CH2), 3.64 (2H, t, J(H,H)= 6.6 Hz, CH2O), 5.18-5.22 (2H, m, =CH2), 5.76 
(1H, ddt, J(H,H)= 16.5, 10.8, 7.2 Hz, =CH); 13C NMR (125 MHz, CDCl3) δ = 22.0 (t, J(C,F)= 4.4 Hz, 
CH2), 25.5 (CH2), 29.1 (CH2), 32.5 (CH2), 35.6 (t, J(C,F)= 25.0 Hz, CH2), 41.1 (t, J(C,F)= 26.4 Hz, 
CH2), 62.8 (CH2O), 120.0 (=CH2), 124.2 (t, J(C,F)= 241 Hz, CF2), 129.8 (t, J(C,F)= 5.9 Hz, =CH); 
19F{1H} NMR (470 MHz, CDCl3) δ = -97.3 (2F, s, CF2); HRMS (ESI+) m/z calcd for C18H26F2NaO2 
[M+Na]+: 335.1793, found: 335.1786. 
 
7,7-difluorodec-9-enal (45). IBX (1.18 g, 4.2 mmol, 1.5 equiv.) was added to a solution of 7,7-
difluorodec-9-en-1-ol 44 (536 mg, 2.8 mmol, 1.0 equiv.) in DMSO (13.5 mL) at room temperature. The 
resulting mixture was stirred overnight. Then, H2O (32 mL) and EtOAc (32 mL) were sequentially 






added and the precipitated white solid was filtered and the filtrate collected. The organic layer was 
separated and washed with H2O (2 x 32 mL) and brine (32 mL), dried over anhydrous MgSO4 and the 
solvent was removed under reduced pressure to gave compound 45 (521 mg, 98%) as a colourless oil, 
which was used without further purification; 1H NMR (500 MHz, CDCl3) δ = 1.35-1.41 (2H, m, CH2), 
1.48-1.54 (2H, m, CH2), 1.66 (2H, quint, J(H,H)= 7.4 Hz, CH2), 1.77-1.87 (2H, m, CH2), 2.46 (2H, td, 
J(H,H)= 7.2, 1.4 Hz, CH2), 2.60 (2H, td, J(H,F)= 15.8 Hz, J(H,H)= 7.2 Hz, CH2), 5.19-5.23 (2H, m, 
=CH2), 5.80 (1H, ddt, J(H,H)= 17.1, 10.2, 7.2 Hz, =CH), 9.78 (1H, bt, J(H,H)= 1.4 Hz, CHO); 13C 
NMR (125 MHz, CDCl3) δ = 21.8 (t, J(C,F)= 4.3 Hz, CH2), 28.8 (CH2), 35.6 (t, J(C,F)= 25.1 Hz, CH2), 
41.2 (t, J(C,F)= 26.3 Hz, CH2), 43.6 (CH2), 120.1 (=CH2), 124.1 (t, J(C,F)= 241 Hz, CF2), 129.7 (t, 
J(C,F)= 6.0 Hz, =CH), 202.5 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.5 (2F, s, CF2); HRMS 
(ESI+) m/z calcd for C18H26F2NaO2 [M+Na]+: 335.1793, found: 335.1786. 
 
4,4-difluorononadeca-1,18-dien-10-ol (46). 9-bromonon-1-ene (742 mg, 3.6 mmol, 4.0 equiv.) was 
added to a suspension of magnesium turnings (87 mg, 3.6 mmol, 4.0 equiv.) and iodine (traces) in dry 
THF (4.4 mL) under argon atmosphere at room temperature. The reaction was heated at reflux for 6 h. 
Then, the reaction was cooled to room temperature and was diluted with dry THF (5 mL). A solution of 
7,7-difluorodec-9-enal 45 (172 mg, 0.9 mmol, 1.0 equiv.) was added to the above solution and the 
reaction was stirred overnight. Then, sat. aq. NH4Cl solution (7.0 mL) and Et2O (14 mL) were 
sequentially added and the aqueous layer was extracted with Et2O (3 x 14 mL). The combined organic 
extracts were dried over anhydrous MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography using silica gel (hexanes/EtOAc 10:1) gave compound 46 (177 
mg, 62%) as a white solid; m.p. 39-40 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.26-1.52 (20H, m, 10 x 
CH2), 1.77-1.86 (2H, m, CH2), 2.05 (2H, q, J(H,H)= 7.1 Hz, CH2), 2.60 (2H, td, J(H,F)= 15.8 Hz, 
J(H,H)= 7.2 Hz, CH2), 3.59 (1H, bs, OCH), 4.92-5.02 (2H, m, =CH2), 5.19-5.22 (2H, m, =CH2), 5.76-
5.86 (2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 22.0 (t, J(C,F)= 4.3 Hz, CH2), 25.4 (CH2), 
25.6 (CH2), 28.9 (CH2), 29.0 (CH2), 29.37 (CH2), 29.44 (CH2), 29.6 (CH2), 33.8 (CH2), 35.8 (t, J(C,F)= 
25.1 Hz, CH2), 37.2 (CH2),  37.5 (CH2), 41.1 (t, J(C,F)= 26.9 Hz, CH2), 71.9 (OCH), 114.1 (=CH2), 
120.0 (=CH2), 124.2 (t, J(C,F)= 241 Hz, CF2), 129.8 (t, J(C,F)= 5.8 Hz, =CH), 139.2 (=CH); 19F{1H} 
NMR (470 MHz, CDCl3) δ = -97.2 (2F, s, CF2); HRMS (CI+) m/z calcd for C19H38F2ON [M+NH4]+: 
334.2916, found: 334.2916. 
 
4,4-difluorononadeca-1,18-dien-10-one (47). IBX (257 mg, 0.92 mmol, 2 equiv.) was added to a 
solution of 4,4-difluorononadeca-1,18-dien-10-ol 46 (145 mg, 0.46 mmol, 1.0 equiv.) in DMSO (2.2 
mL) at room temperature. The resulting mixture was stirred overnight. Then, H2O (5.3 mL) and EtOAc 
(5.3 mL) were sequentially added and the precipitated white solid was filtered and the filtrate collected. 
The organic layer was separated and washed with H2O (2 x 5.3 mL) and brine (5.3 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure to gave compound 47 (134 mg, 
93%) as a white waxy solid, which was used without further purification; m.p. 27-29 ºC; 1H NMR (500 
MHz, CDCl3) δ = 1.25-1.39 (10H, m, 5 x CH2), 1.45-1.51 (2H, m, CH2), 1.54-1.61 (4H, m, 2 x CH2), 
1.75-1.85 (2H, m, CH2), 2.04 (2H, q, J(H,H)= 7.0 Hz, CH2), 2.38 (2H, t, J(H,H)= 7.8 Hz, CH2), 2.40 
(2H, t, J(H,H)= 7.7 Hz, CH2), 2.59 (2H, td, J(H,F)= 15.9 Hz, J(H,H)= 7.2 Hz, CH2), 4.92-5.01 (2H, m, 
=CH2), 5.18-5.22 (2H, m, =CH2), 5.75-5.85 (2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 21.8 (t, 
J(C,F)= 4.4 Hz, CH2), 23.4 (CH2), 23.8 (CH2), 28.82 (CH2), 28.86 (CH2), 28.90 (CH2), 29.17 (CH2), 
29.22 (CH2), 33.7 (CH2), 35.7 (t, J(C,F)= 25.5 Hz, CH2), 41.2 (t, J(C,F)= 26.3 Hz, CH2), 42.4 (CH2), 
42.8 (CH2), 114.2 (=CH2), 120.0 (=CH2), 124.1 (t, J(C,F)= 242 Hz, CF2), 129.8 (t, J(C,F)= 5.9 Hz, 
=CH), 139.1 (=CH), 211.3 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.4 (2F, s, CF2); HRMS 
(CI+) m/z calcd for C19H33F2O [M+H]+: 315.2494, found: 315.2490. 
 






7,7-difluorocycloheptadec-9-en-1-one (18). Grubbs’ 1st generation catalyst (4 mg, 0.005 mmol, 0.05 
equiv.) was added to a stirred solution (protected from sunlight) of 4,4-difluorononadeca-1,18-dien-10-
one 47 (31 mg, 0.10 mmol, 1.0 equiv.) in dry DCM (5.0 mL) under argon atmosphere at room 
temperature. The mixture was heated at reflux temperature for 3 h. Then, the mixture was allowed to 
warm to room temperature and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 10:1) gave compound 18 (E/Z 3:1 inseparable mixture 
of diastereoisomers, 13 mg, 46%) as a colourless oil. (E)-18. 1H NMR (500 MHz, CDCl3) δ = 1.21-1.51 
(12H, m, 6 x CH2), 1.60-1.63 (4H, m, 2 x CH2), 1.72-1.85 (2H, m, CH2), 2.01-2.08 (2H, m, CH2), 2.38-
2.42 (4H, m, 2 x CH2), 2.54 (2H, td, J(H,F)= 14.5 Hz, J(H,H)= 7.2 Hz, CH2), 5.31-5.36 (1H, m, =CH), 
5.51-5.55 (1H, m, =CH); 13C NMR (125 MHz, CDCl3) δ = 20.8 (t, J(C,F)= 4.4 Hz, CH2), 23.8 (2 x 
CH2), 27.7 (CH2), 28.2 (CH2), 28.4 (CH2), 28.5 (2 x CH2), 31.9 (CH2), 34.7 (t, J(C,F)= 25.1 Hz, CH2), 
40.2 (t, J(C,F)= 26.4 Hz, CH2), 41.87 (CH2), 42.4 (CH2), 122.5 (t, J(C,F)= 6.8 Hz, =CH), 124.9 (t, 
J(C,F)= 242 Hz, CF2), 136.3 (=CH), 212.7 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -95.9 (2F, s, 
CF2); IR (thin film) ν (cm-1) = 1707 (C=O); HRMS (CI+) m/z calcd for C17H32F2ON [M+NH4]+: 
304.2446, found: 304.2449; (Z)-18. 1H NMR (500 MHz, CDCl3) δ = 1.21-1.51 (12H, m, 6 x CH2), 
1.60-1.63 (4H, m, 2 x CH2), 1.72-1.85 (2H, m, CH2), 2.01-2.08 (2H, m, CH2), 2.38-2.42 (4H, m, 2 x 
CH2), 2.60 (2H, td, J(H,F)= 15.3 Hz, J(H,H)= 7.4 Hz, CH2), 5.36-5.41 (1H, m, =CH), 5.55-5.61 (1H, m, 
=CH); 13C NMR (125 MHz, CDCl3) δ = 21.7 (t, J(C,F)= 5.0 Hz, CH2), 23.4 (CH2), 23.7 (CH2), 27.1 
(CH2), 27.9 (CH2), 28.1 (CH2), 28.31 (CH2),  28.33 (CH2), 28.6 (CH2), 34.1 (t, J(C,F)= 26.3 Hz, CH2), 
35.3 (t, J(C,F)= 25.3 Hz, CH2), 41.93 (CH2), 42.2 (CH2), 120.8 (t, J(C,F)= 6.3 Hz, =CH), 124.9 (t, 
J(C,F)= 242 Hz, CF2), 134.3 (=CH), 212.1 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -95.1 (2F, s, 
CF2). 
 
7,7-difluorocycloheptadecan-1-one (19). A mixture of 5% Pd/C (21 mg, 0.011 mmol, 0.1 equiv.) in 
0.9 mL of absolute EtOH was stirred for a few minutes under a small positive pressure of H2. A solution 
of 7,7-difluorocycloheptadec-9-en-1-one 18 (32 mg, 0.11 mmol, 1.0 equiv.) in 1.0 mL of absolute EtOH 
was added to the above mixture and the reaction was stirred overnight under H2 atmosphere at room 
temperature. Then, the catalyst was removed by filtration through a short pad of celite and washed with 
Et2O (69 mL). The solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 13:1) gave compound 19 (29 mg, 91%) as a white 
solid; m.p. 50-52 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.26-1.40 (18H, m, 9 x CH2), 1.60-1.66 (4H, m, 2 
x CH2), 1.77-1.89 (4H, m, 2 x CH2), 2.41 (2H, t, J(H,H)= 6.7 Hz, CH2), 2.43 (2H, t, J(H,H)= 6.9 Hz, 
CH2); 13C NMR (125 MHz, CDCl3) δ = 21.3 (t, J(C,F)= 5.2 Hz, CH2), 22.1 (t, J(C,F)= 5.3 Hz, CH2), 
22.9 (CH2), 23.8 (CH2), 26.7 (CH2), 26.9 (CH2), 27.2 (CH2), 27.6 (CH2), 27.8 (CH2), 28.0 (CH2), 28.1 
(CH2), 34.6 (t, J(C,F)= 25.5 Hz, CH2), 34.8 (t, J(C,F)= 25.6 Hz, CH2), 42.07 (CH2), 42.09 (CH2), 126.1 
(t, J(C,F)= 240 Hz, CF2), 211.9 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -92.3 (2F, s, CF2); IR 
(thin film) ν (cm-1) = 1707 (C=O); HRMS (CI+) m/z calcd for C17H34F2ON [M+NH4]+: 306.2603, 
found: 306.2606. 
 
8-(4-methoxybenzyloxy)oct-1-en-4-ol (51). Allylmagnesium bromide (81.6 mL, 1M solution in Et2O, 
81.6 mmol, 1.5 equiv.) was added to a solution of 5-(4-methoxybenzyloxy)pentanal 50 (12.1 g, 54.4 
mmol, 1.0 equiv.) in dry THF (193 mL) at 0ºC. The resulting mixture was stirred overnight at room 
temperature. Then, sat. aq. NH4Cl solution (96 mL) and Et2O (48 mL) were sequentially added and the 
aqueous layer was extracted with Et2O (3 x 96 mL). The combined organic extracts were dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 4:1) gave compound 51 (6.57 g, 46%) as a colourless 
oil; 1H NMR (500 MHz, CDCl3) δ = 1.40-1.69 (6H, m, 3 x CH2), 2.11-2.33 (2H, m, CH2), 3.46 (2H, t, 
J(H,H)= 6.5 Hz, CH2O), 3.63-3.68 (1H, m, OCH), 3.81 (3H, s, MeO), 4.44 (2H, s, CH2O), 5.12-5.16 
(2H, m, =CH2), 5.83 (1H, ddt, J(H,H)= 16.2, 9.6, 7.9 Hz, =CH), 6.88 (2H, AA'XX', 2 x CHAr), 7.27 






(2H, AA'XX', 2 x CHAr); 13C NMR (125 MHz, CDCl3) δ = 22.4 (CH2), 29.6 (CH2), 36.5 (CH2), 41.9 
(CH2), 55.3 (MeO), 69.9 (CH2O), 70.5 (OCH), 72.6 (CH2O), 113.7 (2 x CHAr), 118.1 (=CH2), 129.2 (2 
x CHAr), 130.6 (CAr), 134.8 (=CH), 159.1 (CAr); HRMS (ESI+) m/z calcd for C16H24NaO3 [M+Na]+: 
287.1618, found: 287.1610. 
 
8-(4-methoxybenzyloxy)oct-1-en-4-ona (52). IBX (8.36 g, 30.0 mmol, 1.2 equiv.) was added to a 
solution of 8-(4-methoxybenzyloxy)oct-1-en-4-ol 51 (6.57 g, 24.9 mmol, 1.0 equiv.) in DMSO (118 
mL) at room temperature. The resulting mixture was stirred overnight. Then, H2O (274 mL) and EtOAc 
(274 mL) were sequentially added and the precipitated white solid was filtered and the filtrate collected. 
The organic layer was separated and washed with H2O (2 x 274 mL) and brine (274 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure to gave compound 52 (5.17 g, 
79%) as a colourless oil, which was used without further purification; 1H NMR (500 MHz, CDCl3) δ = 
1.58-1.67 (4H, m, 2 x CH2), 2.47 (2H, t, J(H,H)= 7.2 Hz, CH2), 3.16 (2H, d, J(H,H)= 7.0 Hz, CH2), 3.45 
(2H, t, J(H,H)= 6.2 Hz, CH2O), 3.81 (3H, s, MeO), 4.43 (2H, s, CH2O), 5.12-5.19 (2H, m, =CH2), 5.92 
(1H, ddt, J(H,H)= 17.2, 10.2, 7.0 Hz, =CH), 6.88 (2H, AA'XX', 2 x CHAr), 7.26 (2H, AA'XX', 2 x 
CHAr); 13C NMR (125 MHz, CDCl3) δ = 20.4 (CH2), 29.1 (CH2), 42.0 (CH2), 47.7 (CH2), 55.3 (MeO), 
69.6 (CH2O), 72.5 (CH2O), 113.7 (2 x CHAr), 118.8 (=CH2), 129.2 (2 x CHAr), 130.6 (=CH), 130.7 
(CAr), 159.1 (CAr), 208.7 (C=O); HRMS (ESI+) m/z calcd for C16H22NaO3 [M+Na]+: 285.1461, found: 
285.1456. 
 
1-((5,5-difluorooct-7-en-1-yloxy)methyl)-4-methoxybenzene (53). Neat DAST (9.2 mL, 70.0 mmol, 
4.0 equiv.) was added to 8-(4-methoxybenzyloxy)oct-1-en-4-ona 52 (4.58 g, 17.5 mmol, 1.0 equiv.) 
under argon atmosphere. The mixture was heated at 50 °C and stirred overnight. Crude reaction was 
added portionwise to a biphasic mixture of sat. aq. NaHCO3 solution (192 mL) and DCM (64 mL) at 0 
°C. The aqueous layer was separated and extracted with DCM (3 x 32 mL). The combined organic 
extracts were dried over anhydrous MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography using silica gel (hexanes/EtOAc 15:1) gave compound 53 (1.69 
g, 34%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.54-1.67 (4H, m, 2 x CH2), 1.78-1.88 (2H, 
m, CH2), 2.60 (2H, tdt, J(H,F)= 15.8 Hz, J(H,H)= 7.1, 1.2 Hz, CH2), 3.46 (2H, t, J(H,H)= 6.2 Hz, 
CH2O), 3.82 (3H, s, MeO), 4.44 (2H, s, CH2O), 5.18-5.22 (2H, m, =CH2), 5.80 (1H, ddt, J(H,H)= 16.4, 
10.9, 7.1 Hz, =CH), 6.89 (2H, AA'XX', 2 x CHAr), 7.26 (2H, AA'XX', 2 x CHAr); 13C NMR (125 MHz, 
CDCl3) δ = 19.0 (t, J(C,F)= 4.6 Hz, CH2), 29.4 (CH2), 35.7 (t, J(C,F)= 25.1 Hz, CH2), 41.1 (t, J(C,F)= 
26.2 Hz, CH2), 55.3 (MeO), 69.5 (CH2O), 72.6 (CH2O), 113.8 (2 x CHAr), 120.0 (=CH2), 124.2 (t, 
J(C,F)= 241 Hz, CF2), 129.2 (2 x CHAr), 129.8 (t, J(C,F)= 5.9 Hz, =CH), 130.6 (CAr), 159.1 (CAr); 
19F{1H} NMR (470 MHz, CDCl3) δ = -97.3 (2F, s, CF2); HRMS (ESI+) m/z calcd for C16H22F2O2Na 
[M+Na]+: 307.1480, found: 307.1475. 
 
5,5-difluorooct-7-en-1-ol (54). DDQ (2.75 g, 12.1 mmol, 2.0 equiv.) was added to a solution of 1-((5,5-
difluorooct-7-en-1-yloxy)methyl)-4-methoxybenzene 53 (1.72 g, 6.06 mmol, 1.0 equiv.) in DCM (49 
mL) and water (1.2 mL) at room temperature. The resulting mixture was stirred overnight. Then, aq. sat. 
NaHCO3 solution (49 mL) was added and the aqueous layer was extracted with DCM (2 x 24 mL). The 
combined organic extracts were dried over anhydrous MgSO4 and the solvent was removed under 
reduced pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 10:1) gave 
compound 54 (0.76 g, 78%) as a colourless oil; 1H NMR (400 MHz, CDCl3) δ = 1.49-1.61 (4H, m, 2 x 
CH2), 1.76-1.89 (2H, m, CH2), 2.29 (1H, s, OH), 2.58 (2H, tdt, J(H,F)= 15.8 Hz, J(H,H)= 7.2, 1.1 Hz, 
CH2), 3.61 (2H, t, J(H,H)= 6.2 Hz, CH2O), 5.16-5.20 (2H, m, =CH2), 5.72-5.83 (1H, m, =CH); 13C 
NMR (125 MHz, CDCl3) δ = 18.4 (t, J(C,F)= 4.6 Hz, CH2), 32.1 (CH2), 35.5 (t, J(C,F)= 25.0 Hz, CH2), 
41.0 (t, J(C,F)= 26.1 Hz, CH2), 62.2 (CH2O), 120.0 (=CH2), 124.1 (t, J(C,F)= 241 Hz, CF2), 129.6 (t, 






J(C,F)= 5.9 Hz, =CH); 19F{1H} NMR (376 MHz, CDCl3) δ = -97.5 (2F, s, CF2); HRMS (ESI+) m/z 
calcd for C8H14F2ONa [M+Na]+: 187.0905, found: 187.0904. 
 
5,5-difluorooct-7-enal (55). IBX (1.72 g, 6.16 mmol, 2.0 equiv.) was added to a solution of 5,5-
difluorooct-7-en-1-ol 54 (505 mg, 3.1 mmol, 1.0 equiv.) in DMSO (15.0 mL) at room temperature. The 
resulting mixture was stirred overnight. Then, H2O (34 mL) and EtOAc (34 mL) were sequentially 
added and the precipitated white solid was filtered and the filtrate collected. The organic layer was 
separated and washed with H2O (2 x 34 mL) and brine (34 mL), dried over anhydrous MgSO4 and the 
solvent was removed under reduced pressure to gave compound 55 (361 mg, 72%) as a colourless oil, 
which was used without further purification; 1H NMR (500 MHz, CDCl3) δ = 1.81-1.92 (4H, m, 2 x 
CH2), 2.54 (2H, t, J(H,H)= 6.4 Hz, CH2), 2.62 (2H, td, J(H,F)= 15.8, J(H,H)= 7.2 Hz, CH2), 5.20-5.24 
(2H, m, =CH2), 5.75-5.84 (1H, m, =CH), 9.79 (1H, t, J(H,H)= 1.2 Hz, CHO); 13C NMR (125 MHz, 
CDCl3) δ = 14.8 (t, J(C,F)= 4.8 Hz, CH2), 35.0 (t, J(C,F)= 25.2 Hz, CH2), 41.3 (t, J(C,F)= 26.0 Hz, 
CH2), 43.2 (CH2), 120.4 (=CH2), 123.9 (t, J(C,F)= 241 Hz, CF2), 129.5 (t, J(C,F)= 5.9 Hz, =CH), 201.6 
(C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.8 (2F, s, CF2); HRMS (ESI+) m/z calcd for 
C8H12F2O2Na [M+Na]+: 185.0748, found: 185.0745. 
 
4,4-difluorononadeca-1,18-dien-8-ol (56). 11-bromoundec-1-ene (980 mg, 4.2 mmol, 4.0 equiv.) was 
added to a suspension of magnesium turnings (101 mg, 4.2 mmol, 4.0 equiv.) and iodine (traces) in dry 
THF (5.0 mL) under argon atmosphere at room temperature. The reaction was heated at reflux for 6 h. 
Then, the reaction was cooled to room temperature and was diluted with dry THF (15 mL). A solution 
of 5,5-difluorooct-7-enal 55 (170 mg, 1.1 mmol, 1.0 equiv.) was added to the above solution and the 
reaction was stirred overnight. Then, sat. aq. NH4Cl solution (8.2 mL) and Et2O (17 mL) were 
sequentially added and the aqueous layer was extracted with Et2O (3 x 17 mL). The combined organic 
extracts were dried over anhydrous MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography using silica gel (hexanes/EtOAc 9:1) gave compound 56 (163 
mg, 49%) as a white solid; m.p. 38-39 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.29-1.70 (20H, m, 10 x 
CH2), 1.79-1.90 (2H, m, CH2), 2.05 (2H, q, J(H,H)= 7.2 Hz, CH2), 2.61 (2H, td, J(H,F)= 15.9, J(H,H)= 
7.2 Hz, CH2), 3.58-3.63 (1H, m, OCH), 4.92-5.02 (2H, m, =CH2), 5.19-5.23 (2H, m, =CH2), 5.76-5.86 
(2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 18.4 (t, J(C,F)= 4.5 Hz, CH2), 25.6 (CH2), 28.9 
(CH2), 29.1 (CH2), 29.4 (CH2), 29.5 (CH2), 29.57 (CH2), 29.63 (CH2), 33.8 (CH2), 35.9 (t, J(C,F)= 25.1 
Hz, CH2), 36.9 (CH2), 37.5 (CH2), 41.1 (t, J(C,F)= 26.0 Hz, CH2), 71.6 (OCH), 114.1 (=CH2), 120.0 
(=CH2), 124.2 (t, J(C,F)= 241 Hz, CF2), 129.8 (t, J(C,F)= 5.9 Hz, =CH), 139.2 (=CH); 19F{1H} NMR 
(376 MHz, CDCl3) δ = -97.3 (2F, s, CF2); HRMS (ESI+) m/z calcd for C19H34F2ONa [M+Na]+: 
339.2470, found: 339.2468. 
 
4,4-difluorononadeca-1,18-dien-8-one (57). IBX (285 mg, 1.02 mmol, 2 equiv.) was added to a 
solution of 4,4-difluorononadeca-1,18-dien-8-ol 56 (160 mg, 0.51 mmol, 1.0 equiv.) in DMSO (2.6 mL) 
at room temperature. The resulting mixture was stirred overnight. Then, H2O 6.2 mL) and EtOAc (6.2 
mL) were sequentially added and the precipitated white solid was filtered and the filtrate collected. The 
organic layer was separated and washed with H2O (2 x 6.2 mL) and brine (6.2 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure to gave compound 57 (129 mg, 
81%) as a white waxy solid, which was used without further purification; m.p. 27 ºC; 1H NMR (400 
MHz, CDCl3) δ = 1.27-1.39 (12H, m, 6 x CH2), 1.53-1.60 (2H, m, CH2), 1.73-1.89 (4H, m, 2 x CH2), 
2.01-2.07 (2H, m, CH2), 2.39 (2H, t, J(H,H)= 7.5 Hz, CH2), 2.47 (2H, t, J(H,H)= 6.8 Hz, CH2), 2.61 
(2H, tdt, J(H,F)= 15.8 Hz, J(H,H)= 7.2, 1.2 Hz, CH2), 4.92-5.03 (2H, m, =CH2), 5.19-5.23 (2H, m, 
=CH2), 5.74-5.87 (2H, m, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 16.4 (t, J(C,F)= 4.7 Hz, CH2), 
23.8 (CH2), 28.9 (CH2), 29.1 (CH2), 29.2 (CH2), 29.38 (2 x CH2), 29.40 (CH2), 33.8 (CH2), 35.0 (t, 
J(C,F)= 25.1 Hz, CH2), 41.1 (t, J(C,F)= 26.2 Hz, CH2), 41.8 (CH2), 42.8 (CH2), 114.1 (=CH2), 120.2 






(=CH2), 124.1 (t, J(C,F)= 241 Hz, CF2), 129.6 (t, J(C,F)= 5.9 Hz, =CH), 139.2 (=CH), 210.5 (C=O); 
19F{1H} NMR (376 MHz, CDCl3) δ = -97.4 (2F, s, CF2); HRMS (ESI+) m/z calcd for C19H32F2ONa 
[M+Na]+: 337.2313, found: 337.2307. 
 
5,5-difluorocycloheptadec-7-en-1-one (58). Grubbs’ 1st generation catalyst (22.5 mg, 0.03 mmol, 0.05 
equiv.) was added to a stirred solution (protected from sunlight) of 4,4-difluorononadeca-1,18-dien-8-
one 57 (172 mg, 0.55 mmol, 1.0 equiv.) in dry DCM (110 mL) under argon atmosphere at room 
temperature. The mixture was heated at reflux temperature for 3 h. Then, the mixture was allowed to 
warm to room temperature and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 14:1) gave compound 58 (E/Z 2:1 inseparable mixture 
of diastereoisomers, 100 mg, 64%) as a colourless oil. (E)-58. 1H NMR (500 MHz, CDCl3) δ = 1.12-
1.43 (12H, m, 6 x CH2), 1.64-1.86 (6H, m, 3 x CH2), 2.03-2.09 (2H, m, CH2), 2.37-2.40 (2H, m, CH2), 
2.49-2.53 (2H, m, CH2), 2.56 (2H, td, J(H,F)= 15.0, J(H,H)= 7.4 Hz, CH2), 5.30-5.42 (1H, m, =CH), 
5.50-5.56 (1H, m, =CH); 13C NMR (125 MHz, CDCl3) δ = 15.7 (t, J(C,F)= 4.6 Hz, CH2), 23.1 (CH2), 
27.1 (CH2), 27.3 (CH2), 28.4 (CH2), 28.5 (CH2), 28.62 (CH2), 28.65 (CH2), 31.8 (CH2), 34.4 (t, J(C,F)= 
25.3 Hz, CH2), 40.7 (t, J(C,F)= 26.4 Hz, CH2), 42.0 (CH2), 42.1 (CH2), 121.8 (t, J(C,F)= 6.8 Hz, =CH), 
124.7 (t, J(C,F)= 242 Hz, CF2), 136.5 (=CH), 211.0 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.0 
(2F, s, CF2); IR (thin film) ν (cm-1) = 1704 (C=O); HRMS (ESI+) m/z calcd for C17H28F2ONa [M+Na]+: 
309.2000, found: 309.1998; (Z)-58. 1H NMR (500 MHz, CDCl3) δ = 1.12-1.43 (12H, m, 6 x CH2), 
1.64-1.86 (6H, m, 3 x CH2), 2.03-2.09 (2H, m, CH2), 2.37-2.40 (2H, m, CH2), 2.49-2.53 (2H, m, CH2), 
2.61 (2H, td, J(H,F)= 15.2, J(H,H)= 7.1 Hz, CH2), 5.30-5.42 (1H, m, =CH), 5.50-5.56 (1H, m, =CH); 
13C NMR (125 MHz, CDCl3) δ = 16.1 (t, J(C,F)= 4.5 Hz, CH2), 23.2 (CH2), 26.6 (CH2), 27.5 (CH2), 
27.6 (CH2), 28.17 (CH2), 28.19 (CH2), 28.65 (CH2), 28.68 (CH2), 34.6 (t, J(C,F)= 25.3 Hz, CH2), 35.2 
(t, J(C,F)= 25.9 Hz, CH2), 42.19 (CH2), 42.25 (CH2), 120.7 (t, J(C,F)= 6.1 Hz, =CH), 124.6 (t, J(C,F)= 
242 Hz, CF2), 134.7 (=CH), 211.2 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.6 (2F, s, CF2). 
 
5,5-difluorocycloheptadecan-1-one (20). A mixture of 5% Pd/C (14 mg, 0.01 mmol, 0.1 equiv.) in 1.1 
mL of absolute EtOH was stirred for a few minutes under a small positive pressure of H2. A solution of 
5,5-difluorocycloheptadec-7-en-1-one 58 (18 mg, 0.06 mmol, 1.0 equiv.) in 1.2 mL of absolute EtOH 
was added to the above mixture and the reaction was stirred overnight under H2 atmosphere at room 
temperature. Then, the catalyst was removed by filtration through a short pad of celite and washed with 
Et2O (84 mL). The solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 14:1) gave compound 20 (16 mg, 87%) as a white 
solid; m.p. 52-54 ºC; 1H NMR (500 MHz, CDCl3) δ = 1.26-1.47 (18H, m, 9 x CH2), 1.60-1.65 (2H, m, 
CH2), 1.76-1.90 (6H, m, 3 x CH2), 2.41 (2H, t, J(H,H)= 6.6 Hz, CH2), 2.50 (2H, t, J(H,H)= 6.5 Hz, 
CH2); 13C NMR (125 MHz, CDCl3) δ = 17.2 (t, J(C,F)= 4.9 Hz, CH2), 21.6 (t, J(C,F)= 5.0 Hz, CH2), 
23.7 (CH2), 23.78 (CH2), 26.84 (CH2), 27.0 (CH2), 27.26 (CH2), 27.27 (CH2), 27.5 (CH2), 27.6 (CH2), 
28.1 (CH2), 34.5 (t, J(C,F)= 25.6 Hz, CH2), 35.3 (t, J(C,F)= 25.0 Hz, CH2), 41.8 (CH2), 42.2 (CH2), 
125.8 (t, J(C,F)= 241 Hz, CF2), 211.4 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -94.8 (2F, s, CF2); 
IR (thin film) ν (cm-1) = 1707 (C=O); HRMS (ESI+) m/z calcd for C17H30F2ONa [M+Na]+: 311.2157, 
found: 311.2152. 
 
1,3-bis(2-(hept-6-en-1-yl)-1,3-dithian-2-yl)propane (61). n-BuLi (4.82 mL, 1.5 M solution in 
hexanes, 7.23 mmol, 2.0 equiv.) was added to a solution of 1,3-di(1,3-dithian-2-yl)propane 60 (1.01 g, 
3.61 mmol, 1.0 equiv.) in dry THF (36.1 mL) under argon atmosphere at -30 ºC. The mixture was 
gradually warmed to 0 ºC and stirred for 2 h. Then, 7-bromohept-1-ene (1.1 mL, 7.23 mmol, 2.0 equiv.) 
was added dropwise to the above solution at -30 ºC and the mixture was stirred overnight at room 
temperature. A further aliquot of n-BuLi (4.82 mL, 1.5 M solution in hexanes, 7.23 mmol, 2.0 equiv.) 
was added at -30 ºC and stirred for 2h at room temperature. 7-bromohept-1-ene (1.1 mL, 7.23 mmol, 2.0 






equiv.) was added dropwise at -30 ºC and the mixture was stirred overnight at room temperature. A 
final aliquot of n-BuLi (2.41 mL, 1.5 M solution in hexanes, 3.61 mmol, 1.0 equiv.) was added at -30 ºC 
and stirred for 1h at room temperature. 7-bromohept-1-ene (0.5 mL, 3.61 mmol, 1.0 equiv.) was added 
dropwise at -30 ºC and the mixture was stirred for 6h at room temperature. The reaction mixture was 
quenched with sat. aq. NH4Cl solution (25 mL) and extracted with Et2O (4 x 25 mL). The organic 
extracts were washed with brine (40 mL), dried over anhydrous MgSO4 and the solvent was removed 
under reduced pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 15:1) 
gave compound 61 (1.02 g, 60%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.30-1.36 (4H, m, 
2 x CH2), 1.39-1.47 (8H, m, 4 x CH2), 1.54-1.61 (2H, m, CH2), 1.86-1.91 (8H, m, 4 x CH2), 1.94-1.98 
(4H, m, 2 x CH2), 2.04-2.08 (4H, m, 2 x CH2), 2.80-2.82 (8H, m, 4 x CH2S), 4.93-5.03 (4H, m, 2 x 
=CH2), 5.81 (2H, ddt, J(H,H)= 17.0, 10.2, 6.7 Hz, 2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 19.0 
(CH2), 23.9 (2 x CH2), 25.4 (2 x CH2), 26.0 (4 x CH2S), 28.7 (2 x CH2), 29.2 (2 x CH2), 33.6 (2 x CH2), 
38.1 (2 x CH2), 38.2 (2 x CH2), 53.1 (2 x CS2), 114.3 (2 x =CH2), 138.9 (2 x =CH); HRMS (CI+) m/z 
calcd for C25H45S4 [M+H]+: 473.2399, found: 473.2394. 
 
1,5,11,15-tetrathiadispiro[5.3.5.12]heptacos-21-ene (62). Grubbs’ 1st generation catalyst (44 mg, 0.05 
mmol, 0.05 equiv.) was added to a stirred solution (protected from sunlight) of 1,3-bis(2-(hept-6-en-1-
yl)-1,3-dithian-2-yl)propane 62 (500 mg, 1.06 mmol, 1.0 equiv.) in dry DCM (53 mL) under argon 
atmosphere at room temperature. The mixture was heated at reflux temperature for 2 h. Then, the 
mixture was allowed to warm to room temperature and the solvent was removed under reduced 
pressure. Purification by column chromatography using silica gel (hexanes/EtOAc 15:1) gave 
compound 62 (E/Z 2:1 inseparable mixture of diastereoisomers, 275 mg, 58%) as a colourless oil; (E)-
62. 1H NMR (500 MHz, CDCl3) δ = 1.26-1.55 (14H, m, 7 x CH2), 1.86-2.05 (16H, m, 8 x CH2), 2.80-
2.82 (8H, m, 4 x CH2S), 5.38 (2H, t, J(H,H)= 3.7 Hz,  2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 18.9 
(CH2), 23.8 (2 x CH2), 25.7 (2 x CH2), 26.0 (4 x CH2S), 27.9 (2 x CH2), 28.9 (2 x CH2), 31.0 (2 x CH2), 
37.1 (2 x CH2), 37.4 (2 x CH2), 52.7 (2 x CS2), 130.8 (2 x =CH); (Z)-62. 1H NMR (500 MHz, CDCl3) δ 
= 1.26-1.55 (14H, m, 7 x CH2), 1.86-2.05 (16H, m, 8 x CH2), 2.80-2.82 (8H, m, 4 x CH2S), 5.34 (2H, t, 
J(H,H)= 4.5 Hz,  2 x =CH); 13C NMR (125 MHz, CDCl3) δ = 18.6 (CH2), 22.0 (2 x CH2), 25.4 (2 x 
CH2), 25.8 (2 x CH2), 26.0 (4 x CH2S), 27.5 (2 x CH2), 27.9 (2 x CH2), 37.2 (2 x CH2), 37.4 (2 x CH2), 
52.6 (2 x CS2), 130.2 (2 x =CH); HRMS (CI+) m/z calcd for C23H41S4 [M+H]+: 445.2086, found: 
445.2078. 
1,5,11,15-tetrathiadispiro[5.3.5.12]heptacosan-21-ol (63). Borane dimethyl sulfide complex (0.36 
mL, 2M solution in THF, 0.72 mmol, 1.25 equiv.) was added to a stirred solution of 1,5,11,15-
tetrathiadispiro[5.3.5.12]heptacos-21-ene 62 (256 mg, 0.58 mmol, 1.0 equiv.) in dry THF (6.0 mL) 
under argon atmosphere at 0ºC. The solution was warmed to room temperature and stirred overnight. 
Then, EtOH (0.45 mL), aq. NaOH (2 M, 0.45 mL) and aq. H2O2 (30% w/w, 0.45 mL) were sequentially 
added and the reaction mixture was stirred for 4 h. After evaporation of the volatiles, H2O (2.0 mL) was 
added and the solution was extracted with EtOAc (3 x 12 mL). The combined organic layers were 
washed with brine (12 mL), dried over MgSO4 and the solvent was removed under reduced pressure to 
gave compound 63 (260 mg, 97%) as a colourless oil, which was used without further purification; 1H 
NMR (500 MHz, CDCl3) δ = 1.30-1.57 (20H, m, 10 x CH2), 1.83-2.00 (12H, m, 6 x CH2), 2.75-2.85 
(8H, m, 4 x CH2S), 3.66 (1H, quint, J(H,H)= 5.3 Hz, OCH); 13C NMR (125 MHz, CDCl3) δ = 18.7 
(CH2), 22.3 (CH2), 22.8 (CH2), 23.2 (CH2), 23.6 (CH2), 25.66 (CH2), 25.72 (CH2), 26.0 (4 x CH2S), 
27.5 (CH2), 27.9 (CH2), 28.0 (CH2), 34.9 (CH2), 35.9 (CH2), 37.2 (CH2), 37.3 (CH2), 37.66 (CH2), 
37.75 (CH2), 52.6 (2 x CS2), 70.9 (COH); HRMS (CI+) m/z calcd for C23H41S4 [M+H]+: 445.2086, 
found: 445.2078. 
7,7,11,11-tetrafluorocycloheptadecan-1-ol (64). 70% hydrogen fluoride-pyridine (0.69 mL, 26.5 
mmol, 120 equiv.) was added to a stirred solution of N-iodosuccinimide (398 mg, 1.77 mmol, 8 equiv.) 






in dry DCM (3.5 mL) under argon atmosphere at -78 ºC. The resulting mixture was stirred for 10 min at 
-78 ºC. Then, a solution of 1,5,11,15-tetrathiadispiro[5.3.5.12]heptacosan-21-ol 63 (102 mg, 0.22 mmol, 
1 equiv.) in dry DCM (2.7 mL) was added dropwise to the mixture over 10 min. The reaction mixture 
was stirred at -78 ºC for 4 h and gradually warmed to room temperature overnight. The crude reaction 
was added portionwise to a biphasic mixture of sat. aq. NaHCO3 solution (24 mL) and DCM (12 mL) at 
0 ºC. The aqueous layer was separated and extracted with DCM (3 x 16 mL). The organic extracts were 
washed with 10% w/v sat. aq. Na2S2O3 solution (2 x 24 mL), brine (24 mL), dried over anhydrous 
MgSO4 and the solvent was removed under reduced pressure. Purification by column chromatography 
using silica gel (hexanes/EtOAc 3:1) gave compound 64 (10 mg, 14%) as a colourless oil; 1H NMR 
(500 MHz, CDCl3) δ = 1.36-1.56 (20H, m, 10 x CH2), 1.82-1.97 (8H, m, 4 x CH2), 3.68-3.71 (1H, m, 
OCH); 13C NMR (125 MHz, CDCl3) δ = 17.4 (t, J(C,F)= 6.2 Hz, CH2), 21.16 (t, J(C,F)= 5.8 Hz, CH2), 
21.25 (t, J(C,F)= 5.6 Hz, CH2), 23.0 (CH2), 23.1 (CH2), 27.2 (CH2), 27.4 (CH2), 27.5 (CH2), 34.3 (t, 
J(C,F)= 25.5 Hz, CH2), 34.6 (t, J(C,F)= 25.4 Hz, CH2), 34.7 (CH2), 34.9 (t, J(C,F)= 26.2 Hz, CH2), 35.0 
(t, J(C,F)= 26.4 Hz, CH2), 35.9 (CH2), 70.74 (OCH), 125.5 (t, J(C,F)= 239 Hz, 2 x CF2); 19F{1H} NMR 
(470 MHz, CDCl3) δ = -92.4-93.5 (2F, AB, CF2), -92.68-92.69 (2F, AB, CF2); HRMS (CI+) m/z calcd 
for C17H34F4ON [M+NH4]+: 344.2571, found: 344.2564. 
 
7,7,11,11-tetrafluorocycloheptadecan-1-one (21). IBX (31 mg, 0.11 mmol, 2.0 equiv.) was added to a 
solution of 7,7,11,11-tetrafluorocycloheptadecan-1-ol 64 (18 mg, 0.05 mmol, 1.0 equiv.) in DMSO (0.5 
mL) at room temperature. The resulting mixture was stirred overnight. Then, H2O (1.5 mL) and EtOAc 
(1.5 mL) were sequentially added and the precipitated white solid was filtered and the filtrate collected. 
The organic layer was separated and washed with H2O (2 x 1.5 mL) and brine (1.5 mL), dried over 
anhydrous MgSO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography using silica gel (hexanes/EtOAc 8:1) gave compound 21 (10 mg, 59%) as a white 
solid; m.p. 43-45 ºC;  1H NMR (500 MHz, CDCl3) δ = 1.26-1.33 (2H, m, CH2), 1.37-1.48 (8H, m, 4 x 
CH2), 1.51-1.57 (2H, m, CH2), 1.60-1.67 (4H, m, 2 x CH2), 1.78-1.97 (8H, m, 4 x CH2), 2.42 (2H, t, 
J(H,H)= 6.7 Hz, CH2), 2.43 (2H, t, J(H,H)= 6.7 Hz, CH2); 13C NMR (125 MHz, CDCl3) δ = 17.4 (t, 
J(C,F)= 5.8 Hz, CH2), 21.75 (t, J(C,F)= 4.9 Hz, CH2), 21.85 (t, J(C,F)= 5.1 Hz, CH2), 22.9 (CH2), 23.4 
(CH2), 27.5 (CH2), 27.6 (CH2), 28.1 (CH2), 34.1 (t, J(C,F)= 25.4Hz, CH2), 34.68 (t, J(C,F)= 26.2 Hz, 
CH2), 34.70 (t, J(C,F)= 25.6 Hz, 2 x CH2), 42.0 (CH2), 42.1 (CH2), 125.4 (t, J(C,F)= 241 Hz, CF2), 
125.6 (t, J(C,F)= 240 Hz, CF2), 211.8 (C=O); 19F{1H} NMR (470 MHz, CDCl3) δ = -92.6 (2F, s, CF2), -
93.0 (2F, s, CF2); IR (thin film) ν (cm-1) = 1705 (C=O); HRMS (ESI+) m/z calcd for C17H32F4ON 
[M+NH4]+: 342.2415, found: 342.2417. 
 
(R)-3-methylcyclopentadec-6-en-1-one (66). Grubbs catalyst (2nd generation, 30 mg, 0.035 mmol, 8 
mol%) was added to a solution of (R)-2,6-dimethyloctadeca-2,17-dien-8-one 65 (124 mg, 0.42 mmol, 
1.0 eq) in dry DCE (400 mL) in a foil covered flask at r.t. under argon. The reaction mixture was heated 
at 65 °C for 17 h, then cooled to r.t. and the solvent was removed in vacuo. Purification of the residue 
by column chromatography using silica gel (ehtyl acetate/pet.ether 1:30) gave compound 66 (E/Z 2:1, 
inseparable mixture of diastereoisomers, 30 mg, 30%) as a colorless oil; [α]D -8.2° (c 0.6, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ = 0.91 and 0.94 (3H, d, J(H,H)= 6.5 Hz, CH3), 1.22-1.37 (12H, m, CH2), 
1.58-1.66 (2H, m, CH2), 2.02-2.15 (6H, m, CH2), 2.33-2.39 (3H, m, CH2), 5.33-5.35 (2H, m, CH=CH); 
13C NMR (100 MHz, CDCl3) δ = 19.8 (CH3), 23.3 (CH2), 26.8(CH2), 27.1 (CH2), 27.7 (CH2), 27.9 
(CH2), 28.4 (CH), 29.5 (CH2), 31.7 (CH2), 36.5 (CH2), 42.3 (CH2), 51.3 (CH2), 130.7 (=CH), 131.5 
(=CH), 212.7 (C=O). These data are in good agreement with the literature values.6 
 
(R)-Muscone (2). A solution of (R)-3-methylcyclopentadec-6-en-1-one 66 (45 mg, 0.19 mmol, 1.0 eq) 
and palladium on activated carbon (5 wt% on carbon, 40 mg, 10 mol%) in methanol (2 mL) was stirred 
under a hydrogen atmosphere (1 atm) for 22 h. The reaction mixture was filtered through celite and the 






celite was washed with methanol. The solvent was removed in vacuo to give (R)-muscone 2 (43 mg, 
95%) as a colourless oil that was used without further purification. [α]D -9.8° (c 0.55, CHCl3), [lit.12 
[α]D -12.4° (c 0.76, CHCl3)]; 1H NMR (400 MHz, CDCl3) δ = 0.94 (3H, d, J(H,H)= 6.7 Hz, CH3), 1.18-
1.67 (22H, m, CH2), 2.03-2.04 (1H, m, CH), 2.19 (1H, dd, J(H,H)= 5.2 and 15.0 Hz), 2.37-3.04 (3H, m, 
CH2); 13C NMR (100 MHz, CDCl3) δ = 21.2 (CH3), 23.2 (CH2), 25.2 (CH2), 26.3 (CH2), 26.4 (CH2), 
26.6 (CH2), 26.7 (CH2), 26.7 (CH2), 26.9 (CH2), 27.2 (CH2), 27.7 (CH2), 29.2 (CH), 35.7 (CH2), 42.2 
(CH2), 50.6 (CH2), 212.2 (C=O). These data are in good agreement with the literature values.6 
 
10-((4-Methoxyphenyl)methoxy)dec-1-en-5-ol (76). Iodine (trace) was added to a suspension of 
magnesium turnings (1.96 g, 80.6 mmol, 2.0 eq) in dry diethyl ether (80 mL) under argon at r.t. and 
stirred until the reaction turned colourless. A solution of 4-bromo-1-butene (8.2 mL, 80.6 mmol, 2.0 eq) 
in dry diethyl ether (20 mL) was added at a rate sufficient to maintain autoreflux and stirred for 30 min 
after addition was complete. The reaction mixture was diluted with diethyl ether (180 mL), then cooled 
to 0 °C and a solution of 6-((4-methoxyphenyl)methoxy)hexanal 75 (9.5 g, 40.3 mmol, 1.0 eq) in dry 
diethyl ether (20 mL) was added. The reaction mixture was stirred at 0 °C for 1 h, then warmed to r.t. 
and stirred for 18 h. The reaction mixture was quenched with sat. ammonium chloride solution (250 
mL) and extracted with diethyl ether (2 x 250 mL). The combined organic layers were washed with 
brine (250 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. Purification by 
column chromatography using silica gel (ethyl acetate/pet. ether 1:4) gave compound 76 (6.9 g, 52%) as 
a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.32-1.65 (11H, m, CH2, OH), 2.11-2.25 (2H, m, 
CH2), 3.45 (2H, t, J(H,H)= 6.6 Hz, CH2), 3.59-3.64 (1H, m, CH), 3.81 (3H, s, CH3), 4.44 (2H, s, CH2), 
4.97-5.08 (2H, m, CH2), 5.85 (1H, ddt, J(H,H)= 17.0, 10.2, 6.6, CH), 6.87-6.90 (2H, m, ArH), 7.25-7.28 
(2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 25.7 (CH2), 26.5 (CH2), 29.9 (CH2), 30.3 (CH2), 36.7 
(CH2), 37.6 (CH2), 55.5 (CH3), 70.2 (CH2), 71.6 (CH), 72.7 (CH2), 113.9 (CH), 115.0 (CH2), 129.5 
(CH), 130.9 (C), 138.8 (CH), 159.3 (C); HRMS: m/z calcd for C18H28Na1O3 [M+Na]+: 315.1931; found: 
315.1921. 
 
10-((4-Methoxyphenyl)methoxy)dec-1-en-5-one (77). DMP (10.2 g, 24.1 mmol, 1.2 eq) was added to 
a solution of 10-((4-methoxyphenyl)methoxy)dec-1-en-5-ol 76 (5.88 g, 20.1 mmol, 1.0 eq) in DCM 
(300 mL) at r.t. and stirred for 2 h. The reaction mixture was diluted with diethyl ether (200 mL) and 
sat. NaHCO3 solution (250 mL). Sodium thiosulfate (20 g) was added and the reaction mixture was 
stirred vigorously for 30 min. The organic layer was separated and washed with brine (300 mL), dried 
over anhydrous Na2SO4 and the solvent was removed in vacuo to give compound 77 (5.8 g) as a 
colourless oil that was used without further purification; 1H NMR (500 MHz, CDCl3) δ = 1.33-1.39 
(2H, m, CH2), 1.56-1.64 (4H, m, CH2), 2.30-2.34 (2H, m, CH2), 2.41 (2H, t, J(H,H)= 7.5 Hz, CH2), 2.50 
(2H, t, J(H,H)= 7.6 Hz, CH2), 3.44 (2H, t, J(H,H)= 6.6 Hz, CH2), 3.81 (3H, s, CH3), 4.43 (2H, s, CH2), 
4.97-5.05 (2H, m, CH2), 5.81 (1H, ddt, J(H,H)= 16.8, 10.1, 6.6 Hz, CH), 6.87-6.90 (2H, m, ArH), 7.25-
7.27 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 23.8 (CH2), 26.1 (CH2), 28.0 (CH2), 29.7  42.0 
(CH2), 43.0 (CH2), 55.5 (CH3), 70.0 (CH2), 72.8 (CH2), 114.0 (CH), 115.4 (CH2), 129.4 (CH), 130.9 
(C), 137.4 (CH), 159.3 (C), 210.5 (CO); HRMS: m/z calcd for C18H26Na1O3 [M+Na]+: 313.1774; found: 
313.1764. 
 
1-(((6,6-Difluorodec-9-en-1-yl)oxy)methyl)-4-methoxybenzene (78). A solution of 10-((4-
methoxyphenyl)methoxy)dec-1-en-5-one 77 (5.8 g, 20.1 mmol, 1.0 eq) in DAST (10.6 mL, 80.4 mmol, 
4.0 eq) was heated at 50 °C under argon for 18 h. The reaction mixture was cooled to r.t. and poured 
onto sat. NaHCO3 solution (200 mL). The reaction mixture was extracted with DCM (2 x 200 mL). The 
combined organic layers were washed with brine (250 mL), dried over anhydrous Na2SO4 and the 
solvent was removed in vacuo. Purification by column chromatography using silica gel (ethyl 
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acetate/pet. ether 1:19) gave compound 78 (4.2 g, 67%) as a yellow oil; 1H NMR (500 MHz, CDCl3) δ 
= 1.39-1.54 (4H, m, CH2), 1.62 (2H, tt, J(H,H)= 7.4, 6.6 Hz, CH2), 1.77-1.95 (4H, m, CH2), 2.21-2.26 
(2H, m CH2), 3.45 (2H, t, J(H,H)= 6.5 Hz, CH2), 3.81 (3H, s, CH3), 4.44 (2H, s, CH2), 5.00-5.09 (2H, 
m, CH2), 5.83 (1H, ddt, J(H,H)= 16.7, 10.2, 6.5 Hz, CH2), 6.87-6.90 (2H, m, ArH), 7.26-7.28 (2H, m, 
ArH); 13C NMR (125 MHz, CDCl3) δ = 24.4 (t, J(C,F)= 4.5 Hz, CH2), 26.3 (CH2), 26.7 (t, J(C,F)= 5.2 
Hz, CH2), 29.8 (CH2), 35.8 (t, J(C,F)= 25.5 Hz, CH2), 36.6 (t, J(C,F)= 25.3 Hz, CH2), 55.5 (CH3), 70.0 
(CH2), 72.8 (CH2), 114.0 (CH), 115.4 (CH2), 125.2 (t, J(C,F)= 240.7 Hz, CF2), 129.5 (CH), 130.9 (C), 
137.3 (CH), 159.3 (C); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.2 (2F, s, CF2); HRMS: m/z calcd for 
C18H26F2Na1O2 [M+Na]+: 335.1793; found: 335.1785. 
 
6,6-Difluorodec-9-en-1-ol (79). DDQ (4.6 g, 20.0 mmol, 1.5 eq) was added to a solution of 1-(((6,6-
difluorodec-9-en-1-yl)oxy)methyl)-4-methoxybenzene 78 (4.2 g, 13.4 mmol, 1.0 eq) in DCM (200 mL) 
and water (2 mL) at r.t. and stirred for 1 h. The reaction mixture was quenched with sat. NaHCO3 
solution (250 mL) and extracted with diethyl ether (2 x 200 mL). The combined organic layers were 
washed with brine (250 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:19) gave compound 
79 (2.1 g, 81%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.39-1.45 (3H, m, CH2, OH), 1.48-
1.55 (2H, m ,CH2), 1.57-1.63 (2H, m, CH2), 1.79-1.97 (4H, m, CH2), 2.22-2.26 (2H, m, CH2), 3.66 (2H, 
t, J(H,H)= 6.5 Hz, CH2), 4.99-5.08 (2H, m, CH2), 5.83 (1H, ddt, J(H,H)= 16.8, 10.3, 6.4 Hz, CH); 13C 
NMR (125 MHz, CDCl3) δ = 22.3 (t, J(C,F)= 4.7 Hz, CH2), 25.8 (CH2), 26.7 (t, J(C,F)= 5.1 Hz, CH2), 
32.7 (CH2), 35.8 (t, J(C,F)= 25.7 Hz, CH2), 36.6 (t, J(C,F)= 25.4 Hz, CH2), 62.9 (CH2), 115.4 (CH2), 
125.1 (t, J(C,F)= 240.8 Hz, CF2), 137.3 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.3 (2F, s, CF2); 
HRMS: m/z calcd for C10H18F2Na1O1 [M+Na]+: 215.1218; found: 215.1215. 
 
10-Bromo-5,5-difluorodec-1-ene (80). Carbon tetrabromide (3.7 g, 11.2 mmol, 1.1 eq) and 
triphenylphosphine (2.9 g, 11.2 mmol, 1.1 eq) were added to a solution of 6,6-difluorodec-9-en-1-ol 79 
(1.95 g, 10.1 mmol, 1.0 eq) in dry DCM (200 mL) at 0 °C under argon. The reaction mixture was stirred 
at 0 °C for 1 h, then warmed to r.t. and stirred for 18 h. The solvent was removed in vacuo. Purification 
of the residue by column chromatography using silica gel (ethyl acetate/pet. ether 1:19) gave compound 
80 (1.92 g, 75%) as a colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.50-1.55 (4H, m, CH2), 1.80-0.97 
(6H, m ,CH2), 2.22-2.27 (2H, m, CH2), 3.42 (2H, t, J(H,H)= 6.7 Hz, CH2), 5.00-5.09 (2H, m, CH2), 5.83 
(1H, ddt, J(H,H)= 16.8, 10.2, 6.5 Hz, CH); 13C NMR (125 MHz, CDCl3) δ = 21.7 (t, J(C,F)= 4.7 Hz, 
CH2), 26.7 (t, J(C,F)= 5.0 Hz, CH2), 28.1 (CH2), 33.8 (CH2), 35.9 (t, J(C,F)= 25.5 Hz, CH2), 36.5 (t, 
J(C,F)= 25.5 Hz, CH2), 115.5 (CH2), 125.0 (t, J(C,F)= 240.7 Hz, CF2), 137.2 (CH); 19F{1H} NMR (470 
MHz, CDCl3) δ = -98.5 (2F, s, CF2). 
 
(5R)-13,13-Difluoro-5-methylheptadeca-1,16-diene-7-ol (82). Iodine (trace) was added to a 
suspension of magnesium turnings (76 mg, 3.1 mmol, 2.0 eq) in dry diethyl ether (5 mL) under argon at 
r.t. and stirred until the reaction turned colourless. A solution of 10-bromo-5,5-difluorodec-1-ene 80 
(0.8 g, 3.1 mmol, 2.0 eq) in dry diethyl ether (5 mL) was added and the reaction was heated at reflux for 
2 h. The reaction mixture was cooled to r.t. and diluted with diethyl ether (10 mL), then cooled to 0 °C 
and a solution of 81 (0.2 g, 1.6 mmol, 1.0 eq) in dry diethyl ether (10 mL) was added. The reaction 
mixture was stirred at 0 °C for 30 min, then warmed to r.t. and stirred for 18 h. The reaction mixture 
was quenched with sat. ammonium chloride solution (60 mL) and extracted with ethyl acetate (2 x 50 
mL). The combined organic layers were washed with brine (60 mL), dried over anhydrous Na2SO4 and 
the solvent was removed in vacuo. Purification by column chromatography using silica gel (ethyl 
acetate/pet. ether 1:9) gave compound 82 (0.20 g, 43%) as a colourless oil, as a 1:1 mixture of 
diastereoisomers; [α]D -2.1° (c 0.71, CHCl3);  1H NMR (500 MHz, CDCl3) δ = 0.92 and 0.93 (3H, d, 
J(H,H)= 6.0 Hz, CH3), 1.15-1.72 (14H, m, CH, CH2, OH), 1.78-1.96 (4H, m, CH2), 1.99-2.16 (2H, m, 






CH2), 2.22-2.27 (2H, m, CH2), 3.66-3.73 (1H, m, CH), 4.94-5.08 (4H, m, CH2), 5.78-5.87 (2H, m, CH); 
13C NMR (125 MHz, CDCl3) δ = 19.3 and 20.4 (CH3), 22.5 (t, J(C,F)= 4.4 Hz, CH2), 25.5 and 25.7 
(CH2), 26.7 (t, J(C,F)= 5.1 Hz, CH2), 29.0 and 29.3 (CH), 29.6 (CH2), 31.4 and 31.5 (CH2), 35.8 (t, 
J(C,F)= 25.7 Hz, CH2), 36.6 (t, J(C,F)= 25.2 Hz, CH2), 37.2 (CH2), 37.8 and 38.4 (CH2), 45.1 and 45.4 
(CH2), 69.7 and 70.0 (CH), 114.4 and 114.5 (CH2), 115.4 (CH2), 125.7 (t, J(C,F)= 240.7 Hz, CF2), 
137.3 (CH), 139.3 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.2 (2F, s, CF2); HRMS: m/z calcd for 
C18H32F2Na1O1 [M+Na]+: 325.2313; found: 325.2304. 
 
(5R)-13,13-Difluoro-5-methylheptadeca-1,16-diene-7-one (83). DMP (0.38 g, 0.9 mmol, 1.5 eq) was 
added to a solution of (5R)-13,13-difluoro-5-methylheptadeca-1,16-diene-7-ol 82 (0.18 g, 0.6 mmol, 1.0 
eq) in DCM (10 mL) at r.t. and stirred for 1 h. The reaction mixture was diluted with diethyl ether (10 
mL) and sat. NaHCO3 solution (100 mL). Sodium thiosulfate (0.8 g) was added and the reaction 
mixture was stirred vigorously for 30 min. The organic layer was separated and the aqueous layer was 
re-extracted with diethyl ether (20 mL). The combined organic layers were washed with brine (30 mL), 
dried over anhydrous Na2SO4 and the solvent was removed in vacuo to give compound 83 (0.18 g) as a 
yellow oil that was used without further purification; [α]D +2.2° (c 0.59, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ = 0.90 (3H, d, J(H,H)= 6.5 Hz, CH3), 1.22-1.42 (4H, m, CH2), 1.45-1.51 (2H, m, CH2), 1.56-
1.62 (2H, m, CH2), 1.77-1.95 (4H, m, CH2), 2.01-2.13 (3H, m, CH2, CH), 2.20-2.26 (3H, m, CH2, 
CHAHB), 2.37-2.41 (3H, m, CH2, CHAHB), 4.94-5.08 (4H, m, CH2), 5.76-5.86 (2H, m, CH); 13C NMR 
(125 MHz, CDCl3) δ = 19.9 (CH3), 22.3 (t, J(C,F)= 4.6 Hz, CH2), 23.6 (CH2), 26.7 (t, J(C,F)= 5.1 Hz, 
CH2), 29.0 (CH), 29.1 (CH2), 31.4 (CH2), 35.8 (t, J(C,F)= 25.5 Hz, CH2), 36.2 (CH2), 36.5 (t, J(C,F)= 
25.2 Hz, CH2), 43.2 (CH2), 50.4 (CH2), 114.7 (CH2), 115.4 (CH2), 125.1 (t, J(C,F)= 241.3 Hz, CF2), 
137.3 (CH), 138.9 (CH), 211.0 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.4 (2F, s, CF2); HRMS: 
m/z calcd for C18H30F2Na1O1 [M+Na]+: 323.2157; found: 323.2150. 
 
(3R)-10,10-Difluoro-3-methylcyclopentadec-6-en-1-one (84). Grubbs catalyst (1st generation, 25 mg, 
0.03 mmol, 6 mol%) was added to a solution of (5R)-13,13-difluoro-5-methylheptadeca-1,16-diene-7-
one 83 (0.16 g, 0.53 mmol, 1.0 eq) in dry DCM (200 mL) in a foil covered flask at r.t. under argon. The 
reaction mixture was heated at 45 °C for 17 h, then cooled to r.t. and the solvent was removed in vacuo. 
Purification of the residue by column chromatography using silica gel (ethyl acetate/pet. ether 1:49) 
gave compound (E)-84 (39 mg, 27%) as a pale brown oil and compound (Z)-84 (36 mg, 25%) as a pale 
brown, waxy solid. (E)-84. [α]D  +14.4° (c 0.89, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.95 (3H, d, 
J(H,H)= 6.7 Hz, CH3), 1.21-1.45 (6H, m, CH2), 1.52-1.60 (1H, m, CHAHB), 1.66-1.86 (3H, m, CHAHB, 
CH2), 1.91-2.14 (5H, m, CH2, CH), 2.15-2.24 (3H, m, CHAHB, CH2), 2.35-2.46 (3H, m, CHAHB, CH2), 
5.39-5.49 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 20.1 (CH3), 20.6 (t, J(C,F)= 5.0 Hz, CH2), 
22.5 (CH2), 26.5-26.6 (m, CH2), 27.2 (CH2), 28.9 (CH2), 29.3 (CH), 35.1 (t, J(C,F)= 25.8 Hz, CH2), 
35.2 (t, J(C,F)= 25.4 Hz, CH2), 35.6 (CH2), 41.4 (CH2), 50.5 (CH2), 125.9 (t, J(C,F)= 240.3 Hz, CF2), 
129.9 (CH), 131.7 (CH), 212.3 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -91.2 (1F, d, J(F,F)= 242.5 
Hz, CFAFB), -92.5 (1F, d, J(F,F)= 242.5 Hz, CFAFB); IR (thin film) ν (cm-1) = 1709 (C=O); (Z)-84. [α]D  
-7.3° (c 0.91, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.99 (3H, d, J(H,H)= 6.8 Hz, CH3), 1.21-1.49 
(8H, m, CH2), 1.57-1.90 (4H, m, CH2), 1.93-2.15 (5H, m, CH2, CH), 2.25-2.53 (4H, m, CH2), 5.35-5.45 
(2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 21.4 (CH3), 21.5 (t, J(C,F)= 5.8 Hz, CH2), 21.8 (CH2), 
21.9 (t, J(C,F)= 5.4 Hz, CH2), 24.8 (CH2), 28.4 (CH2), 29.5 (CH), 34.8 (t, J(C,F)= 25.5 Hz, CH2), 35.6 
(t, J(C,F)= 25.5 Hz, CH2), 36.6 (CH2), 41.6 (CH2), 50.4 (CH2), 125.9 (t, J(C,F)= 241.1 Hz, CF2), 128.4 
(CH), 130.7 (CH), 211.1 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -91.5 (1F, d, J(F,F)= 243.6 Hz, 
CFAFB), -92.0 (1F, d, J(F,F)= 243.6 Hz, CFAFB); IR (thin film) ν (cm-1) = 1710 (C=O); HRMS: m/z 
calcd for C16H26F2Na1O1 [M+Na]+: 295.1844; found: 295.1839. 
 






(3R)-10,10-Difluoro-3-methylcyclopentadecan-1-one (67). A solution of (3R,6E)-10,10-difluoro-3-
methylcyclopentadec-6-en-1-one 84 (20 mg, 0.07 mmol, 1.0 eq) and palladium on activated carbon (10 
wt% on carbon, 8 mg, 10 mol%) in methanol (5 mL) was stirred under a hydrogen atmosphere (1 atm) 
for 22 h. The reaction mixture was filtered through celite and the celite was washed with methanol (20 
mL). The solvent was removed in vacuo to give compound 67 (12 mg, 59%) as a colourless oil that was 
used without further purification. The compound solidified upon cooling to -20 ºC; [α]D -10.6° (c 0.33, 
CHCl3);  1H NMR (500 MHz, CDCl3) δ = 0.97 (3H, d, J(H,H)= 6.8 Hz, CH3), 1.19-1.49 (14H, CH2-
4,5,6,7,8,12,13), 1.58-1.65 (1H, m, CHAHB-14), 1.71-1.89 (5H, m, CH2-9,11, CHAHB-14), 2.02-2.09 
(1H, m, CH-3), 2.26 (1H, dd, J(H,H)= 15.6, 4.2 Hz, CHAHB-2), 2.38 (1H, dd, J(H,H)= 15.5, 9.1 Hz, 
CHAHB-2), 2.42-2.51 (2H, m, CH2-15); 13C NMR (125 MHz, CDCl3) δ = 20.9 (t, J(C,F)= 5.4 Hz, CH2 
C8/12), 21.6 (CH3), 22.0 (t, J(C,F)= 6.3 Hz, CH2 C8/12), 22.0 (CH2, C14), 24.7 (CH2, C5), 26.6 (CH2, 
C6), 27.1 (CH2, C7), 28.2 (CH2, C13), 29.5 (CH, C3), 34.3 (t, J(C,F)= 25.5 Hz, CH2 C9/11), 34.7 (t, 
J(C,F)= 25.6 Hz, CH2 C9/11), 35.6 (CH2, C4), 41.9 (CH2, C15), 50.4 (CH2, C2), 126.6 (t, J(C,F)= 240.1 
Hz, CF2 C10), 211.4 (CO, C1); 19F{1H} NMR (470 MHz, CDCl3) δ = -90.2 (1F, d, J(F,F)= 242.7 Hz, 
CFAFB), -91.3 (1F, d, J(F,F)= 242.7 Hz, CFAFB); IR (thin film) ν (cm-1) = 1711 (C=O); HRMS: m/z 
calcd for C16H28F2Na1O1 [M+Na]+: 297.2000; found: 297.1995. 
 
10-Bromo-4,4-difluorodec-1-ene (85). Using the same procedure as for 80, 7,7-difluorodec-9-en-1-ol 
44 (4.9 g, 25.4 mmol, 1.0 eq) gave compound 85 (4.36 g, 67%) as a colourless oil; 1H NMR (500 MHz, 
CDCl3) δ = 1.33-1.39 (2H, m, CH2), 1.44-1.56 (4H, m, CH2), 1.77-1.90 (2H, m, CH2), 2.60 (2H, td, 
J(H,F)= 15.8 Hz, J(H,H)= 7.2 Hz, CH2), 3.42 (2H, t, J(H,H)= 6.8 Hz, CH2), 5.19-5.23 (2H, m, CH2), 
5.76-5.84 (1H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 22.1 (t, J(C,F)= 4.6 Hz, CH2), 28.1 (CH2), 
28.7 (CH2), 32.8 (CH2), 34.0 (t, J(C,F)= 25.2 Hz, CH2), 41.4 (t, J(C,F)= 26.6 Hz, CH2), 120.3 (CH2), 
124.4 (t, J(C,F)= 241.5 Hz, CF2), 130.0 (t, J(C,F)= 5.9 Hz, CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -
97.3 (2F, s, CF2); HRMS: m/z calcd for C10H21Br1F2N1 [M(78Br)+NH4]+: 272.0820; found: 272.0815. 
 
(5R)-14,14-Difluoro-5-methylheptadeca-1,16-diene-7-ol (86). Iodine (trace) was added to a 
suspension of magnesium turnings (406 mg, 16.7 mmol, 4.0 eq) in dry THF (10 mL) under argon at r.t. 
and stirred until the reaction turned colourless. A solution of 10-bromo-4,4-difluorodec-1-ene 85 (4.26 
g, 16.7 mmol, 4.0 eq) in dry THF (10 mL) was added and the reaction was heated at reflux for 6 h. The 
reaction mixture was cooled to r.t. and diluted with THF (60 mL), then cooled to 0 °C and a solution of 
(3R)-3-methylhept-6-enal 81 (0.53 g, 4.2 mmol, 1.0 eq) in dry THF (20 mL) was added. The reaction 
mixture was stirred at 0 °C for 30 min, then warmed to r.t. and stirred for 18 h. The reaction mixture 
was quenched with sat. ammonium chloride solution (100 mL) and extracted with ethyl acetate (2 x 100 
mL). The combined organic layers were washed with brine (200 mL), dried over anhydrous Na2SO4 and 
the solvent was removed in vacuo. Purification by column chromatography using silica gel (ethyl 
acetate/pet. ether 1:9) gave compound 86 (0.51 g, 40%) as a colourless oil, as a 1:1 mixture of 
diastereoisomers; [α]D -0.2° (c 0.84, CHCl3);  1H NMR (500 MHz, CDCl3) δ = 0.92 (3H, d, J(H,H)= 6.6 
Hz, CH3) and 0.93 (3H, d, J(H,H)= 6.7 Hz, CH3), 1.15-1.52 (15H, m, CH2, OH), 1.57-1.71 (1H, m, 
CH), 1.76-1.86 (2H, m, CH2), 1.99-2.16 (2H, m, CH2), 2.60 (2H, td, J(H,F)= 15.8 Hz, J(H,H)= 7.1 Hz, 
CH2), 3.68-3.71 (1H, m, CH), 4.93-5.04 (2H, m, CH2), 5.19-5.22 (2H, m, CH2), 5.76-5.86 (2H, m, CH); 
13C NMR (125 MHz, CDCl3) δ = 19.3 and 20.5 (CH3), 22.2 (t, J(C,F)= 4.4 Hz, CH2), 25.6 and 25.7 
(CH2), 29.0 and 29.3 (CH), 29.5 and 29.7 (CH2), 31.4 and 31.5 (CH2), 35.9 and 36.1 (CH2), 36.1 (t, 
J(C,F)= 25.0 Hz, CH2), 37.2 (CH2), 37.9 and 38.5 (CH2), 41.4 (t, J(C,F)= 26.4 Hz, CH2), 45.1 and 45.4 
(CH2), 69.8 and 70.1 (CH), 114.4 and 114.5 (CH2), 120.2 (CH2), 124.5 (t, J(C,F)= 241.3 Hz, CF2), 
130.1 (t, J(C,F)= 6.1 Hz, CH), 139.4 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.2 (2F, s, CF2); 
HRMS: m/z calcd for C18H32F2Na1O1 [M+Na]+: 325.2313; found: 325.2312. 
 






(5R)-14,14-Difluoro-5-methylheptadeca-1,16-diene-7-one (87). Using the same procedure as for 77, 
(5R)-14,14-difluoro-5-methylheptadeca-1,16-diene-7-ol 86 (0.46 g, 1.5 mmol, 1.0 eq) gave compound 
87 (0.45 g) as a yellow oil; [α]D +2.6° (c 0.54, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.90 (3H, d, 
J(H,H)= 6.7 Hz, CH3), 1.22-1.42 (6H, m, CH2), 1.44-1.50 (2H, m, CH2), 1.54-1.60 (2H, m, CH2), 1.75-
1.85 (2H, m, CH2), 1.98-2.14 (2H, m, CH2), 2.20-2.25 (1H, m, CHAHB), 2.37-2.41 (3H, m, CH2, 
CHAHB), 2.60 (2H, td, J(H,F)= 15.8 Hz, J(H,H)= 7.2 Hz, CH2), 4.94-5.03 (2H, m, CH2), 5.18-5.22 (2H, 
m, CH2), 5.75-5.84 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.9 (CH3), 22.1 (CH2, t, J(C,F)= 
4.3 Hz), 23.7 (CH2), 29.0 (CH), 29.2 (CH2), 31.4 (CH2), 36.0 (CH2, t, J(C,F)= 24.9 Hz), 36.2 (CH2), 
41.4 (CH2, t, J(C,F)= 26.4 Hz), 43.4 (CH2), 50.4 (CH2), 114.7 (CH2), 120.2 (CH2), 124.4 (CF2, t, 
J(C,F)= 241.2 Hz), 130.0 (t, J(C,F)= 5.8 Hz, CH), 138.9 (CH), 211.3 (CO); 19F{1H} NMR (470 MHz, 
CDCl3) δ = -97.3 (2F, s, CF2); HRMS: m/z calcd for C18H30F2Na1O1 [M+Na]+: 323.2157; found: 
323.2154. 
 
(3R)-10,10-Difluoro-3-methylcyclopentadec-6-en-1-one (88). Grubbs catalyst (1st generation, 70 mg, 
0.06 mmol, 6 mol%) was added to a solution of (5R)-14,14-difluoro-5-methylheptadeca-1,16-diene-7-
one 87 (0.46 g, 1.5 mmol, 1.0 eq) in dry DCM (400 mL) in a foil covered flask at r.t. under argon. The 
reaction mixture was heated at 45 °C for 21 h, then cooled to r.t. and the solvent was removed in vacuo. 
Purification of the residue by column chromatography using silica gel (ethyl acetate/pet. ether 1:49) 
gave RCM product 88-1 (186 mg, 45%) as a pale brown solid as a single isomer and RCM product 88-2 
(200 mg, 49%) as a pale brown oil as a 1.0:0.8 mixture of isomers. RCM product 88-1; [α]D  -2.2° (c 
1.02, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.96 (3H, d, J(H,H)= 6.6 Hz, CH3, A), 0.99 (3H, d, 
J(H,H)= 6.8 Hz, CH3, B), 1.23-1.49 (10H, m, CH2), 1.57-1.70 (2H, m, CH2), 1.73-1.85 (2H, m, CH2), 
1.89-1.95 (1H, m, CH, A), 1.98-2.12 (2H, m, CH (B), CHAHB), 2.16-2.22 (2H, m, CHAHB, CHAHB), 
2.28-2.48 (3H, m, CHAHB, CH2), 2.51-2.66 (2H, m, CH2), 5.35-5.43 (1H, m, CH), 5.52-5.58 (1H, m, 
CH); 13C NMR (125 MHz, CDCl3) δ = 19.9 (CH3, A), 20.6 (CH2, t, J(C,F)= 5.0 Hz, A), 21.0 (CH3, B), 
21.8 (CH2, t, J(C,F)= 5.1 Hz, B), 23.0 (CH2, A), 25.1 (CH2, B), 26.8 (CH2, A+B), 27.0 (CH2, B), 27.3 
(CH2 A), 28.7 (CH, A), 29.4 (CH2, A), 29.8 (CH, B), 34.3 (CH2, t, J(C,F)= 26.4 Hz, B), 34.6 (CH2, t, 
J(C,F)= 25.1 Hz, A), 35.1 (CH2, t, J(C,F)= 25.2 Hz, B), 36.0 (CH2, A), 36.2 (CH2, B), 39.9 (CH2, t, 
J(C,F)= 26.7 Hz, A), 41.3 (CH2, B), 42.3 (CH2, A), 50.4 (CH2, B), 51.6 (CH2, A), 121.6 (CH, t, J(C,F)= 
6.6 Hz, B), 123.2 (CH, t, J(C,F)= 7.1 Hz, A), 125.4 (CF2, t, J(C,F)= 241.6 Hz, B), 125.4 (CF2, t, 
J(C,F)= 241.3 Hz, A), 133.9 (CH, B), 135.8 (CH, A), 212.0 (CO, B), 212.4 (CO, A); 19F{1H} NMR 
(470 MHz, CDCl3) A: δ = -93.3 (1F, d, J(F,F)= 242.2 Hz, CFAFB), -94.0 (1F, d, J(F,F)= 242.2 Hz, 
CFAFB), B: -93.3 (1F, d, J(F,F)= 242.2 Hz, CFAFB), -94.2 (1F, d, J(F,F)= 242.0 Hz, CFAFB); HRMS: 
m/z calcd for C16H26F2Na1O1 [M+Na]+: 295.1844; found: 295.1841. RCM product 88-2. [α]D  +0.4° (c 
1.14, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.96 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.23-1.51 (10H, m, 
CH2), 1.60 (2H, t, J(H,H)= 7.2, 6.7 Hz, CH2), 1.73-1.83 (2H, m, CH2), 1.89-1.95 (1H, m, CH), 2.04-
2.12 (1H, m, CHAHB), 2.28-2.34 (2H, m, CHAHB, CHAHB), 2.39-2.45 (1H, m, CHAHB), 2.51-2.60 (2H, 
m, CH2), 5.36-5.43 (1H, m, CH), 5.51-5.58 (1H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.9 (CH3), 
20.6 (CH2, t, J(C,F)= 5.0 Hz), 23.0 (CH2), 26.8 (CH2), 27.3 (CH2), 28.7 (CH), 29.4 (CH2), 34.6 (CH2, t, 
J(C,F)= 25.1 Hz), 36.0 (CH2), 39.9 (CH2, t, J(C,F)= 26.7 Hz), 42.3 (CH2), 51.6 (CH2), 123.2 (CH, t, 
J(C,F)= 7.1 Hz), 125.4 (CF2, t, J(C,F)= 241.3 Hz), 135.8 (CH), 212.4 (CO); 19F{1H} NMR (470 MHz, 
CDCl3) δ = -93.3 (1F, d, J(F,F)= 242.2 Hz, CFAFB), -94.0 (1F, d, J(F,F)= 242.2 Hz, CFAFB); IR (thin 
film) ν (cm-1) = 1709; HRMS: m/z calcd for C16H26F2Na1O1 [M+Na]+: 295.1844; found: 295.1840.  
 
(3R)-9,9-Difluoro-3-methylcyclopentadecan-1-one (68). A solution of (3R)-10,10-difluoro-3-
methylcyclopentadec-6-en-1-one 88 (160 mg, 0.59 mmol, 1.0 eq) and palladium on activated carbon (10 
wt% on carbon, 63 mg, 10 mol%) in methanol (10 mL) was stirred under a hydrogen atmosphere (1 
atm) for 24 h. The reaction mixture was filtered through celite and the celite was washed with methanol 
(20 mL). The solvent was removed in vacuo to give compound 68 (66 mg, 41%) as a colourless oil that 






was used without further purification; [α]D +1.7° (c 0.63, CHCl3);  1H NMR (500 MHz, CDCl3) δ = 
0.97 (3H, d, J(H,H)= 6.7 Hz, CH3), 1.08-1.15 (1H, m, CHAHB-14), 1.22-1.44 (13H, CHAHB-14, CH2-
5,6,7,11,12,13), 1.56-1.93 (6H, m, CH2-8,10,14), 1.97-2.07 (1H, m, CH-3), 2.25-2.34 (2H, m, CH2-2), 
2.37-2.51 (2H, m, CH2-15); 13C NMR (125 MHz, CDCl3) δ = 20.7 (CH3), 21.5 (CH2, t, J(C,F)= 5.3 Hz, 
C11), 21.9 (CH2, t, J(C,F)= 5.5 Hz, C7), 22.2 (CH2, C14), 24.8 (CH2, C5), 27.1 (CH2, C12), 27.3 (CH2, 
C13), 27.4 (CH2, C6), 29.8 (CH, C3), 34.1 (CH2, t, J(C,F)= 25.7 Hz, C8/10), 34.3 (CH2, t, J(C,F)= 25.5 
Hz, C8/10), 34.7 (CH2, C4), 42.0 (CH2, C15), 51.4 (CH2, C2), 126.7 (CF2, t, J(C,F)= 240.4 Hz, C9), 
212.0 (CO, C1); 19F{1H} NMR (470 MHz, CDCl3) δ = -90.8 (1F, d, J(F,F)= 243.0 Hz, CFAFB), -91.5 
(1F, d, J(F,F)= 243.0 Hz, CFAFB); HRMS: m/z calcd for C16H28F2Na1O1 [M+Na]+: 297.2000; found: 
297.1997. 
 
12-(4-methoxybenzyloxy)dodec-1-en-4-ol (92). Allylmagnesium bromide (65.0mL, 1M solution in 
Et2O, 65.0 mmol, 1.5 equiv.) was added to a solution of 9-(4-methoxybenzyloxy)nonanal 91 (12.0 g, 
43.0 mmol, 1.0 equiv.) in dry THF (200 mL) at 0 ºC. The resulting mixture was stirred overnight at 
room temperature. Then, sat. aq. NH4Cl solution (115 mL) and EtOAc (58 mL) were sequentially added 
and the aqueous layer was extracted with EtOAc (3 x 115 mL). The combined organic extracts were 
dried over anhydrous Na2SO4 and the solvent was removed under reduced pressure. Purification by 
column chromatography using silica gel (pet. ether/EtOAc 10:1) gave compound 92 (6.0 g, 44%) as a 
colourless oil; 1H NMR (500 MHz, CDCl3) δ = 1.29-1.35 (12H, m, CH2), 1.43-1.60 (2H, m, CH2), 2.14 
(1H, br, OH), 3.43 (2H, t, J(H,H)= 5.9 Hz, CH2), 3.65-3.67 (1H, m, CH), 3.80 (3H, s, CH3), 4.43 (2H, s, 
CH2), 5.11-5.15 (2H, m, CH2), 5.79-5.89 (1H, m, J(H,H)= CH),  6.88 (2H, d, J(H,H)= 8.0 Hz, ArH), 
7.26 (2H, d, J(H,H)= 8.0 Hz, ArH); 13C NMR (125 MHz, CDCl3) δ = 25.7 (CH2), 26.3 (CH2), 29.5 
(CH2), 29.6 (CH2), 29.7 (CH2), 29.8 (CH2), 36.9 (CH2), 42.0 (CH2), 55.4 (CH3), 70.3 (CH2), 70.7 (CH), 
72.6 (CH2), 113.8 (CHAr), 118.1 (=CH2), 129.3 (CHAr), 130.9 (CAr), 135.0 (=CH), 159.1 (CAr); HRMS: 
m/z calcd for C20H32Na1O3 [M+Na]+: 343.2249; found: 343.2235. 
 
12-(4-methoxybenzyloxy)dodec-1-en-4-one (93). IBX (8.1 g, 29 mmol, 1.5 eq) was added to a 
solution of 12-(4-methoxybenzyloxy)dodec-1-en-4-ol 92 (6.0 g, 19.0 mmol, 1.0 eq) in DMSO (100 mL) 
at r.t. The reaction mixture was stirred at r.t. for 18 h. The reaction mixture was queched with water. 
The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4 and the solvent was removed in 
vacuo to give compound 93 (5.0 g, 83%) as a yellow oil, which was used without further purification; 
1H NMR (500 MHz, CDCl3) δ = 1.28-1.30 (8H, m, CH2), 1.57-1.61 (4H, m, CH2), 2.43 (2H, t, J(H,H)= 
6.6 Hz, CH2), 3.16 (2H, d, J(H,H)= 5.5 Hz, CH2), 3.44 (2H, t, J(H,H)= 6.6 Hz, CH2), 3.80 (3H, s, CH3), 
4.43 (2H, s, CH2), 5.12-5.19 (2H, m, =CH2), 5.90-5.94 (1H, m, =CH), 6.87-6.89 (2H, d, J(H,H)= 7.9 
Hz, ArH), 7.26-7.28 (2H, d, J(H,H)= 7.9 Hz, ArH); 13C NMR (125 MHz, CDCl3) δ = 23.7 (CH2), 26.2 
(CH2), 29.1 (CH2), 29.3 (CH2), 29.4 (CH2), 29.8 (CH2), 42.3 (CH2), 47.7 (CH2), 55.2 (CH3), 70.2 (CH2), 
72.5 (CH2), 113.7 (CHAr), 118.7 (=CH2), 129.2 (CHAr), 130.8 (CAr), 130.8 (=CH), 137.4 (CH), 159.1 
(CAr), 208.9 (C=O); HRMS: m/z calcd for C20H30Na1O3 [M+Na]+: 341.2093; found: 341.2079. 
 
1-((9,9-difluorododec-11-enyloxy)methyl)-4-methoxybenzene (94). A solution of 12-(4-
methoxybenzyloxy)dodec-1-en-4-one 93 (3.0 g, 9.4 mmol, 1.0 eq) in DAST (5.0 mL, 37.7 mmol, 4.0 
eq) was heated at 50 °C under argon for 18 h. The reaction mixture was cooled to r.t. and poured onto 
sat. NaHCO3 solution. The reaction mixture was extracted with DCM. The combined organic layers 
were washed with brine (250 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:10) gave compound 
94 (2.0 g, 63%) as a yellow oil; 1H NMR (500 MHz, CDCl3) δ = 1.32-1.50 (10H, m, CH2), 1.59-1.62 
(2H, m, CH2), 1.81-1.84 (2H, m, CH2), 2.58-2.66 (2H, m CH2), 3.46 (2H, t, J(H,H)= 6.3 Hz, CH2), 3.83 
(3H, s, CH3), 4.46 (2H, , s, CH2), 5.21-5.249 (2H, m, =CH2), 5.80-5.85 (1H, m, CH2), 6.91 (2H, t, 






J(H,H)= 8.5 Hz, ArH), 7.28 (2H, t, J(H,H)= 8.5 Hz, ArH); 13C NMR (125 MHz, CDCl3) δ = 14.2 
(CH2), 22.0 (CH2), 22.1 (CH2), 22.1 (CH2), 22.2 (CH2),22.3 (CH2), 22.3 (CH2), 29.8 (CH2), 35.9 (t, 
J(C,F)= 25.0 Hz, CH2), 41.1 (t, J(C,F)= 25.0 Hz, CH2), 55.3 (CH3), 70.2 (CH2), 72.5 (CH2), 113.7 
(CHAr), 120.0 (=CH2), 124.3 (t, J(C,F)= 249.3 Hz, CF2), 129.2 (CHAr), 129.9 (t, J(C,F)= 7.0 Hz, =CH), 
130.8 (CAr), 159.1 (CAr); 19F{1H} NMR (470 MHz, CDCl3) δ = -97.2 (2F, s, CF2); HRMS: m/z calcd for 
C20H30F2Na1O2 [M+Na]+: 363.2112; found: 363.2096. 
 
9,9-difluorododec-11-en-1-ol (95). DDQ (2.0 g, 8.9 mmol, 1.5 eq) was added to a solution of 1-((9,9-
difluorododec-11-enyloxy)methyl)-4-methoxybenzene 94 (2.0 g, 5.9 mmol, 1.0 eq) in DCM (80 mL) 
and water (0.5 mL) at r.t. and stirred for 1 h. The reaction mixture was quenched with sat. NaHCO3 
solution and extracted with ethyl acetate. The combined organic layers were washed with brine, dried 
over anhydrous Na2SO4 and the solvent was removed in vacuo. Purification by column chromatography 
using silica gel (ethyl acetate/pet. ether 1:10) gave compound 95 (0.9 g, 69%) as a colourless oil; 1H 
NMR (400 MHz, CDCl3) δ = 1.30-1.56 (12H, m, CH2), 1.72-1.80 (2H, m ,CH2), 2.53-2.62 (2H, m, 
CH2), 3.61 (2H, t, J(H,H)= 6.5 Hz, CH2), 2.60 (2H, dt, J(H,F)= 15.8, J(H,H)= 7.3 Hz, CH2), 3.66 (2H, t, 
J(H,H)= 6.5 Hz, CH2), 5.18-5.22 (2H, m, =CH2), 5.77-5.84 (1H, m, =CH); 13C NMR (100 MHz, 
CDCl3) δ = 22.0 (t, J(C,F)= 4.0 Hz, CH2), 25.7 (CH2), 29.2 (CH2), 29.3 (CH2), 29.3 (CH2), 32.7 (CH2), 
35.9 (t, J(C,F)= 24.4 Hz, CH2), 41.1 (t, J(C,F)= 24.4 Hz, CH2), 62.9 (CH2), 119.9 (CH2), 125.4 (t, 
J(C,F)= 241.3 Hz, CF2), 129.9 (t, J(C,F)= 5.7 Hz, CH); 19F{1H} NMR (377 MHz, CDCl3) δ = -97.2 
(2F, s, CF2); HRMS: m/z calcd for C12H22F2Na1O1 [M+Na]+: 243.1536; found: 243.1527. 
 
9,9-difluorododec-11-enal (96). IBX (588 mg, 2.1 mmol, 1.5 eq) was added to a solution of 9,9-
difluorododec-11-en-1-ol 95 (303 mg, 1.4 mmol, 1.0 eq) in DMSO (15 mL) at r.t. The reaction mixture 
was stirred at r.t. for 18 h. The reaction mixture was quenched with water. The organic layer was 
separated and the aqueous layer was extracted with ethyl acetate. The combined organic layers were 
washed with brine, dried over anhydrous Na2SO4 and the solvent was removed in vacuo to give 96 (240 
mg, 80%) as a colorless oil; 1H NMR (500 MHz, CDCl3) δ = 1.32-1.48 (8H, m, CH2), 1.60-1.64 (2H, m 
,CH2), 1.74-1.83 (2H, m, CH2),  2.43 (2H, t, J(H,H)= 7.1 Hz, CH2), 2.61 (2H, dt, J(H,F)= 16.0, J(H,H)= 
7.1 Hz, CH2), 5.18-5.21 (2H, m, =CH2), 5.76-5.83 (1H, m, =CH), 9.78 (1H, s, CHO); 13C NMR (100 
MHz, CDCl3) δ = 22.0 (CH2), 22.0 (CH2), 28.9 (CH2), 28.9 (CH2), 29.0 (CH2), 29.1 (CH2), 35.8 (t, 
J(C,F)= 24.5 Hz, CH2), 41.1 (t, J(C,F)= 24.5 Hz, CH2), 43.8 (CH2), 119.9 (=CH2), 124.2 (t, J(C,F)= 
232.4 Hz, CF2), 129.8 (t, J(C,F)= 6.4 Hz, =CH), 202.7 (CHO); 19F{1H} NMR (377 MHz, CDCl3) δ = -
97.3 (2F, s, CF2); HRMS: m/z calcd for C12H20F2Na1O1 [M+Na]+: 241.1380; found: 241.1371. 
 
(4R)-14,14-Difluoro-4-methylheptadeca-1,16-diene-6-ol (98). A solution of (R)-4-
(bromomethyl)pent-1-ene 97 (680 mg, 4.2 mmol, 4.0 eq) in dry THF (4 mL) was added to a mixture of 
magnesium turnings (101 mg, 4.2 mmol, 4.0 eq) and iodine (trace) under argon at r.t. and stirred until 
the reaction turned colourless. The reaction was heated at reflux for 4 h. The reaction mixture was 
cooled to r.t. and diluted with THF (4.0 mL), then a solution of 9,9-difluorododec-11-enal 96 (240 mg, 
1.1 mmol, 1.0 eq) in dry THF (4.0 mL) was added. The reaction mixture was stirred r.t. for 18 h. The 
reaction mixture was quenched with sat. ammonium chloride solution and extracted with ethyl acetate. 
The combined organic layers were washed with brine, dried over anhydrous Na2SO4 and the solvent 
was removed in vacuo. Purification by column chromatography using silica gel (ethyl acetate/pet. ether 
1:10) gave compound 98 (200 mg, 60%) as a colourless oil, as a 1:1 mixture of diastereoisomers; [α]D -
6.2° (c 0.6, CHCl3);  1H NMR (400 MHz, CDCl3) δ = 0.91 and 0.92 (3H, d, J(H,H)= 6.5 Hz, CH3), 
1.29-1.48 (14H, m, CH, CH2), 1.73-2.18 (4H, m, CH2), 2.61 (2H, dt, J(H,F)= 15.4, J(H,H)= 7.1 Hz, 
CH2), 2.22-2.27 (2H, m, CH2), 3.71 (1H, m, CH), 4.98-5.03 (2H, m, =CH2), 5.17-5.22 (2H, m, =CH2), 
5.76-5.80 (2H, m, =CH); 13C NMR (100 MHz, CDCl3) δ = 19.3 and 20.4 (CH3), 22.2 (t, J(C,F)= 4.5 Hz, 
CH2), 25.6 and 25.8 (CH2), 29.4 (CH2), 29.6 (CH2), 29.5 and 29.7 (CH), 38.5 (t, J(C,F)= 24.5 Hz, CH2), 






41.0 and 41.3 (CH2), 41.6 (CH2), 42.4(t, J(C,F)= 26.2 Hz, CH2), 44.6 (CH2), 44.7 (CH2), 69.8 and 70.1 
(CH), 116.0 and 116.7 (=CH2), 120.1 (=CH2), 124.4 (t, J(C,F)= 241.4 Hz, CF2), 130.0 (t, J(C,F)= 6.0 
Hz, =CH), 137.3 and 137.5 (=CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.2 (2F, s, CF2); HRMS: 
m/z calcd for C18H32F2Na1O1 [M+Na]+: 325.2319; found: 325.2306. 
 
(4R)-14,14-Difluoro-4-methylheptadeca-1,16-diene-6-one (99). IBX (280 mg, 0.99 mmol, 1.5 eq) 
was added to a solution of (4R)-14,14-Difluoro-4-methylheptadeca-1,16-diene-6-ol 98 (200 mg, 0.66 
mmol, 1.0 eq) in DMSO (8 mL) at r.t. The reaction mixture was stirred at r.t. for 18 h. The reaction 
mixture was queched with water. The organic layer was separated and the aqueous layer was extracted 
with ethyl acetate. The combined organic layers were washed with brine, dried over anhydrous Na2SO4 
and the solvent was removed in vacuo to give compound 99 (190 mg, 95%) as a colorless oil; [α]D 
+5.8° (c 0.4, CHCl3); 1H NMR (300 MHz, CDCl3) δ = 0.90 (3H, d, J(H,H)= 6.2 Hz, CH3), 1.25-1.33 
(10H, m, CH2), 1.52-2.22 (6H, m, CH2), 2.34-2.42 (2H, m, CH2), 2.57-2.60 (2H, dt, J(H,F)= 15.8, 
J(H,H)= 7.3 Hz, CH2), 4.97-5.22 (4H, m, CH2), 5.70-5.74 (2H, m, CH); 13C NMR (100 MHz, CDCl3) δ 
= 19.9 (CH3), 22.1 (t, J(C,F)= 4.0 Hz, CH2), 23.8 (CH2), 29.0 (CH), 29.2 (CH2), 29.3 (CH2), 36.0 (t, 
J(C,F)= 25.2 Hz, CH2), 36.2 (CH2), 41.3 (t, J(C,F)= 23.4 Hz, CH2), 41.3 (CH2), 49.5 (CH2), 116.5 
(=CH2), 120.1 (=CH2), 126.8 (t, J(C,F)= 242.7 Hz, CF2), 130.0 (t, J(C,F)= 6.0 Hz, =CH), 136.8 (=CH), 
211.1 (C=O); 19F{1H} NMR (377 MHz, CDCl3) δ = -97.2 (2F, s, CF2); HRMS: m/z calcd for 
C18H30F2Na1O1 [M+Na]+: 323.2162; found: 323.2148. 
 
(3R,5E)-8,8-Difluoro-3-methylcyclopentadec-5-en-1-one (100). Hoveyda-Grubbs catalyst (2nd 
generation, 7.6 mg, 0.012 mmol, 6 mol%) was added to a solution of (4R)-14,14-Difluoro-4-
methylheptadeca-1,16-diene-6-one 99 (60 mg, 0.2 mmol, 1.0 eq) in dry toluene (80 mL) in a foil 
covered flask at r.t. under argon. The reaction mixture was heated at 120 °C for 17 h, then cooled to r.t. 
and the solvent was removed in vacuo. Purification of the residue by column chromatography using 
silica gel (ehtyl acetate/pet.ether 1:25) to give compound (E)-100 (30 mg, 56%) as a colorless oil; [α]D 
+5.7° (c 0.35, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.95 (3H, d, J(H,H)= 6.1 Hz, CH3), 1.18-1.82 
(13H, m, CH2), 2.14-2.55 (8H, m, CH2), 5.36-5.52 (2H, m, =CH); 13C NMR (100 MHz, CDCl3) δ = 
19.7 (t, J(C,F)= 4.2 Hz, CH2), 19.8 (CH3), 24.6 (CH2), 26.0 (CH2), 26.6 (CH2), 27.0 (CH2), 27.9 (CH), 
34.4 (t, J(C,F)= 25.2 Hz, CH2), 39.7 (t, J(C,F)= 27.3 Hz, CH2), 39.7 (CH2), 42.1 (CH2), 48.7 (CH2), 
125.3 (t, J(C,F)= 242.1 Hz, CF2), 124.1 (=CH), 134.6 (=CH), 211.5 (C=O); 19F{1H} NMR (470 MHz, 
CDCl3) δ = -93.3 (1F, d, J(F,F)= 242.6 Hz, CFAFB), -94.3 (1F, d, J(F,F)= 242.6 Hz, CFAFB); HRMS: 
m/z calcd for C16H26F2Na1O1 [M+Na]+: 295.1849; found: 295.1832. 
 
(3R)-8,8-Difluoro-3-methylcyclopentadecan-1-one (69). A solution of (3R,5E)-8,8-difluoro-3-
methylcyclopentadec-5-en-1-one 100 (30 mg, 0.11 mmol, 1.0 eq) and palladium on activated carbon (5 
wt% on carbon, 23 mg, 10 mol%) in methanol (1 mL) was stirred under a hydrogen atmosphere (1 atm) 
for 22 h. The reaction mixture was filtered through celite and washed with methanol. The solvent was 
removed in vacuo to give compound 69 (28 mg, 93%) as a colourless oil that was used without further 
purification. [α]D -3.8° (c 0.8, CHCl3);  1H NMR (400 MHz, CDCl3) δ = 0.94 (3H, d, J(H,H)= 7.5 Hz, 
CH3), 1.25-1.42 (14H, m, CH2), 1.59-1.84 (6H, m, CH2), 2.17-2.47 (5H, m, CH, CH2); 13C NMR (100 
MHz, CDCl3) δ = 21.2 (t, J(C,F)= 5.6 Hz, CH2), 21.3 (CH3), 22.5 (t, J(C,F)= 4.8 Hz, CH2), 23.6 (CH2), 
25.7 (CH2), 26.6 (CH2), 26.9 (CH2), 27.4 (CH2), 28.3 (CH), 34.2 (t, J(C,F)= 25.5 Hz, CH2), 34.4 (t, 
J(C,F)= 24.0 Hz, CH2), 35.6 (CH2), 42.4 (CH2), 50.1 (CH2), 126.5 (t, J(C,F)= 240.4 Hz, CF2), 211.8 
(C=O); 19F{1H} NMR (377 MHz, CDCl3) δ = -91.4 (1F, d, J(F,F)= 241.1 Hz, CFAFB), -91.8 (1F, d, 
J(F,F)= 241.1 Hz, CFAFB);  HRMS: m/z calcd for C16H28F2Na1O1 [M+Na]+: 297.2006; found: 297.1991. 
 
(3R)-1-(((3,7-dimethyloct-6-en-1-yl)oxy)methyl)-4-methoxybenzene (102). A solution of α-
citronellol 101 (3.5 g, 22.2 mmol, 1.0 eq) in dry DMF (5 mL) was added to a suspension of sodium 






hydride (60 % in oil, 0.98 g, 24.4 mmol, 1.1 eq) in dry DMF (5 mL) at 0 ºC under argon and stirred for 
15 min. 4-Methoxybenzyl chloride (3.3 mL, 24.4 mmol, 1.1 eq) was added and the reaction mixture was 
stirred at 0 ºC for 1 h, then warmed to r.t. and stirred for 18 h. The reaction mixture was quenched with 
water (100 mL) and extracted with diethyl ether (2 x 100 mL). The combined organic layers were 
washed with brine (150 mL), dried over anhydrous Na2SO4 and the solvent removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:19) gave compound 
102 (5.0 g, 82%) as a colourless oil; [α]D +1.7° (c 1.10, CHCl3);  1H NMR (500 MHz, CDCl3) δ = 0.89 
(3H, d, J(H,H)= 6.6 Hz, CH3), 1.12-1.20 (1H, m, CHAHB), 1.31-1.38 (1H, m, CHAHB), 1.39-1.46 (1H, 
m, CHAHB), 1.56-1.63 (1H, m, CH), 1.61 (3H, s, CH3), 1.63-1.69 (1H, m, CHAHB), 1.69 (3H, s, CH3), 
1.91-2.05 (2H, m, CH2), 3.44-3.52 (2H, m, CH2), 3.82 (3H, s, CH3), 4.44 (2H, s, CH2), 5.09-5.12 (1H, 
m, CH), 6.87-6.90 (2H, m, ArH), 7.26-7.29 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 17.9 (CH3), 
19.8 (CH3), 25.7 (CH3), 25.9 (CH2), 29.8 (CH), 36.9 (CH2), 37.4 (CH2), 55.5 (CH3), 68.6 (CH2), 72.8 
(CH2), 113.9 (CH), 125.1 (CH), 129.4 (CH), 131.0 (C), 131.3 (C), 159.3 (C); HRMS: m/z calcd for 
C18H28Na1O2 [M+Na]+: 299.1982; found: 299.1982. 
 
(3R)-1-Methoxy-4-(((3-methylhept-6-en-1-yl)oxy)methyl)benzene (103). Ozone was bubbled through 
a solution of (3R)-1-(((3,7-dimethyloct-6-en-1-yl)oxy)methyl)-4-methoxybenzene 102 (3.3 g, 11.9 
mmol, 1.0 eq) in dry DCM (100 mL) at -78 ºC until the solution turned blue to indicate the presence of 
excess ozone. Oxygen was bubbled through the reaction mixture for a further ten minutes. 
Triphenylphosphine (3.4 g, 13.1 mmol, 1.1 eq) was added and the reaction mixture was stirred at -78 ºC 
for 1 h, then warmed to r.t. and left to stir for 18 h. The solvent was removed in vacuo and the residue 
was subjected to a quick purification by column chromatography using silica gel (ethyl acetate/pet. 
ether 1:9) to give the intermediate aldehyde as a colourless oil that was used without further 
purification.  
n-Butyllithium (2.5 M in hexanes, 12.8 mL, 32.1 mmol, 2.7 eq) was added to a suspension of 
methyltriphenylphosphonium bromide (12.8 g, 35.7 mmol, 3.0 eq) in dry THF (130 mL) at -78 ºC under 
argon and stirred for 30 min. A solution of the intermediate aldehyde in dry THF (20 mL) was added 
and the reaction mixture was stirred at -78 ºC for 4 h, then allowed to warm to r.t. and stirred for a 
further 16 h. The reaction mixture was quenched with sat. NH4Cl solution (250 mL) and extracted with 
diethyl ether (2 x 200 mL). The combined organic layers were washed with brine (250 mL), dried over 
anhydrous Na2SO4 and the solvent was removed in vacuo. Purification by column chromatography 
using silica gel (ethyl acetate/pet. ether 1:39) gave compound 103 (1.05 g, 36%) as a colourless oil; [α]D 
+1.3° (c 1.40, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.90 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.19-1.26 
(1H, m, CHAHB), 1.38-1.46 (2H, m, CHAHB, CHAHB), 1.58-1.70 (2H, m, CHAHB, CH), 1.99-2.14 (2H, 
m, CH2), 3.44-3.52 (2H, m, CH2), 3.81 (3H, s, CH3), 4.44 (2H, s, CH2), 4.92-5.03 (2H, m, CH2), 5.77-
5.85 (1H, m, CH), 6.87-6.90 (2H, m, ArH), 7.26-7.28 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 
19.7 (CH3), 29.6 (CH), 31.5 (CH2), 36.5 (CH2), 39.6 (CH2), 55.5 (CH3), 68.5 (CH2), 72.8 (CH2), 113.9 
(CH), 114.3 (CH2), 129.4 (CH), 131.0 (C), 139.4 (CH), 159.3 (C); HRMS: m/z calcd for C16H24Na1O2 
[M+Na]+: 271.1669; found: 271.1666. 
 
(5R)-7-((4-Methoxybenzyl)oxy)-5-methylheptan-1-ol (104). 9-BBN dimer (0.88 g, 3.6 mmol, 1.0 eq) 
was added to a solution of (3R)-1-methoxy-4-(((3-methylhept-6-en-1-yl)oxy)methyl)benzene 103 (0.9 
g, 3.6 mmol, 1.0 eq) in dry THF (20 mL) at r.t. under argon and stirred for 18 h. The reaction mixture 
was cooled to 0 ºC. Ethanol (2.4 mL) was added, followed by NaOH solution (2 N, 2.4 mL) and 
hydrogen peroxide (30%, 2.4 mL). The reaction mixture was warmed to r.t. and stirred for 4 h. The 
solvent was removed in vacuo. The residue was dissolved in ethyl acetate (100 mL) and washed with 
water (100 mL), brine (100 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:4) gave compound 
104 (0.95 g, 99%) as a colourless oil; [α]D +0.7° (c 0.73, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.88 
(3H, d, J(H,H)= 6.6 Hz, CH3), 1.10-1.21 (1H, m, CHAHB), 1.27-1.45 (5H, m, CHAHB, CHAHB, CH2, 






OH), 1.49-1.69 (4H, m, CHAHB, CH2, CH), 3.43-3.52 (2H, m, CH2), 3.63 (2H, t, J(H,H)= 6.6 Hz, CH2), 
3.81 (3H, s, CH3), 4.43 (2H, s, CH2), 6.87-6.90 (2H, m, ArH), 7.25-7.28 (2H, m, ArH); 13C NMR (125 
MHz, CDCl3) δ = 19.8 (CH3), 23.3 (CH2), 30.0 (CH), 33.2 (CH2), 36.9 (CH2), 37.0 (CH2), 55.5 (CH3), 
63.2 (CH2), 72.7 (CH2), 113.9 (CH), 129.4 (CH), 130.9 (C), 159.3 (C); HRMS: m/z calcd for 
C16H26Na1O3 [M+Na]+: 289.1774; found: 289.1767. 
 
(5R)-7-((4-Methoxybenzyl)oxy)-5-methylheptanal (105). Using the same procedure as for 77, (5R)-7-
((4-methoxybenzyl)oxy)-5-methylheptan-1-ol 104 (1.6 g, 6.0 mmol, 1.0 eq) gave compound 105 (1.59 
g) as a yellow oil; 1H NMR (500 MHz, CDCl3) δ = 0.89 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.12-1.22 (1H, 
m, CHAHB), 1.29-1.46 (2H, m, CHAHB, CHAHB), 1.54-1.74 (4H, m, CHAHB, CH2, CH), 2.39-2.43 (2H, 
m, CH2), 3.43-3.52 (2H, m, CH2), 3.81 (3H, s, CH3), 4.43 (2H, s, CH2), 6.87-6.90 (2H, m, ArH), 7.25-
7.28 (2H, m, ArH), 9.76 (1H, t, J(H,H)= 1.9 Hz, CHO); 13C NMR (125 MHz, CDCl3) δ = 19.6 (CH3), 
19.7 (CH2), 29.9 (C), 36.7 (CH2), 36.8 (CH2), 44.3 (CH2), 55.5 (CH3), 68.4 (CH2), 72.8 (CH2), 114.0 
(CH), 129.4 (CH), 130.9 (C), 159.3 (C), 203.0 (CO).  
 
(9R)-11-((4-Methoxybenzyl)oxy)-9-methylundec-1-en-5-ol (106). Iodine (trace) was added to a 
suspension of magnesium turnings (0.34 g, 13.8 mmol, 4.0 eq) in dry diethyl ether (10 mL) under argon 
at r.t. and stirred until the reaction turned colourless. A solution of 4-bromo-1-butene (1.4 mL, 13.8 
mmol, 4.0 eq) in dry diethyl ether (10 mL) was added at a rate sufficient to maintain autoreflux and 
stirred for 30 min after addition was complete. The reaction mixture was diluted with diethyl ether (50 
mL), then cooled to 0 °C and a solution of 6-((4-methoxyphenyl)methoxy)hexanal 105 (0.93 g, 3.5 
mmol, 1.0 eq) in dry diethyl ether (10 mL) was added. The reaction mixture was stirred at 0 °C for 1 h, 
then warmed to r.t. and stirred for 18 h. The reaction mixture was quenched with sat. ammonium 
chloride solution (100 mL) and extracted with diethyl ether (2 x 100 mL). The combined organic layers 
were washed with brine (150 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:9) gave compound 
106 (0.72 g, 65%) as a colourless oil, as a 1:1 mixture of diastereoisomers; [α]D +2.2° (c 0.78, CHCl3); 
1H NMR (500 MHz, CDCl3) δ = 0.88 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.10-1.19 (1H, m, CHAHB), 1.25-
1.68 (11H, m, CHAHB, CH2, CH), 2.10-2.25 (2H, m, CH2), 3.43-3.51 (2H, m, CH2), 3.58-3.65 (1H, bm, 
CH), 3.81 (3H, s, CH3), 4.43 (2H, m, CH2), 4.97-5.08 (2H, m, CH2), 5.81-5.89 (1H, m, CH), 6.87-6.90 
(2H, m, ArH), 7.26-7.29 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 19.8 and 19.8 (CH3), 23.1 and 
23.2 (CH2), 30.0 (CH), 30.3 and 30.3 (CH2), 36.7 and 36.7 (CH2), 36.9 and 36.9 (CH2), 37.2 and 37.3 
(CH2), 37.9 and 37.9 (CH2), 55.5 (CH3), 68.5 and 68.5 (CH2), 71.6 and 71.7 (CH), 72.7 (CH2), 113.9 
(CH), 114.9 (CH2), 129.4 (CH), 130.9 (C), 138.9 (CH), 159.3 (C); HRMS: m/z calcd for C20H32Na1O3 
[M+Na]+: 343.2244; found: 343.2234. 
 
(9R)-11-((4-Methoxybenzyl)oxy)-9-methylundec-1-en-5-one (107). Using the same procedure as for 
77, (9R)-11-((4-methoxybenzyl)oxy)-9-methylundec-1-en-5-ol 106 (0.70 g, 2.2 mmol, 1.0 eq) gave 
compound 107 (0.70 g) as a yellow oil; [α]D +1.9° (c 0.57, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 
0.88 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.08-1.15 (1H, m, CHAHB), 1.25-1.32 (1H, m, CHAHB), 1.37-1.44 
(1H, m, CHAHB), 1.49-1.67 (4H, m, CHAHB, CH2, CH), 2.30-2.40 (4H, m, CH2), 2.50 (2H, t, J(H,H)= 
7.1 Hz, CH2), 3.43-3.502 (2H, m, CH2), 3.81 (3H, s, CH3), 4.43 (2H, s, CH2), 4.97-5.05 (2H, m, CH2), 
5.77-5.85 (1H, m, CH), 6.87-6.90 (2H, m, ArH), 7.25-7.27 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) 
δ = 19.7 (CH3), 24.4 (CH2), 28.0 (CH2), 29.9 (CH), 36.7 (CH2), 36.8 (CH2), 42.0 (CH2), 43.3 (CH2), 
55.5 (CH3), 68.4 (CH2), 72.8 (CH2), 113.9 (CH), 115.4 (CH2), 129.4 (CH), 130.9 (C), 137.4 (CH), 159.3 
(C), 210.6 (CO); HRMS: m/z calcd for C20H30Na1O3 [M+Na]+: 341.2087; found: 341.2078. 
 
(3R)-1-(((7,7-Difluoro-3-methylundec-10-en-1-yl)oxy)methyl)-4-methoxybenzene (108). Using the 
same procedure as for 78, (9R)-11-((4-methoxybenzyl)oxy)-9-methylundec-1-en-5-one (0.70 g, 2.2 






mmol, 1.0 eq) 107 gave compound 108 (0.52 g, 70%) as a colourless oil; [α]D +2.1° (c 0.92, CHCl3); 1H 
NMR (500 MHz, CDCl3) δ = 0.89 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.13-1.21 (1H, m, CHAHB), 1.30-1.37 
(1H, m, CHAHB), 1.39-1.68 (5H, m, CH2, CH), 1.74-1.96 (4H, m, CH2), 2.22-2.26 (2H, m, CH2), 3.44-
3.52 (2H, m, CH2), 3.81 (3H, s, CH3), 4.44 (2H, s, CH2), 5.00-5.09 (2H, m, CH2), 5.79-5.87 (1H, m, 
CH), 6.87-6.90 (2H, m, ArH), 7.26-7.28 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 19.7 (CH3), 
19.9 (CH2, t, J(C,F)= 4.4 Hz), 26.7 (CH2, t, J(C,F)= 5.0 Hz), 29.9 (CH), 35.8 (CH2, t, J(C,F)= 25.7 Hz), 
36.9 (CH2), 36.9 (CH2, t, J(C,F)= 25.4 Hz), 55.5 (CH3), 68.4 (CH2), 72.8 (CH2), 113.9 (CH), 115.4 
(CH2), 125.2 (CF2, t, J(C,F)= 240.5 Hz), 129.4 (CH), 130.9 (C), 137.3 (CH), 159.3 (C); 19F{1H} NMR 
(470 MHz, CDCl3) δ = -98.2 (2F, s, CF2); HRMS: m/z calcd for C20H30F2Na1O2 [M+Na]+: 363.2106; 
found: 363.2097. 
 
(3R)-7,7-Difluoro-3-methylundec-10-en-1-ol (109). Using the same procedure as for 79, (3R)-1-(((7,7-
difluoro-3-methylundec-10-en-1-yl)oxy)methyl)-4-methoxybenzene 108 (0.50 g, 1.5 mmol, 1.0 eq) 
gave compound 110 (0.25 g, 74%) as a colourless oil; [α]D +1.5° (c 0.55, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ = 0.92 (3H, d, J(H,H)= 6.7 Hz, CH3), 1.16-1.23 (1H, m, CHAHB), 1.31 (1H, bs, OH), 1.32-
1.65 (6H, m, CHAHB, CH2, CH), 1.76-1.97 (4H, m, CH2), 2.22-2.27 (2H, m, CH2), 3.65-3.74 (2H, m, 
CH2), 4.99-5.09 (2H, m, CH2), 5.79-5.87 (1H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.6 (CH3), 
19.9 (t, J(C,F)= 4.6 Hz, CH2), 26.7 (t, J(C,F)= 5.1 Hz, CH2), 29.5 (CH), 35.8 (t, J(C,F)= 25.6 Hz, CH2), 
36.9 (t, J(C,F)= 25.4 Hz, CH2), 37.0 (CH2), 40.0 (CH2), 61.3 (CH2), 115.4 (CH2), 125.1 (t, J(C,F)= 
240.8 Hz, CF2), 137.3 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.25 (1F, s, CF2), -98.26 (1F, s, 
CF2); HRMS: m/z calcd for C12H22F2Na1O1 [M+Na]+: 243.1531; found: 243.1526. 
 
(3R)-7,7-Difluoro-3-methylundec-10-en-1-al (110). Using the same procedure as for 77, (3R)-7,7-
difluoro-3-methylundec-10-en-1-ol 109 (0.22 g, 1.0 mmol, 1.0 eq) gave compound 110 (233 g, 97%) as 
a yellow oil; [α]D +2.2° (c 0.65, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.99 (3H, d, J(H,H)= 6.6 Hz, 
CH3), 1.22-1.31 (1H, m, CHAHB), 1.34-1.59 (3H, m, CHAHB, CH2), 1.73-1.99 (4H, m, CH2), 2.04-2.14 
(1H, m, CH), 2.21-2.30 (3H, m, CHAHB, CH2), 2.42 (1H, ddd, J(H,H)= 16.4, 5.9, 1.9 Hz, CHAHB), 
5.00-5.09 (2H, m, CH2), 5.79-5.87 (1H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.9 (t, J(C,F)= 4.5 
Hz, CH2), 20.0 (CH3), 26.7 (t, J(C,F)= 5.0 Hz, CH2), 28.1 (CH), 35.9 (t, J(C,F)= 25.6 Hz, CH2), 36.7 
(CH2), 36.7 (t, J(C,F)= 25.9 Hz, CH2), 51.2 (CH2), 115.5 (CH2), 125.0 (t, J(C,F)= 240.5 Hz, CF2), 137.2 
(CH), 202.9 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.53 (1F, s, CF2), -98.54 (1F, s, CF2); 19F 
NMR (470 MHz, CDCl3) δ = -98.4-(-98.6) (2F, m, CF2). 
 
(9R)-13,13-Difluoro-9-methylheptadeca-1,16-diene-7-ol (111). Iodine (trace) was added to a 
suspension of magnesium turnings (0.17 mg, 6.8 mmol, 5.0 eq) in dry diethyl ether (5 mL) under argon 
at r.t. and stirred until the reaction turned colourless. A solution of 6-bromo-1-hexene (0.9 mL, 4.8 
mmol, 5.0 eq) in dry diethyl ether (5 mL) was added and the reaction was heated at reflux for 30 min. 
The reaction mixture was cooled to r.t. and diluted with diethyl ether (20 mL), then cooled to 0 °C and a 
solution of (3R)-7,7-difluoro-3-methylundec-10-en-1-al 110 (0.31 g, 1.4 mmol, 1.0 eq) in dry diethyl 
ether (10 mL) was added. The reaction mixture was stirred at 0 °C for 30 min, then warmed to r.t. and 
stirred for 18 h. The reaction mixture was quenched with sat. ammonium chloride solution (100 mL) 
and extracted with ethyl acetate (2 x 100 mL). The combined organic layers were washed with brine 
(200 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. Purification by column 
chromatography using silica gel (ethyl acetate/pet. ether 1:9) gave compound 111 (0.30 g, 72%) as a 
colourless oil, as a 1:1 mixture of diastereoisomers; [α]D -2.7° (c 1.02, CHCl3);  1H NMR (500 MHz, 
CDCl3) δ = 0.92 and 0.93 (3H, d, J(H,H)= 6.2 Hz, CH3), 1.10-1.71 (14H, m, CH, CH2, OH), 1.76-1.97 
(4H, m, CH2), 2.06-2.09 (2H, m, CH2), 2.22-2.27 (2H, m, CH2), 3.66-3.73 (1H, m, CH), 4.94-5.09 (4H, 
m, CH2), 5.78-5.87 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.3 and 20.4 (CH3), 19.8 (t, 
J(C,F)= 4.6 Hz, CH2) and 19.9 (t, J(C,F)= 4.5 Hz, CH2), 20.4 (CH2), 25.2 and 25.4 (CH2), 26.7 (t, 






J(C,F)= 4.9 Hz, CH2), 29.1 (CH2),  29.3 and 29.6 (CH), 34.0 (CH2), 35.8 (t, J(C,F)= 24.9 Hz, CH2), 
36.4 and 37.9 (CH2), 36.9 (t, J(C,F)= 25.2 Hz, CH2) and 36.9 (t, J(C,F)= 25.5 Hz, CH2), 37.8 and 38.5 
(CH2), 45.0 and 45.3 (CH2), 69.7 and 70.0 (CH), 114.6 (CH2), 115.4 (CH2), 125.1 (CF2, t, J(C,F)= 
240.8 Hz), 137.3 (CH), 139.1 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.2 (2F, s, CF2), -98.2 (1F, 
s, CF2), -98.3 (1F, s, CF2); HRMS: m/z calcd for C18H32F2Na1O1 [M+Na]+: 325.2313; found: 325.2304. 
 
(9R)-13,13-Difluoro-9-methylheptadeca-1,16-diene-7-one (112). Using the same procedure as for 77, 
(9R)-13,13-difluoro-9-methylheptadeca-1,16-diene-7-ol 111 (0.28 g, 0.9 mmol, 1.0 eq) gave compound 
112 (0.27 g, 99%) as a yellow oil; [α]D +2.9° (c 0.76, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.90 
(3H, d, J(H,H)= 6.6 Hz, CH3), 1.16-1.62 (8H, m, CH2), 1.74-1.96 (4H, m, CH2), 1.99-2.10 (3H, m, CH2, 
CH), 2.21-2.26 (3H, m, CH2, CHAHB), 2.35-2.40 (3H, m, CH2, CHAHB), 4.94-5.09 (4H, m, CH2), 5.76-
5.87 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.9 (CH3), 19.9 (CH2), 23.4 (CH2), 26.7 (CH2, t, 
J(C,F)= 4.8 Hz), 28.7 (CH2), 29.1 (CH), 33.7 (CH2), 35.9 (CH2, t, J(C,F)= 25.5 Hz), 36.7 (CH2), 36.7 
(CH2, t, J(C,F)= 25.3 Hz), 43.5 (CH2), 50.3 (CH2), 114.9 (CH2), 115.4 (CH2), 125.0 (CF2, t, J(C,F)= 
240.5 Hz), 137.3 (CH), 138.7 (CH), 211.1 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.2 (1F, d, 
J(F,F)= 239.6 Hz, CFAFB), -98.7 (1F, d, J(F,F)= 239.6 Hz, CFAFB); HRMS: m/z calcd for 
C18H30F2Na1O1 [M+Na]+: 323.2157; found: 323.2152. 
 
(14R)-10,10-Difluoro-14-methylcyclopentadec-6-en-1-one (113). Grubbs catalyst (1st generation, 50 
mg, 0.06 mmol, 7 mol%) was added to a solution of (9R)-13,13-difluoro-9-methylheptadeca-1,16-
diene-7-one 112 (0.25 g, 0.83 mmol, 1.0 eq) in dry DCM (200 mL) in a foil covered flask at r.t. under 
argon. The reaction mixture was heated at 45 °C for 46 h, then cooled to r.t. and the solvent was 
removed in vacuo. Purification of the residue by column chromatography using silica gel (ethyl 
acetate/pet. ether 1:49) gave compound (Z)-113 (40 mg, 17%) as a pale brown solid and compound (E)-
113 as a pale brown solid. (Z)-113. [α]D -6.5° (c 0.57, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.97 
(3H, d, J(H,H)= 6.9 Hz, CH3), 1.21-1.47 (6H, m, CH2), 1.51-1.58 (1H, m, CHAHB), 1.70-1.96 (6H, m, 
CH, CH2, CHAHB), 2.00-2.25 (5H, m, CH2, CHAHB), 2.35-2.41 (1H, m, CHAHB), 2.45-2.52 (2H, m, 
CHAHB, CHAHB),  5.35-5.46 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 20.8 (CH2, t, J(C,F)= 5.3 
Hz), 21.5 (CH2, t, J(C,F)= 6.2 Hz), 22.0 (CH3), 23.4 (CH2), 26.4 (CH2), 28.5 (CH2), 28.7 (CH), 35.3 
(CH2, t, J(C,F)= 25.6 Hz), 35.6 (CH2, t, J(C,F)= 25.5 Hz), 36.7 (CH2), 42.6 (CH2), 49.6 (CH2), 125.8 
(CF2, t, J(C,F)= 240.4 Hz), 128.7 (CH), 130.4 (CH), 211.2 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = 
-91.1 (1F, d, J(F,F)= 243.1 Hz, CFAFB), -93.3 (1F, d, J(F,F)= 243.1 Hz, CFAFB); IR (thin film) ν (cm-1) 
= 1702 (C=O); HRMS: m/z calcd for C16H26F2Na1O1 [M+Na]+: 295.1844; found: 295.1841. (E)-113; 1H 
NMR (500 MHz, CDCl3) δ = 0.97 (3H, d, J(H,H)= 6.8 Hz, CH3), 1.23-1.30 (4H, m, CH2), 1.37-1.56 
(4H, m, CH2),1.57-1.64 (4H, m, CH2), 1.68-2.10 (7H, m, CH2, CH), 2.16 (1H, dd, J(H,H)= 14.1, 5.4 
Hz, CHAHB), 2.21-2.25 (2H, m, CH2), 2.28-2.33 (1H, m, CHAHB), 2.39-2.46 (2H, m, CHAHB, CHAHB),  
5.38-5.46 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 18.6 (CH2, t, J(C,F)= 4.8 Hz), 20.7 (CH3), 
23.9 (CH2), 26.5 (CH2, t, J(C,F)= 5.1 Hz), 28.3 (CH2), 29.2 (CH), 31.4 (CH2), 35.0 (CH2), 35.5 (CH2, t, 
J(C,F)= 25.9 Hz), 36.0 (CH2, t, J(C,F)= 25.3 Hz), 42.5 (CH2), 50.0 (CH2), 125.8 (CF2, t, J(C,F)= 240.6 
Hz), 130.4 (CH), 131.7 (CH), 212.6 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -91.3 (1F, d, J(F,F)= 
241.9 Hz, CFAFB), -94.2 (1F, d, J(F,F)= 241.9 Hz, CFAFB); IR (thin film) ν (cm-1) = 1707 (C=O). 
 
(3R)-7,7-Difluoro-3-methylcyclopentadecan-1-one (70). A solution of (14R)-10,10-difluoro-14-
methylcyclopentadec-6-en-1-one 113 (110 mg, 0.40 mmol, 1.0 eq) and palladium on activated carbon 
(10 wt% on carbon, 43 mg, 10 mol%) in methanol (10 mL) was stirred under a hydrogen atmosphere (1 
atm) for 22 h. The reaction mixture was filtered through celite and the celite was washed with methanol 
(20 mL). The solvent was removed in vacuo to give compound 70 (65 mg, 72%) as a colourless oil that 
was used without further purification; [α]D -11.9° (c 0.70, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 
0.97 (3H, d, J(H,H)= 6.8 Hz, CH3), 1.23-1.43 (14H, CH2-4,5,9,10,11,12,13), 1.54-1.60 (1H, m, CHAHB-






14), 1.70-1.94 (5H, m, CH2-6,8, CHAHB-14), 2.07-2.14 (1H, m, CH-3), 2.26 (1H, dd, J(H,H)= 16.8, 4.7 
Hz, CHAHB-2), 2.36-2.48 (3H, m, CHAHB-2, CH2-15); 13C NMR (125 MHz, CDCl3) δ = 20.8 (CH2, t, 
J(C,F)= 5.6 Hz, C5/9), 20.9 (CH2, t, J(C,F)= 5.4 Hz, C5/9), 21.8 (CH3), 23.2 (CH2, C14), 26.2 (CH2, 
C5), 26.4 (CH2, C11/12), 27.0 (CH2, C11/12), 27.8 (CH2, C13), 28.3 (CH, C3), 34.2 (CH2, t, J(C,F)= 
25.6 Hz, C6/8), 35.2 (CH2, t, J(C,F)= 25.8 Hz, C6/8), 36.2 (CH2, C4), 40.1 (CH2, C15), 50.0 (CH2, C2), 
126.5 (CF2, t, J(C,F)= 239.7 Hz, C7), 211.3 (CO, C1); 19F{1H} NMR (470 MHz, CDCl3) δ = -90.4 (1F, 
d, J(F,F)= 243.0 Hz, CFAFB), -91.5 (1F, d, J(F,F)= 243.0 Hz, CFAFB); HRMS: m/z calcd for 
C16H28F2Na1O1 [M+Na]+: 297.2000; found: 297.1997. 
 
(8R)-10-((4-Methoxybenzyl)oxy)-8-methyldec-1-en-5-ol (114). Ozone was bubbled through a solution 
of (3R)-1-(((3,6-dimethylhept-5-en-1-yl)oxy)methyl)-4-methoxybenzene 102 (1.73 g, 6.3 mmol, 1.0 eq) 
in dry DCM (100 mL) at -78 °C until a pale blue colour appeared (approx. 15 min). Oxygen was 
bubbled through the reaction until the blue colour disappeared. Triphenylphosphine (1.8 g, 6.9 mmol, 
1.1 eq) was added and the reaction was stirred at -78 °C for 1 h, then warmed to r.t. and stirred for 18 h. 
The solvent was removed in vacuo. Pentane (150 mL) was added to the residue, causing the 
precipitation of a white solid. The solid was filtered, the filtrate collected and the solvent removed in 
vacuo to give the intermediate aldehyde as a colourless oil that was used in the next step without 
purification. 
Iodine (trace) was added to a suspension of magnesium turnings (0.54 g, 22.4 mmol, 4.0 eq) in dry 
diethyl ether (20 mL) under argon at r.t. and stirred until the reaction turned colourless. A solution of 4-
bromo-1-butene (2.3 mL, 22.4 mmol, 4.0 eq) in dry diethyl ether (20 mL) was added at a rate sufficient 
to maintain autoreflux and stirred for 30 min after addition was complete. The reaction mixture was 
diluted with diethyl ether (60 mL), then cooled to 0 °C and a solution of the aldehyde prepared above 
(1.4 g, 5.6 mmol, 1.0 eq) in dry diethyl ether (20 mL) was added. The reaction mixture was stirred at 0 
°C for 1 h, then warmed to r.t. and stirred for 18 h. The reaction mixture was quenched with sat. 
ammonium chloride solution (150 mL) and extracted with diethyl ether (200 mL). The combined 
organic layers were washed with brine (150 mL), dried over anhydrous Na2SO4 and the solvent was 
removed in vacuo. Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:9) 
gave compound 114 (0.99 g, 58%) as a colourless oil, as a 1:1 mixture of diastereoisomers; [α]D +1.9° 
(c 0.70, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.89 (3H, d, J(H,H)= 6.6 Hz, CH3) and 0.89 (3H, d, 
J(H,H)= 6.6 Hz, CH3), 1.11-1.69 (10H, m, CH2, CH, OH), 2.10-2.25 (2H, m, CH2), 3.44-3.52 (2H, m , 
CH2), 3.55-3.62 (1H, m, CH), 3.81 (3H, s, CH3), 4.44 (2H, s, CH2), 4.97-5.08 (2H, m, CH2), 5.81-5.89 
(1H, m, CH), 6.87-6.90 (2H, m, ArH), 7.25-7.28 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 19.8 
and 19.9 (CH3), 30.0 and 30.2 (CH), 30.3 and 30.3 (CH2), 32.9 and 33.0 (CH2), 34.9 and 35.0 (CH2), 
36.6 and 36.7 (CH2), 55.5 (CH3), 68.4 and 68.5 (CH2), 71.9 and 72.0 (CH), 72.8 (CH2), 113.9 (CH), 
115.0 (CH2), 129.5 (CH), 130.9 (C), 138.9 (CH), 159.3 (C); HRMS: m/z calcd for C19H30Na1O3 
[M+Na]+: 329.2087; found: 329.2086. 
 
(8R)-10-((4-Methoxybenzyl)oxy)-8-methyldec-1-en-5-one (115). Using the same procedure as for 77, 
(8R)-10-((4-methoxybenzyl)oxy)-8-methyldec-1-en-5-ol 114 (0.94 g, 3.1 mmol, 1.0 eq) gave compound 
115 (0.89 g, 96%) as a yellow oil that was used without further purification; [α]D +3.0° (c 0.70, CHCl3);  
1H NMR (500 MHz, CDCl3) δ = 0.88 (3H, d, J(H,H)= 6.5 Hz, CH3), 1.39-1.46 (2H, m, CHAHB x 2), 
1.54-1.67 (3H, m, CHAHB x 2, CH), 2.30-2.35 (2H, m, CH2), 2.36-2.47 (2H, m, CH2), 2.50 (2H, t, 
J(H,H)= 7.2 Hz, CH2), 3.44-3.51 (2H, m, CH2), 3.81 (3H, s, CH3), 4.41 (1H, d, J(H,H)= 11.6 Hz, 
CHAHB), 4.44 (1H, d, J(H,H)= 11.6 Hz, CHAHB), 4.96-5.05 (2H, m, CH2), 5.76-5.84 (1H, m, CH), 6.87-
6.89 (2H, m, ArH), 7.24-7.27 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 19.6 (CH3), 28.0 (CH2), 
29.8 (CH), 30.8 (CH2), 36.7 (CH2), 40.7 (CH2), 42.0 (CH2), 55.5 (CH3), 68.3 (CH2), 72.8 (CH2), 113.9 
(CH), 115.4 (CH2), 129.4 (CH), 130.8 (C), 137.4 (CH), 159.3 (C), 210.7 (CO); HRMS: m/z calcd for 
C19H28Na1O3 [M+Na]+: 327.1931; found: 327.1932. 







(3R)-1-(((6,6-Difluoro-3-methyldec-9-en-1-yl)oxy)methyl)-4-methoxybenzene (116). Using the same 
procedure as for 78, (8R)-10-((4-methoxybenzyl)oxy)-8-methyldec-1-en-5-one 115 (0.94 g, 3.1 mmol, 
1.0 eq) gave compound 116 (0.59 g, 64%) as a yellow oil; [α]D +1.5° (c 0.54, CHCl3); 1H NMR (500 
MHz, CDCl3) δ = 0.90 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.21-1.97 (9H, m, CH, CH2), 2.21-2.26 (2H, m, 
CH2), 3.44-3.53 (2H, m, CH2), 3.81 (3H, s, CH3), 4.44 (2H, m, CH2), 4.99-5.09 (2H, m, CH2), 5.78-5.88 
(1H, m, CH), 6.87-6.91 (2H, m, ArH), 7.25-7.28 (2H, m, ArH); 13C NMR (125 MHz, CDCl3) δ = 19.6 
(CH3), 26.7 (CH2, t, J(C,F)= 5.1 Hz), 29.4 (CH2, t, J(C,F)= 4.1 Hz), 29.8 (CH), 34.2 (CH2, t, J(C,F)= 
25.3 Hz), 35.8 (CH2, t, J(C,F)= 25.6 Hz), 36.7 (CH2), 55.5 (CH3), 68.2 (CH2), 72.8 (CH2), 114.0 (CH), 
115.4 (CH2), 125.3 (CF2, t, J(C,F)= 240.8 Hz), 129.4 (CH), 130.8 (C), 137.3 (CH), 159.3 (C); 19F{1H} 
NMR (470 MHz, CDCl3) δ = -98.7 (2F, s, CF2); HRMS: m/z calcd for C19H28F2Na1O2 [M+Na]+: 
349.1950; found: 349.1941. 
 
(3R)-6,6-Difluoro-3-methyldec-9-en-1-ol (117). Using the same procedure as for 79, (3R)-1-(((6,6-
difluoro-3-methyldec-9-en-1-yl)oxy)methyl)-4-methoxybenzene 116 (0.53 g, 1.6 mmol, 1.0 eq) gave 
compound 117 (0.29 g, 88%) as a colourless oil; [α]D +0.4° (c 0.58, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ = 0.93 (3H, d, J(H,H)= 6.6 Hz, CH3), 1.22 (1H, bs, OH), 1.29-1.67 (5H, m, CH2, CH), 1.76-
1.98 (4H, m, CH2), 2.22-2.27 (2H, m, CH2), 3.65-3.76 (2H, m, CH2), 4.99-5.10 (2H, m, CH2), 5.78-5.8 
(1H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.6 (CH3), 26.7 (CH2, t, J(C,F)= 5.1 Hz), 29.4 (CH2, t, 
J(C,F)= 4.5 Hz), 29.4 (CH), 34.1 (CH2, t, J(C,F)= 25.1 Hz), 35.8 (CH2, t, J(C,F)= 25.8 Hz), 39.7 (CH2), 
115.4 (CH2), 125.3 (CF2, t, J(C,F)= 241.2 Hz), 137.3 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.8 
(2F, s, CF2); HRMS: m/z calcd for C11H20F2Na1O1 [M+Na]+: 229.1374; found: 229.1370. 
 
(10R)-13,13-Difluoro-10-methylheptadec-1,16-dien-8-ol (118). DMP (0.80 g, 1.9 mmol, 1.5 eq) was 
added to a solution of (3R)-6,6-difluoro-3-methyldec-9-en-1-ol 117 (0.26 g, 1.3 mmol, 1.0 eq) in DCM 
(20 mL) at r.t. and stirred for 1 h. The reaction mixture was diluted with diethyl ether (20 mL) and sat. 
NaHCO3 solution (20 mL). Sodium thiosulfate (1.6 g) was added and the reaction mixture was stirred 
vigorously for 30 min. The organic layer was separated and the aqueous layer was re-extracted with 
diethyl ether (30 mL). The combined organic layers were washed with brine (50 mL), dried over 
anhydrous Na2SO4 and the solvent was removed in vacuo to give the intermediate aldehyde  as a yellow 
oil that was used without further purification. 
Iodine (trace) was added to a suspension of magnesium turnings (0.13 g, 5.2 mmol, 4.0 eq) in dry 
diethyl ether (5 mL) under argon at r.t. and stirred until the reaction turned colourless. A solution of 7-
bromo-1-heptene (0.8 mL, 5.2 mmol, 4.0 eq) in dry diethyl ether (5 mL) was added and the reaction 
mixture was heated at reflux for 1 h. The reaction mixture was cooled to r.t. and diluted with diethyl 
ether (10 mL), then cooled to 0 °C and a solution of the aldehyde prepared above (0.26 g, 1.3 mmol, 1.0 
eq) in dry diethyl ether (10 mL) was added. The reaction mixture was stirred at 0 °C for 1 h, then 
warmed to r.t. and stirred for 3 h. The reaction mixture was quenched with sat. ammonium chloride 
solution (50 mL) and extracted with diethyl ether (2 x 50 mL). The combined organic layers were 
washed with brine (100 mL), dried over anhydrous Na2SO4 and the solvent was removed in vacuo. 
Purification by column chromatography using silica gel (ethyl acetate/pet. ether 1:9) gave compound 
118 (0.23 g, 60%) as a colourless oil, as a ~1.0:1.4 mixture of diastereoisomers; [α]D -3.8° (c 0.29, 
CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.93 (3H, d, J(H,H)= 6.6 Hz, CH3) and 0.94 (3H, d, J(H,H)= 
6.6 Hz, CH3), 1.18-1.51 (12H, m, CH2), 1.58-1.98 (5H, m, CH2, CH), 2.04-2.08 (2H, m, CH2), 2.22-
2.27 (2H, m, CH2), 3.65-3.74 (1H, bm, CH), 4.93-5.09 (4H, m, CH2), 5.78-5.87 (2H, m, CH); 13C NMR 
(125 MHz, CDCl3) δ = 19.2 and 20.4 (CH3), 26.8 (CH2, t, J(C,F)= 4.9 Hz), 28.7 (CH2, t, J(C,F)= 4.4 
Hz) and 30.2 (CH2, t, J(C,F)= 4.1 Hz), 29.3 and 29.3 (CH2), 29.4 and 29.5 (CH), 33.8-34.4 (CH2, m), 
33.9 (CH2), 35.8 (CH2, t, J(C,F)= 25.6 Hz) and 35.8 (CH2, t, J(C,F)= 25.4 Hz), 38.1 (CH2), 38.6 (CH2), 
44.8 and 45.0 (CH2), 69.7 and 67.0 (CH), 114.5 (CH2), 115.4 (CH2), 125.3 (CF2, t, J(C,F)= 240.9 Hz) 






and 125.3 (CF2, t, J(C,F)= 240.5 Hz), 137.3 (CH), 139.3 (CH); 19F{1H} NMR (470 MHz, CDCl3) δ = -
98.2 (1F, d, J(F,F)= 13.7 Hz, CFAFB), -98.3 (1F, d, J(F,F)= 13.7 Hz, CFAFB), -98.3 (2F, s); HRMS: m/z 
calcd for C18H32F2Na1O1 [M+Na]+: 325.2313; found: 325.2308. 
 
(10R)-13,13-Difluoro-10-methylheptadec-1,16-dien-8-one (119). Using the same procedure as for 77, 
(10R)-13,13-difluoro-10-methylheptadec-1,16-dien-8-ol 118 (0.2 g, 0.66 mmol, 1.0 eq) gave compound 
119 (0.2 g) as a yellow oil; [α]D +1.7° (c 041, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 0.91 (3H, d, 
J(H,H)= 6.6 Hz, CH3), 1.23-1.61 (8H, m, CH2, CH), 1.72-1.97 (4H, m, CH2), 2.00-2.07 (2H, m, CH2, 
CH), 2.21-2.29 (2H, m, CH2, CHAHB), 2.36-2.40 (2H, m, CH2, CHAHB), 4.83-5.09 (4H, m, CH2), 5.76-
5.86 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 19.8 (CH3), 26.7 (CH2, t, J(C,F)= 5.1 Hz), 28.9 
(CH), 28.9 (CH2), 28.9 (CH2), 29.3 (CH2, t, J(C,F)= 4.1 Hz), 33.8 (CH2), 34.2 (CH2, t, J(C,F)= 25.4 
Hz), 35.8 (CH2, t, J(C,F)= 25.7 Hz), 43.6 (CH2), 50.1 (CH2), 114.6 (CH2), 115.5 (CH2), 125.1 (CF2, t, 
J(C,F)= 240.3 Hz), 137.2 (CH), 139.1 (CH), 210.8 (CO); 19F{1H} NMR (470 MHz, CDCl3) δ = -98.4 
(2F, s, CF2); HRMS: m/z calcd for C18H30F2Na1O1 [M+Na]+: 323.2157; found: 323.2147. 
 
(14R)-11,11-Difluoro-14-methylcyclopentadec-7-en-1-one (120). Grubbs catalyst (1st generation, 30 
mg, 0.04 mmol, 6 mol%) was added to a solution of (10R)-13,13-difluoro-10-methylheptadec-1,16-
dien-8-one 119 (0.18 g, 0.60 mmol, 1.0 eq) in dry DCM (250 mL) in a foil covered flask at r.t. under 
argon. The reaction mixture was heated at 45 °C for 17 h, then cooled to r.t. and the solvent was 
removed in vacuo. Purification of the residue by column chromatography using silica gel (ethyl 
acetate/pet. ether 1:49) gave compound 120 (82 mg, 50%) as a brown oil, as a E:Z ~3:2 inseparable 
mixture of isomers; [α]D -12.2° (c 0.78, CHCl3);  1H NMR (500 MHz, CDCl3) δ = 1.00 (3H, d, J(H,H)= 
6.8 Hz, CH3 (E)), 1.01 (3H, d, J(H,H)= 6.8 Hz, CH3 (Z)), 1.11-1.48 (6H, m, CH2), 1.56-2.55 (15H, m, 
CH2, CH), 5.31-5.44 (2H, m, CH); 13C NMR (125 MHz, CDCl3) δ = 20.7 (CH3, Z), 21.2 (CH2, t, 
J(C,F)= 6.0 Hz, Z), 21.5 (CH3, E), 22.8 (CH2, Z), 24.2 (CH2, E), 26.6 (CH2, t, J(C,F)= 6.2 Hz, E), 27.2 
(CH2, Z), 27.8 (CH2, E), 28.2 (CH2, E), 28.3 (CH2, t, J(C,F)= 4.2 Hz, E), 28.4 (CH, E), 28.6 (CH2, Z), 
28.7 (CH2, Z), 29.3 (CH2, t, J(C,F)= 25.5 Hz, E), 30.3 (CH, Z), 31.7 (CH2, E), 32.9 (CH2, t, J(C,F)= 
25.7 Hz, Z), 33.8 (CH2, t, J(C,F)= 25.5 Hz, E), 35.6 (CH2, t, J(C,F)= 25.6 Hz, Z), 35.7 (CH2, t, J(C,F)= 
25.7 Hz, E), 42.1 (CH2, E), 42.8 (CH2, Z), 50.7 (CH2, E), 51.2 (CH2, Z), 125.7 (CF2, t, J(C,F)= 241.0 
Hz, E), 125.8 (CF2, t, J(C,F)= 241.0 Hz, Z), 128.7 (CH, Z), 130.2 (CH, E), 130.5 (CH, Z), 132.0 (CH, 
E), 211.7 (CO, E), 211.9 (CO, Z); 19F{1H} NMR (470 MHz, CDCl3) δ = -92.4 (1F, d, J(F,F)= 241.3 Hz, 
CFAFB, (E)), -92.4 (1F, d, J(F,F)= 243.3 Hz, CFAFB, (Z)), -93.0 (1F, d, J(F,F)= 243.3 Hz, CFAFB, (Z)), -
94.0 (1F, d, J(F,F)= 241.3 Hz, CFAFB, (E)); HRMS: m/z calcd for C16H26F2Na1O1 [M+Na]+: 295.1844; 
found: 295.1832. 
 
(3R)-6,6-Difluoro-3-methylcyclopentadecan-1-one (71). Using the same procedure as for 77, (14R)-
11,11-difluoro-14-methylcyclopentadec-7-en-1-one 120 (60 mg, 0.22 mmol, 1.0 eq) gave compound 71 
(39.4 mg, 65%) as a colourless oil; [α]D -2.2° (c 0.51, CHCl3); 1H NMR (500 MHz, CDCl3) δ = 1.00 
(3H, d, J(H,H)= 6.9 Hz, CH3), 1.23-1.41 (14H, CH2-4,8,9,10,11,12,13), 1.55-1.61 (1H, m, CHAHB-14), 
1.70-1.93 (5H, m, CH2-5,7, CHAHB-14), 2.06-2.12 (1H, m, CH-3), 2.30 (1H, dd, J(H,H)= 15.3, 3.8 Hz, 
CHAHB-2), 2.37 (1H, dd, J(H,H)= 15.2, 9.7 Hz, CHAHB-2), 2.44 (2H, t, J(H,H)= 6.6 Hz, CH2-15); 13C 
NMR (125 MHz, CDCl3) δ = 20.7 (CH3), 21.4 (CH2, t, J(C,F)= 5.5 Hz, C8), 22.0 (CH2, C4), 26.4 (CH2 
x 2), 26.7 (CH2), 27.0 (CH2, C13), 27.9 (CH2, C9), 29.5 (CH, C3), 29.5 (CH2, C13), 29.5 (CH2, t, 
J(C,F)= 6.0 Hz, C4), 32.8 (CH2, t, J(C,F)= 26.0 Hz, C5), 34.7 (CH2, t, J(C,F)= 25.3 Hz, C7), 42.3 (CH2, 
C15), 50.6 (CH2, C2), 126.4 (CF2, t, J(C,F)= 239.5 Hz, C6), 211.4 (CO, C1); 19F{1H} NMR (470 MHz, 
CDCl3) δ = -91.1 (1F, d, J(F,F)= 242.8 Hz, CFAFB), -92.1 (1F, d, J(F,F)= 242.8 Hz, CFAFB); HRMS: 
m/z calcd for C16H28F2Na1O1 [M+Na]+: 297.2000; found: 297.1988. 
  








A selection of relevant synthetic samples of civetone and muscone was assessed by an expert Perfumer 
(Dominique Lelièvre) at Givaudan company (Switzerland). A 10% solution in ethanol was prepared for 






1 (E/Z 3:1) 
 
Musky, ketonic, powdery, 
hot iron facet 




Musky, ketonic, powdery, 
waxy facet 




Very weak, musky, green 
off-note Very weak, musky 
14 
 
Very weak, musky, slightly 
fatty 
Very weak, musky, a hint 
green, powdery  
15 
 
Very weak, musky, green 
bell pepper off-note 




Very weak, musky, slightly 
oily Very weak, musky  
17 
 
Musky, anisic, powdery, 
waxy Weak, musky, slightly waxy 






18 (E/Z 3:1) 
 
Musky, slightly powdery, 
waxy 




Musky, slightly green, 
powdery 
Weak, musky, powdery, 






Weak, waxy, lactonic, 
slightly metallic, rosey Weak 
20 
 
Weak, honey, floral, polish, 
wax effect Weak 
21 
 
Weak, slight solvent      off-
note Weak, hint off green 
2 
 
Musky, slightly powdery, 
waxy 
Weak, musky, slightly 
powdery, waxy 
66 (E/Z 2:1) 
 
Musky, waxy, hot iron, 
metallic, rosy, Rosalva like 
Weak, a hint of musky, 
powdery, slightly animalic 
(E)-84 
 
Musky, slightly waxy, 
powdery 
Weak, musky, slightly 
powdery, waxy, slightly 
green, parsley leaf 
(Z)-84 
 
Green, waxy, candle wax Weak, slightly waxy 








Weak, musky Weak  
58 
 
Weak, powdery, anisic, 
green floral facet 
Weak, hint of musk, 
powdery, slightly fatty 
69 
 
Musky, powdery, Exaltone 
aspect, slightly fatty, waxy, 
green 
Musky, powdery, Exaltone 
aspect, slightly fatty, 
100 (E/Z 9:1) 
 
Musky, powdery, Exaltone 
aspect, waxy 




Weak, slightly green, hot 
iron off-note Weak  
71 
 
Musky, waxy, slightly green, 
muscone direction Weak, musky, waxy, green 
 
Relative volatility study of selected civetone derivatives 
 
The relative volatility of the fluorinated civetone analogues was analysed by GC-MS. Samples of 
compounds X-X (~1 mg) were dissolved in 400 µL of chloroform and 1 µL was injected into a 
programmable temperature vaporising (PTV) injector on the GC operating at a split of 160:1. The GC 
column used was a relatively non-polar Agilent Technologies J&W DB5-MS (15m x 0.25mm x 
0.25mm) using helium as carrier gas at a constant flow of 1.5 mL/min. The GC temperature programme 
was 100° for 2.1 minutes, increasing at 25°/min up to 320° with a further 3.5 min isothermal at 320°. 
The injector temperature was 132° on injection and after 1 minute the injector temperature increased at 
14.5°/sec to 320°  (sample transfer phase). After 1 minute at 320° the temperature increased at 14.5°/sec 
to 400° and was held at this temperature for a further 2 minutes (injector cleaning phase) before cooling 
to prepare for the next sample injection. The ion source and GC-MS transfer line temperatures were 
200° and 250° respectively and 70 eV EI mass spectra were acquired at 6 scans/sec using the Xcalibur 
software programme (v. 2.0.7). 







The mass spectra of all of the fluorinated compounds showed molecular ions and M-20, M-20-20 ions 
for loss of one and two molecules of HF. The spectra of civetone and dihydrocivetone also match with 
their entries in our mass spectral databases. 
  
All of the samples gave a single sharp peak, or two for the E/Z diastereoisomers, for the expected 
compound. The variability in retention time is < 0.005 minutes (0.30 seconds), based on repeat analysis 
of several samples.  On the type of GC column used elution order should be based primarily on 
volatility and molecular mass. The observed retention time are listed below (see table).  
 
According to this data, the relative volatility order for the selected compounds is: 
 
11  >  (E)-1  >  16  >  (E)-18  ≈  (Z)-1  >  14  >  (Z)-18  >  19  ≈  21  >  13  ≈  15 
 
Although the volatility of all civetone derivatives is quite similar, there are some subtle differences 
depending on the exact location and number of fluorine atoms and double bonds. Thus, fluorinated 
compounds are less volatile than their non-fluorinated counterparts. Also in most cases the unsaturated 
compounds elute later than the saturated equivalents, which suggests additional interaction between the 
column stationary phase and the double bonds. In particular, the trans-derivatives are more volatile than 
the corresponding cis-compounds. On the other hand, saturated 1,4-di-CF2 derivatives seem to be more 















time (min) ΔRt (tn−t1) (s) ΔRt (tn−tn-1) (s) 
1st 11 
 
252 6.855  −  −  
2nd (E)-1 
 
250 6.861  0.36  0.36  
3rd 16 
 
324 6.882  1.62 1.26  
4th (E)-18 
 
286 6.889  2.04  0.42  








250 6.893  2.28  0.24  
6th 14 
 
324 6.907  3.12  0.84  
7th (Z)-18 
 
286 6.954  5.94  2.82  
8th 19 
 
288 6.961  6.36  0.42  
9th 21 
 
324 6.966  6.66  0.30  
10th 13 
 
322 7.008  9.18  2.52  
11th 15 
 
322 7.011  9.36  0.18  
 
